<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000014.pub3" GROUP_ID="PREG" ID="664599081020063932" MERGED_FROM="" MODIFIED="2014-01-20 13:52:23 +0000" MODIFIED_BY="Leanne Jones" REVIEW_NO="0051" REVMAN_SUB_VERSION="5.2.7 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2014-01-20 13:52:23 +0000" MODIFIED_BY="Leanne Jones">
<TITLE>Amnioinfusion for meconium-stained liquor in labour</TITLE>
<CONTACT MODIFIED="2014-01-20 13:52:23 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-01-20 13:52:23 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON><PERSON ID="6011036E82E26AA2014E8936A667687F" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Hairong</FIRST_NAME><LAST_NAME>Xu</LAST_NAME><POSITION>PhD Student</POSITION><EMAIL_1>hairongxx@yahoo.ca</EMAIL_1><ADDRESS><DEPARTMENT>Département d'Obstétrique-Gynécologie</DEPARTMENT><ORGANISATION>Université de Montréal</ORGANISATION><ADDRESS_1>Hôpital Sainte-Justine, Bureau 4974</ADDRESS_1><ADDRESS_2>3175 Chemin de la côte Sainte-Catherine</ADDRESS_2><CITY>Montréal</CITY><ZIP>H3T 1C5</ZIP><REGION>Province of Quebec</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>514 3454931</PHONE_1><FAX_1>+1 514 3452195</FAX_1></ADDRESS></PERSON><PERSON ID="3A175D1E82E26AA20164DA257C2077F8" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ahizechukwu</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Eke</LAST_NAME><EMAIL_1>ahizeeke2nd@yahoo.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>Michigan State University School of Medicine/Sparrow Hospital</ORGANISATION><ADDRESS_1>1322 East Michigan Avenue</ADDRESS_1><ADDRESS_2>Suite 220</ADDRESS_2><CITY>Lansing</CITY><ZIP>48912</ZIP><REGION>Michigan</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-01-07 11:35:45 +0000" MODIFIED_BY="Frances Kellie">
<UP_TO_DATE>
<DATE DAY="1" MONTH="12" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="12" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="12" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1995"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1995"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2014-01-14 17:10:16 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-01-07 11:36:43 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="12" YEAR="2013"/>
<DESCRIPTION>
<P>Conclusions not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-01-14 17:10:16 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="12" YEAR="2013"/>
<DESCRIPTION>
<P>Search updated. One new trial included (<LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>) and two new trials excluded (<LINK REF="STD-Gupta-2011" TYPE="STUDY">Gupta 2011</LINK>; <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>). In addition, two studies previously in <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (<LINK REF="STD-Engel-2008" TYPE="STUDY">Engel 2008</LINK>; <LINK REF="STD-Mukhopadhyay-2006" TYPE="STUDY">Mukhopadhyay 2006</LINK>) have now been excluded. Methods updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-10-31 11:31:20 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-10-31 11:31:20 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="7" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details edited.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-04-30 05:37:24 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Four new trials included (<LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>; <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK>; <LINK REF="STD-Rathore-2002" TYPE="STUDY">Rathore 2002</LINK>; <LINK REF="STD-Sood-2004" TYPE="STUDY">Sood 2004</LINK>); two new trials added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (Engel 2008a; Mukhopadhyay 2006a); two previously included trials have now been excluded (<LINK REF="STD-Adam-1989" TYPE="STUDY">Adam 1989</LINK>; <LINK REF="STD-Ilagan-1992" TYPE="STUDY">Ilagan 1992</LINK>) and the previously excluded <LINK REF="REF-Alvarez-1999" TYPE="REFERENCE">Alvarez 1999</LINK> is now included as another report of <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK> (confirmed by correspondence with Dr Puertas). Four new trials have been excluded (<LINK REF="STD-Ashfaq-2004" TYPE="STUDY">Ashfaq 2004</LINK>; <LINK REF="STD-Das-2007" TYPE="STUDY">Das 2007</LINK>; <LINK REF="STD-Gonzalez-2002" TYPE="STUDY">Gonzalez 2002</LINK>; <LINK REF="STD-Khosla-1997" TYPE="STUDY">Khosla 1997</LINK>). <LINK REF="STD-Adam-1989" TYPE="STUDY">Adam 1989</LINK>, previously included, is now excluded. We have added two additional outcomes post hoc and updated <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> references.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2010-07-02 10:27:33 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="3" YEAR="2009"/>
<DESCRIPTION>
<P>Amnioinfusion is not beneficial for babies releasing medium to heavy meconium during labour, except in settings with limited facilities to monitor the baby's condition during labour. </P>
<P>A new author helped to update this review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-03-14 16:57:25 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Review withdrawn from publication.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-03-14 16:56:08 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-06-16 11:59:39 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="5" MONTH="10" YEAR="2001"/>
<DESCRIPTION>
<P>Five studies have been assessed of which two have been included (<LINK REF="REF-Alvarez-1999" TYPE="REFERENCE">Alvarez 1999</LINK>; <LINK REF="STD-Moodley-1998" TYPE="STUDY">Moodley 1998</LINK>) in this version of the review. Inclusion of these studies has not changed the substantive findings of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of the Witwatersrand</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>South African Medical Research Council</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-11-10 02:31:43 +0000" MODIFIED_BY="Sonja L  Henderson">
<TITLE MODIFIED="2009-03-14 16:43:07 +0000" MODIFIED_BY="[Empty name]">Amnioinfusion for meconium-stained liquor in labour</TITLE>
<SUMMARY_BODY MODIFIED="2013-11-10 02:31:43 +0000" MODIFIED_BY="Sonja L  Henderson">
<P>Amnioinfusion is not beneficial for babies releasing medium to heavy meconium during labour, except in settings with limited facilities to monitor the baby's condition during labour.</P>
<P>A bowel movement (meconium) from the unborn baby during labour can enter the baby's lungs, causing breathing difficulties after birth. Extra liquid can be injected through the woman's vagina or abdomen into the womb (amnioinfusion) to provide more liquid to dilute the meconium and surround the baby. The review of 14 trials (4435 women) found that amnioinfusion with a salt (saline) solution is beneficial for babies only in settings in which babies are at high risk due to limited monitoring facilities. Further research into the effects on women is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-01-13 16:55:59 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-11-03 22:25:01 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion is thought to dilute meconium present in the amniotic fluid and so reduce the risk of meconium aspiration.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effects of amnioinfusion for meconium-stained liquor on perinatal outcome.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-01-07 11:36:00 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (1 December 2013).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-01-13 11:44:48 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised trials comparing amnioinfusion with no amnioinfusion for women in labour with moderate or thick meconium staining of the amniotic fluid.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-01-13 16:55:44 +0000" MODIFIED_BY="[Empty name]">
<P>Three review authors independently assessed eligibility and trial quality, and extracted data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-01-13 16:55:59 +0000" MODIFIED_BY="[Empty name]">
<P>Fourteen studies of variable quality (4435 women) are included.</P>
<P>Subgroup analysis was performed for studies from settings with limited facilities to monitor the baby's condition during labour and intervene effectively, and settings with standard peripartum surveillance.</P>
<P>Settings with standard peripartum surveillance: there was considerable heterogeneity for several outcomes. There was no significant reduction in the primary outcomes meconium aspiration syndrome, perinatal death or severe morbidity, and maternal death or severe morbidity. There was a reduction in caesarean sections (CSs) for fetal distress but not overall. Meconium below the vocal cords diagnosed by laryngoscopy was reduced, as was neonatal ventilation or neonatal intensive care unit admission, but there was no significant reduction in perinatal deaths or other morbidity. Planned sensitivity analysis excluding trials with greater risk of bias resulted in an absence of benefits for any of the outcomes studied.</P>
<P>Settings with limited peripartum surveillance: three studies were included. In the amnioinfusion group there was a reduction in CS for fetal distress and overall; meconium aspiration syndrome (three studies, 1144 women; risk ratio (RR) 0.17, 95% confidence interval (CI) 0.05 to 0.52); perinatal mortality (three studies, 1151 women; RR 0.24, 95% CI 0.11 to 0.53) and neonatal ventilation or neonatal intensive care unit admission. In one of the studies, meconium below the vocal cords was reduced and, in the other, neonatal encephalopathy was reduced.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-11-03 22:35:06 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion is associated with substantive improvements in perinatal outcome only in settings where facilities for perinatal surveillance are limited. It is not clear whether the benefits are due to dilution of meconium or relief of oligohydramnios.</P>
<P>In settings with standard peripartum surveillance, some non-substantive outcomes were improved in the initial analysis, but sensitivity analysis excluding trials with greater risk of bias eliminated these differences. Amnioinfusion is either ineffective in this setting, or its effects are masked by other strategies to optimise neonatal outcome.</P>
<P>The trials reviewed are too small to address the possibility of rare but serious maternal adverse effects of amnioinfusion.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="Sonja L  Henderson">
<BACKGROUND MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion has been used to improve neonatal outcomes in cases complicated by meconium aspiration (<LINK REF="STD-Sadovsky-1989" TYPE="STUDY">Sadovsky 1989</LINK>; <LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK>). Meconium aspiration may occur before birth, or during the birth process, and is associated with significant mortality. Airways suctioning of the neonate has been suggested to reduce, but does not eliminate, the occurrence of meconium aspiration (<LINK REF="REF-Davis-1985" TYPE="REFERENCE">Davis 1985</LINK>). Strategies have therefore, been sought to reduce fetal meconium aspiration before birth.</P>
<P>The presence of thick meconium staining of the amniotic fluid is an indication of oligohydramnios, as meconium passed into a normal volume of amniotic fluid will usually appear thin. Amnioinfusion may thus at the same time dilute the meconium and correct oligohydramnios, relieving umbilical cord compression. It is difficult to distinguish effects of amnioinfusion due to these two mechanisms.</P>
<P>Readers are referred to other reviews of the subject (<LINK REF="REF-Gelfand-2004" TYPE="REFERENCE">Gelfand 2004</LINK>; <LINK REF="REF-Gramellini-2003" TYPE="REFERENCE">Gramellini 2003</LINK>; <LINK REF="REF-Hofmeyr-1996" TYPE="REFERENCE">Hofmeyr 1996</LINK>; <LINK REF="REF-Hofmeyr-2000" TYPE="REFERENCE">Hofmeyr 2000</LINK>; <LINK REF="REF-Lameier-1993" TYPE="REFERENCE">Lameier 1993</LINK>; <LINK REF="REF-Pierce-2000" TYPE="REFERENCE">Pierce 2000</LINK>; <LINK REF="REF-Velaphi-2006" TYPE="REFERENCE">Velaphi 2006</LINK>; <LINK REF="REF-Xu-2007" TYPE="REFERENCE">Xu 2007</LINK>), and to related Cochrane reviews (<LINK REF="REF-Hofmeyr-2012" TYPE="REFERENCE">Hofmeyr 2012</LINK>; <LINK REF="REF-Novikova-2012" TYPE="REFERENCE">Novikova 2012</LINK>).</P>
<CONDITION MODIFIED="2014-01-13 16:56:55 +0000" MODIFIED_BY="[Empty name]">
<P>Meconium aspiration refers to fetal aspiration of meconium-stained amniotic fluid (MSAF) during the antepartum or intrapartum period.  Meconium aspiration syndrome (MAS) refers to newborn respiratory distress secondary to the presence of meconium in the tracheobronchial airways. Passage of fetal meconium before birth occurs in 8% to 20% of pregnancies (<LINK REF="REF-Nathan-1994" TYPE="REFERENCE">Nathan 1994</LINK>; <LINK REF="REF-Woods-1994" TYPE="REFERENCE">Woods 1994</LINK>). It occurs mainly in term and post-term pregnancies. It may be associated with fetal compromise, but is also common in uncompromised labours. Possible causes that have been proposed include fetal hypoxia, a normal physiological function of the mature gastro-intestinal tract, vagally-mediated peristalsis in response to cord compression, and a direct effect on the fetal gastro-intestinal tract of maternal medication such as misoprostol (<LINK REF="REF-Hofmeyr-2003" TYPE="REFERENCE">Hofmeyr 2003</LINK>), castor oil and certain herbal remedies (<LINK REF="REF-Mitri-1987" TYPE="REFERENCE">Mitri 1987</LINK>). Thick, but not thin meconium staining of the amniotic fluid is associated with poor perinatal outcome (<LINK REF="REF-Mahomed-1994" TYPE="REFERENCE">Mahomed 1994</LINK>; <LINK REF="REF-Ziadeh-2000" TYPE="REFERENCE">Ziadeh 2000</LINK>). The association between severe meconium aspiration syndrome and aspiration of meconium has been challenged (<LINK REF="REF-Ghidini-2001" TYPE="REFERENCE">Ghidini 2001</LINK>).</P>
<P>Amnioinfusion has been described as a method of preventing or relieving umbilical cord compression during labour (<LINK REF="REF-Miyazaki-1983" TYPE="REFERENCE">Miyazaki 1983</LINK>), eliciting fetal heart rate accelerations during labour (<LINK REF="REF-Wax-2004" TYPE="REFERENCE">Wax 2004</LINK>), or of diluting meconium in the amniotic fluid to try to reduce the risk of meconium aspiration. Saline or Ringer's lactate is infused transcervically through a catheter into the uterine cavity, or transabdominally through a 'spinal' needle when membranes are intact. Amnioinfusion has also been used transabdominally for antepartum indications (<LINK REF="REF-Gramellini-2003b" TYPE="REFERENCE">Gramellini 2003b</LINK>) and to facilitate external cephalic version at term (<LINK REF="REF-Benifla-1995" TYPE="REFERENCE">Benifla 1995</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-01-17 11:01:33 +0000" MODIFIED_BY="[Empty name]">
<P>The technique for amnioinfusion has been clearly described (<LINK REF="REF-Weismiller-1998" TYPE="REFERENCE">Weismiller 1998</LINK>). Saline or Ringer's lactate is usually infused through a purpose-designed intrauterine pressure catheter using an infusion pump. However, studies from low-income countries where such catheters are unaffordable have demonstrated that amnioinfusion can be successfully achieved using inexpensive infant feeding tubes or suction catheters, and gravity infusion (<LINK REF="REF-Abdel_x002d_Aleem-2005" TYPE="REFERENCE">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Ashfaq-2004" TYPE="STUDY">Ashfaq 2004</LINK>; <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>; <LINK REF="STD-Moodley-1998" TYPE="STUDY">Moodley 1998</LINK>). A study in which women with meconium-stained amniotic fluid were randomly allocated to receive amnioinfusion with saline or lactated Ringer's solution found no effect on neonatal plasma concentrations or pH, compared with a non-randomised normal control group (<LINK REF="STD-Gonzalez-2002" TYPE="STUDY">Gonzalez 2002</LINK>). While randomised trials have not found increased risks associated with amnioinfusion, isolated case reports have documented complications following amnioinfusion (<LINK REF="REF-Dorairajan-2005" TYPE="REFERENCE">Dorairajan 2005</LINK>). It is difficult to know whether there was a causal relationship in such reports. Amnioinfusion in women with previous caesarean section has not been found to carry risks of uterine rupture, though larger studies are needed (<LINK REF="REF-Hicks-2005" TYPE="REFERENCE">Hicks 2005</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2013-12-03 09:59:47 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion has been used to improve neonatal outcomes in cases complicated by meconium aspiration (<LINK REF="STD-Sadovsky-1989" TYPE="STUDY">Sadovsky 1989</LINK>; <LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK>). Amnioinfusion has also proven effective for reducing overall complication rates in meconium aspiration syndrome. The success of amnioinfusion for prevention of meconium aspiration syndrome may be secondary to a dilutional effect. The amnioinfusion dilutes the meconium thereby reducing complications following meconium aspiration. Other investigators have shown a significant reduction in meconium concentration when amnioinfusion is used (<LINK REF="STD-Ashfaq-2004" TYPE="STUDY">Ashfaq 2004</LINK>; <LINK REF="REF-Weismiller-1998" TYPE="REFERENCE">Weismiller 1998</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-01-13 16:57:12 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion has been shown to be beneficial in reducing the complications following meconium-stained amniotic fluid in several randomised clinical trials. However, there has been no systematic review to address this topic, hence this review.</P>
<P>In several perinatal interventions, differences in effectiveness have been reported in studies conducted in low-income compared with high-income settings. Possible explanations include less stringent methodology in under-resourced settings; or the fact that in well-resourced settings outcomes are close to optimal, leaving little scope for further improvement with additional interventions. The latter concept has been discussed recently with respect to the potential benefits of early pregnancy ultrasound (<LINK REF="REF-Hofmeyr-2009" TYPE="REFERENCE">Hofmeyr 2009</LINK>). For this reason we have undertaken subgroup analyses for settings with limited and with standard peripartum surveillance.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effects of amnioinfusion for meconium-stained liquor in labour on maternal and perinatal morbidity and mortality.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-01-20 12:26:54 +0000" MODIFIED_BY="Sonja L  Henderson">
<SELECTION_CRITERIA MODIFIED="2014-01-13 16:57:49 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-01-13 16:57:49 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials comparing the effect of amnioinfusion for meconium-stained liquor on clinically meaningful outcomes, with a control group (no or sham amnioinfusion).  Quasi-randomised (alternate allocation) were considered eligible, but cross-over and cluster-randomised trials were not considered.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-01-13 11:45:22 +0000" MODIFIED_BY="Heather Maxwell">
<P>Women in labour with moderate or thick meconium staining of the amniotic fluid.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-05-26 20:09:05 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion (the infusion of physiological saline or lactated Ringer's solution into the amniotic cavity) compared with no or sham amnioinfusion.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-01-13 11:52:23 +0000" MODIFIED_BY="[Empty name]">
<P>Method of delivery, neonatal outcome and maternal complications. Two additional composite outcomes were added post hoc to accommodate data from <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>: perinatal death or severe morbidity; and maternal death or severe morbidity.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-01-13 11:51:40 +0000" MODIFIED_BY="[Empty name]">
<P>1. Meconium aspiration syndrome<BR/>2. Perinatal death or serious morbidity (post hoc)<BR/>3. Maternal death or serious morbidity (post hoc)</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-01-13 11:52:23 +0000" MODIFIED_BY="[Empty name]">
<P>4. Heavy meconium staining of amniotic fluid<BR/>5. Variable fetal heart rate decelerations<BR/>6. Caesarean section for fetal distress<BR/>7. Caesarean section overall<BR/>8. One-minute Apgar score less than four<BR/>9. One-minute Apgar score less than seven<BR/>10. Five-minute Apgar score less than seven<BR/>11. Umbilical arterial blood pH less than 7.20<BR/>12. Meconium below the vocal cords<BR/>13. Neonatal ventilation/neonatal intensive care unit admission<BR/>14. Neonatal encephalopathy<BR/>15. Perinatal death<BR/>16. Puerperal pyrexia (as defined by trial authors)<BR/>17. Puerperal endometritis<BR/>18. Oxytocin augmentation of labour<BR/>19. Narcotic analgesia<BR/>20. Epidural analgesia<BR/>21. First stage of labour (minutes)<BR/>22. Instrumental vaginal delivery for fetal distress<BR/>23. Instrumental vaginal delivery overall<BR/>24. Second stage of labour (minutes)<BR/>25. Respiratory distress syndrome (post hoc)<BR/>26. Mean maternal hospital stay (post hoc)</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-01-07 11:36:11 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2014-01-07 11:36:11 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (1 December 2013). </P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from: </P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of Embase;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.  </P>
<P>We did not apply any language restrictions. </P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-01-20 12:26:54 +0000" MODIFIED_BY="Sonja L  Henderson">
<P>For the methods used when assessing the trials identified in the previous version of this review, see<I> </I>
<LINK REF="REF-Hofmeyr-2010" TYPE="REFERENCE">Hofmeyr 2010</LINK>.</P>
<P>For this update we used the following methods when assessing the report identified by the updated search - <LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>.</P>
<STUDY_SELECTION MODIFIED="2014-01-13 17:24:06 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion with the third review author. We created a study flow diagram to map out the number of records identified, included and excluded.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-01-13 17:24:13 +0000" MODIFIED_BY="[Empty name]">
<P>We designed a form to extract data. For eligible studies, two review authors extracted data using the agreed form. We resolved discrepancies through discussion or, when required, we consulted the third review author. We entered data into Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we attempted to contact the authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-01-20 12:26:54 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Any disagreements were resolved by involving the third author.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the methods used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. We assessed the methods as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal the allocation sequence in sufficient detail and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:<BR/>
</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study all the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We also provided information on whether the intended blinding was effective. Where blinding was not possible, we assessed whether the lack of blinding was likely to have introduced bias. We assessed blinding separately for different outcomes or classes of outcomes. We assessed the methods as:<BR/>
</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re-included missing data in the analyses which we undertook.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We described for each included study how the possibility of selective outcome reporting bias was examined by us and what we found.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We described for each included study any important concerns we have about other possible sources of bias. We assessed whether each study was free of other problems that could put it at risk of bias:<BR/>
</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at a high risk of bias, according to the criteria given in the <I>Handbook </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses - see <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-01-13 16:59:14 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we planned to use the mean difference for outcomes measured in the same way between trials and the standardised mean difference to combine trials that measured the same outcome, but used different methods.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-11-25 13:47:27 +0000" MODIFIED_BY="[Empty name]">
<P>Only randomised clinical trials were included in this review. We did not include cluster-randomised trials or cross-over trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-01-13 16:59:24 +0000" MODIFIED_BY="[Empty name]">
<P>For included studies, levels of attrition were noted. The impact of including studies with high levels of missing data in the overall assessment of treatment effect was explored by using sensitivity analysis. For all outcomes analyses were carried out, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-01-13 16:59:42 +0000" MODIFIED_BY="[Empty name]">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau, I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (&lt; 0.10) in the Chi² test for heterogeneity.<B> </B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-01-13 17:00:13 +0000" MODIFIED_BY="[Empty name]">
<P>Where we suspected reporting bias (see &#8217;Selective reporting bias&#8217; above), we attempted to contact study authors to ask them to provide missing outcome data. Where this was not possible, and the missing data were thought to introduce serious bias, the impact of including such studies in the overall assessment of results was explored by a sensitivity analysis.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-01-13 17:23:30 +0000" MODIFIED_BY="[Empty name]">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials.</P>
<P>If we used random-effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-01-13 17:01:18 +0000" MODIFIED_BY="[Empty name]">
<P>We carried out the following subgroup analyses.</P>
<OL>
<LI>Standard peripartum surveillance.</LI>
<LI>Limited peripartum surveillance.</LI>
</OL>
<P>All the outcomes were used in the subgroup analysis.</P>
<P>We assessed subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
<P>For significant heterogeneity within subgroups, we used a random-effects model and explored the heterogeneity by planned sensitivity analysis excluding trials with greater risk of bias, as well as a post hoc sensitivity analysis based on sample size. In view of considerable heterogeneity and differences in adverse events rates between the two subgroups, overall meta-analyses were not reported for outcomes with significant heterogeneity.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-01-13 17:01:23 +0000" MODIFIED_BY="[Empty name]">
<P>We conducted a sensitivity analysis by excluding trials with greater risk of bias and examining the effect on the outcomes. A post-hoc sensitivity analysis was also performed to assess the effect of trial size on heterogeneity</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-01-14 17:10:36 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-01-14 17:10:36 +0000" MODIFIED_BY="[Empty name]">
<P>Of 30 studies identified, 14 studies with data on 4435 women met the predefined criteria for inclusion for this update - <I>see </I>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>The rate of saline infusion varied between studies. <LINK REF="STD-Sadovsky-1989" TYPE="STUDY">Sadovsky 1989</LINK> infused 600 mL in one hour, then 180 mL per hour continuously. <LINK REF="STD-Adam-1989" TYPE="STUDY">Adam 1989</LINK> used a single infusion of 1000 mL. <LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK> infused 1000 mL over 20 to 40 minutes, repeated six-hourly. <LINK REF="STD-Macri-1992" TYPE="STUDY">Macri 1992</LINK> infused 500 mL initially, then 250 to 500 mL as required to maintain a four-quadrant amniotic fluid index above 10 cm. <LINK REF="STD-Ilagan-1992" TYPE="STUDY">Ilagan 1992</LINK> infused 500 mL saline. <LINK REF="STD-Cialone-1994" TYPE="STUDY">Cialone 1994</LINK> infused 600 mL over one hour followed by 150 mL per hour. <LINK REF="STD-Eriksen-1994" TYPE="STUDY">Eriksen 1994</LINK> infused 800 mL over one hour, then 180 mL per hour. <LINK REF="STD-Spong-1994" TYPE="STUDY">Spong 1994</LINK> infused 600 mL as a bolus, followed by 3 mL per minute. <LINK REF="STD-Moodley-1998" TYPE="STUDY">Moodley 1998</LINK> used amnioinfusion with normal saline 10 to 15 mL per minute by gravity via a central venous manometer set and a size eight nasogastric infant feeding tube (1 litre over four hours). <LINK REF="STD-Hofmeyr-1998a" TYPE="STUDY">Hofmeyr 1998a</LINK> infused saline 800 mL at 15 mL per minute, them 3 mL per minute maintenance infusion. <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK> infused saline 500 mL over 30 minutes then 500 mL at 30 drops per minute. <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK> used saline via an infusion pump at 600 mL per hour for one hour, then 180 mL per hour until full cervical dilation, or basal uterine pressure increase to 20 mmHg. <LINK REF="STD-Rathore-2002" TYPE="STUDY">Rathore 2002</LINK> used saline via an FG 8 nasogastric tube, 500 mL over 30 minutes, then 3 mL per minute, to a maximum dose of 1000 mL. <LINK REF="STD-Sood-2004" TYPE="STUDY">Sood 2004</LINK> infused saline through a plastic suction catheter (50 cases) or an amnioinfusion catheter (46 cases) until the returning fluid was clear. In most women 1000 mL was infused over 30 to 45 minutes. <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK> used 800 mL saline over 40 minutes, then at 3 mL per minute to a maximum of 1500 mL. <LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK> passed transcervical nasogastric tubes cephalad to the baby&#8217;s head with infusion of 500 cc&#8217;s of normal saline over a period of 30 minutes, followed by 2 mL/min under gravity till time of delivery.</P>
<SEARCH_RESULTS MODIFIED="2014-01-14 17:05:20 +0000" MODIFIED_BY="[Empty name]">
<P>Thirty studies were identified after the search. Of the 30 studies, 14 studies with data on 4435 women met the predefined criteria for inclusion.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-01-13 17:02:52 +0000" MODIFIED_BY="[Empty name]">
<P>Fourteen studies were included (<LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>; <LINK REF="STD-Cialone-1994" TYPE="STUDY">Cialone 1994</LINK>; <LINK REF="STD-Eriksen-1994" TYPE="STUDY">Eriksen 1994</LINK>; <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>; <LINK REF="STD-Hofmeyr-1998a" TYPE="STUDY">Hofmeyr 1998a</LINK>; <LINK REF="STD-Macri-1992" TYPE="STUDY">Macri 1992</LINK>; <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>; <LINK REF="STD-Moodley-1998" TYPE="STUDY">Moodley 1998</LINK>; <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK>; <LINK REF="STD-Rathore-2002" TYPE="STUDY">Rathore 2002</LINK>; <LINK REF="STD-Sadovsky-1989" TYPE="STUDY">Sadovsky 1989</LINK>; <LINK REF="STD-Sood-2004" TYPE="STUDY">Sood 2004</LINK>; <LINK REF="STD-Spong-1994" TYPE="STUDY">Spong 1994</LINK>;<LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK>).</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-01-13 17:18:47 +0000" MODIFIED_BY="[Empty name]">
<P>Sixteen studies were excluded (<LINK REF="STD-Adam-1989" TYPE="STUDY">Adam 1989</LINK>; <LINK REF="STD-Ashfaq-2004" TYPE="STUDY">Ashfaq 2004</LINK>; <LINK REF="STD-Das-2007" TYPE="STUDY">Das 2007</LINK>; <LINK REF="STD-Edwards-1999" TYPE="STUDY">Edwards 1999</LINK>; <LINK REF="STD-Engel-2008" TYPE="STUDY">Engel 2008</LINK>; <LINK REF="STD-Gonzalez-1998" TYPE="STUDY">Gonzalez 1998</LINK>; <LINK REF="STD-Gonzalez-2002" TYPE="STUDY">Gonzalez 2002</LINK>; <LINK REF="STD-Gupta-2011" TYPE="STUDY">Gupta 2011</LINK>; <LINK REF="STD-Ilagan-1992" TYPE="STUDY">Ilagan 1992</LINK>; <LINK REF="STD-Khosla-1997" TYPE="STUDY">Khosla 1997</LINK>; <LINK REF="STD-Kirubamani-2000" TYPE="STUDY">Kirubamani 2000</LINK>; <LINK REF="STD-Lembet-1999" TYPE="STUDY">Lembet 1999</LINK>; <LINK REF="STD-Lo-1993" TYPE="STUDY">Lo 1993</LINK>; <LINK REF="STD-Mukhopadhyay-2006" TYPE="STUDY">Mukhopadhyay 2006</LINK>; <LINK REF="STD-Nageotte-1991" TYPE="STUDY">Nageotte 1991</LINK>; <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-01-13 17:19:33 +0000" MODIFIED_BY="[Empty name]">
<P>
<I>See</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, particularly the 'Methods' and 'Notes' sections and <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> for summaries of 'Risk of bias' assessments.</P>
<ALLOCATION MODIFIED="2014-01-13 17:19:18 +0000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>, <LINK REF="STD-Moodley-1998" TYPE="STUDY">Moodley 1998</LINK>, <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK> and <LINK REF="STD-Sadovsky-1989" TYPE="STUDY">Sadovsky 1989</LINK> randomly assigned women to two groups according to a list of randomly generated numbers in a sealed envelope assigned to each woman. However, they did not specify how participants were 'randomly' assigned to these groups (e.g. computer-generated, shuffling envelopes). <LINK REF="STD-Cialone-1994" TYPE="STUDY">Cialone 1994</LINK> and <LINK REF="STD-Spong-1994" TYPE="STUDY">Spong 1994</LINK> used computer-generated random numbers methods for sequence generation, but they did not describe methods of allocation concealment. <LINK REF="STD-Eriksen-1994" TYPE="STUDY">Eriksen 1994</LINK>, <LINK REF="STD-Hofmeyr-1998a" TYPE="STUDY">Hofmeyr 1998a</LINK>, <LINK REF="STD-Macri-1992" TYPE="STUDY">Macri 1992</LINK>, <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>, <LINK REF="STD-Rathore-2002" TYPE="STUDY">Rathore 2002</LINK> and <LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK> used computer randomisation and prevented selection bias due to allocation concealment by using sealed envelopes. <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK> used a centralised computer randomisation service, while <LINK REF="STD-Sood-2004" TYPE="STUDY">Sood 2004</LINK> assigned women to each group by a coin toss.</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-12-03 09:59:47 +0000" MODIFIED_BY="[Empty name]">
<P>Blinding of the intervention was not possible, though some of the outcome measures could be assessed in a blinded fashion. In none of the studies were obstetricians blinded to the treatment, and only <LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>; <LINK REF="STD-Cialone-1994" TYPE="STUDY">Cialone 1994</LINK>; <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>; <LINK REF="STD-Hofmeyr-1998a" TYPE="STUDY">Hofmeyr 1998a</LINK>; <LINK REF="STD-Macri-1992" TYPE="STUDY">Macri 1992</LINK>; <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>; <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK>; <LINK REF="STD-Sadovsky-1989" TYPE="STUDY">Sadovsky 1989</LINK> and <LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK> specified that the neonatologists evaluating the babies were blind to the assigned group of each baby.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-01-13 17:19:33 +0000" MODIFIED_BY="[Empty name]">
<P>Comparability of the groups was compromised by the following exclusions after randomisation: <LINK REF="STD-Wenstrom-1989" TYPE="STUDY">Wenstrom 1989</LINK> excluded 5/41 (12%) of women allocated to receive amnioinfusion but who did not (four gave birth spontaneously after 30, 45, 60 and 180 minutes, and one required emergency caesarean section for fetal distress - this information has been included in the analysis for this review in respect of delivery outcomes); <LINK REF="STD-Cialone-1994" TYPE="STUDY">Cialone 1994</LINK> excluded 7/54 (13%) of the study group who had diabetes (three) or requested withdrawal (four) and 1/59 (1.7%) allocated to the control group who requested withdrawal; <LINK REF="STD-Eriksen-1994" TYPE="STUDY">Eriksen 1994</LINK> excluded 9/139 (6%) women whose records were unavailable or incomplete, and 6/71 (8%) randomised to the amnioinfusion group who delivered before they could receive amnioinfusion. In the study by Hofmeyr et al (<LINK REF="STD-Hofmeyr-1998a" TYPE="STUDY">Hofmeyr 1998a</LINK>), one woman in the control group received amnioinfusion (analysis was by intention-to-treat), and data were missing on about 7% of outcome measures. In <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>, four amnioinfusion allocations were missed and could not be traced. <LINK REF="STD-Sood-2004" TYPE="STUDY">Sood 2004</LINK> excluded 3/99 women from the amnioinfusion group in whom amnioinfusion was abandoned because of vaginal bleeding. Fetal heart rate abnormalities before enrolment were present in 48/96 women in the amnioinfusion versus 60/100 in the control group. The perinatal mortality data are difficult to interpret because the reported rate (2.8%) in the amnioinfusion group does not reflect a whole number of the group of 96. In <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>, 1.2% of women were excluded from the analysis because of loss to follow-up (amnioinfusion 7/995; control 12/1003), because they did not meet inclusion criteria (breech presentation or multiple pregnancy: two in each group).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-12-12 13:59:48 +0000" MODIFIED_BY="[Empty name]">
<P>All expected outcomes were reported in one study <LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK> and a published protocol was available for another study (<LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>). All predefined outcomes were reported (<LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-12-15 16:52:08 +0000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Spong-1994" TYPE="STUDY">Spong 1994</LINK> do not account for a small discrepancy in group size (43 versus 50) despite using computer-generated allocation to create equal sized groups. The <LINK REF="STD-Cialone-1994" TYPE="STUDY">Cialone 1994</LINK> report does not account for a discrepancy in birth weights between the groups. There are thus several methodological shortcomings in all the studies except <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>.A potential source of bias in this review was the degree of heterogeneity in the individual trials.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-01-13 17:20:43 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Settings with standard peripartum surveillance</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>There was no significant reduction in meconium aspiration syndrome (11 studies, 3374 women; average risk ratio (RR) 0.52, 95% confidence interval (CI) 0.26 to 1.06; Heterogeneity: Tau² = 0.56; Chi² = 20.08, df = 9 (P = 0.02); I² = 55%), <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>, nor in perinatal deaths (seven studies, 2762 women; RR 1.00, 95% CI 0.29 to 3.45), <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>, nor the combined outcome perinatal death or severe morbidity (one study, 1975 women; RR 1.13, 95% CI 0.88 to 1.47), <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>. Analgesia use recorded in one trial and first stage of labour duration in two, were not significantly different between groups. The incidence of puerperal infection was not statistically different between the groups in these studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>There was considerable heterogeneity for several outcomes, in which case a random-effects model has been used. In two small studies (138 women) with relevant data, heavy meconium staining was virtually eliminated (RR 0.03, 95% CI 0.01 to 0.15), <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>. There was a reduction in caesarean sections for fetal distress (eight studies, 2765 women; average RR 0.40, 95% CI 0.19 to 0.86; Heterogeneity: Tau² = 0.70; Chi² = 24.49, df = 7 (P = 0.0009); I² = 71%), <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>, and a trend overall (11 studies, 3380 women; average RR 0.78, 95% CI 0.60 to 1.02; Heterogeneity: Tau² = 0.11; Chi² = 32.97, df = 10 (P = 0.0003); I² = 70%), <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>. There was a reduction in variable fetal heart rate decelerations (five studies, 2101 women; average RR 0.67, 95% CI 0.47 to 0.96; Heterogeneity: Tau² = 0.10; Chi² = 20.46, df = 4 (P = 0.0004); I² = 80%), <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>. There was no statistically significant reduction in five-minute Apgar score less than seven (seven studies, 2868 women; RR 0.80, 95% CI 0.52 to 1.22), <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>. Cord arterial pH less than 7.20 was reduced (seven studies, 1788 women; average RR 0.62, 95% CI 0.40 to 0.96; Heterogeneity: Tau² = 0.23; Chi² = 21.95, df = 6 (P = 0.001); I² = 73%), <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>. Meconium below the vocal cords diagnosed by laryngoscopy was reduced (10 studies, 3298 women; RR 0.31, 95% CI 0.18 to 0.53; Heterogeneity: Tau² = 0.46; Chi² = 33.13, df = 9 (P = 0.0001); I² = 73%), <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>, as was neonatal ventilation or neonatal intensive care unit admission (three studies, 472 women; RR 0.45, 95% CI 0.23 to 0.90), <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>.</P>
<P>Because in the outcomes with significant heterogeneity, the magnitude of effects tended to be greater in the smaller studies, a post-hoc sensitivity analysis was performed to assess the effect of trial size on heterogeneity. Successive elimination of trials with fewer than 100, 200 and 300 participants did not eliminate the heterogeneity for the outcomes variable decelerations; caesarean section (for fetal distress and overall); umbilical artery pH less than 7.2; and meconium below vocal cords. For the primary outcome, meconium aspiration syndrome, exclusion of trials with fewer than 200 participants reduced the heterogeneity (I² = 0%: three trials, 2506 women; RR 1.22, 95% CI 0.82 to 1.84 fixed-effect model). Planned sensitivity analysis excluding trials with greater risk of bias (all trials except <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>) rendered results showing no benefits from amnioinfusion for any of the outcomes measured. As this trial included considerably more women than the other trials combined, the interpretation of results below has taken account of the negative results of this trial.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Studies with limited peripartum surveillance</HEADING>
<P>Three studies were included (<LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>; <LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>; <LINK REF="STD-Rathore-2002" TYPE="STUDY">Rathore 2002</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>In the amnioinfusion group there was a reduction in meconium aspiration syndrome (three studies, 1144 women; average RR 0.17, 95% CI 0.05 to 0.52; Heterogeneity: Tau² = 0.39; Chi² = 2.94, df = 2 (P = 0.23); I² = 32%), <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>, and perinatal mortality (three studies, 1151 women; RR 0.24, 95% CI 0.11 to 0.53), <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>In the amnioinfusion group there was a reduction in caesarean section for fetal distress (three studies, 1147 women; RR 0.38, 95% CI 0.27 to 0.54), <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>, and overall (three studies, 1137 women; average RR 0.59, 95% CI 0.41 to 0.84; Heterogeneity: Tau² = 0.06; Chi² = 4.94, df = 2 (P = 0.08); I² = 60%), <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>; one minute Apgar scores (two studies, 492 women; RR 0.32, 95% CI 0.19 to 0.54), <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>; five-minute Apgar score less than seven (three studies, 1152 women; RR 0.28, 95% CI 0.14 to 0.53), <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; neonatal ventilation or neonatal intensive care unit admission (two studies, 853 women; RR 0.52, 95% 0.37 to 0.73), <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>; and no measurable effect on instrumental delivery or puerperal pyrexia. In one of the studies (<LINK REF="STD-Rathore-2002" TYPE="STUDY">Rathore 2002</LINK>) meconium below the vocal cords was reduced (200 women; RR 0.42, 95% CI 0.21 to 0.83), <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>; and in the other (<LINK REF="STD-Mahomed-1998" TYPE="STUDY">Mahomed 1998</LINK>) neonatal encephalopathy was reduced (649 women; RR 0.07, 95% CI 0.01 to 0.56), <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>. In another study (<LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK>) respiratory distress was reduced.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-01-16 12:34:10 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-01-16 12:33:05 +0000" MODIFIED_BY="[Empty name]">
<P>Fouteen studies of variable quality (4435 women) are included. Subgroup analysis was performed for studies from settings with limited facilities to monitor the baby's condition during labour and intervene effectively, and settings with standard peripartum surveillance. </P>
<P>
<B>Settings with standard peripartum surveillance:</B> there was considerable heterogeneity for several outcomes. There was no significant reduction in the primary outcomes meconium aspiration syndrome, perinatal death or severe morbidity, and maternal death or severe morbidity. There was a reduction in caesarean sections (CSs) for fetal distress but not overall. Meconium below the vocal cords diagnosed by laryngoscopy was reduced, as was neonatal ventilation or neonatal intensive care unit admission, but there was no significant reduction in perinatal deaths or other morbidity. Planned sensitivity analysis excluding trials with greater risk of bias resulted in an absence of benefits for any of the outcomes studied.</P>
<P>Several of the smaller studies reviewed were compromised by exclusion of significant numbers of women from the analyses. In addition, outcomes such as the decision to perform caesarean section might have been influenced by the fact that caregivers were not blind to the group allocation, and may have been more motivated to avoid caesarean section in those women subjected to amnioinfusion. The reported reduction in caesarean sections for fetal distress must be interpreted in the light of large variations among institutions with respect to thresholds for intervention for 'fetal distress'. The rates of caesarean section in the control groups ranged from under 10% to 47.5%. Overall, caesarean sections were not significantly reduced.</P>
<P>As thick meconium staining of the amniotic fluid is usually associated with oligohydramnios, beneficial perinatal outcomes seen in some smaller studies may have been related to correction of oligohydramnios rather than dilution of amniotic fluid. In <LINK REF="STD-Spong-1994" TYPE="STUDY">Spong 1994</LINK>, the results were generally less favourable than in the other smaller studies. The use of amnioinfusion in 8/50 of the control group who developed fetal heart rate decelerations may have obscured beneficial effects of amnioinfusion related to correction of oligohydramnios. This is in keeping with the finding that prophylactic amnioinfusion for oligohydramnios does not have demonstrable benefits over amnioinfusion used only when fetal heart rate decelerations occur (<LINK REF="REF-Novikova-2012" TYPE="REFERENCE">Novikova 2012</LINK>).</P>
<P>
<B>Settings with limited peripartum surveillance:</B> three studies were included. In the amnioinfusion group there was a reduction in CS for fetal distress and overall; meconium aspiration syndrome (three studies, 1141 women; average RR 0.17, 95% CI 0.05 to 0.52); perinatal mortality (three studies, 1151 women; RR 0.24, 95% CI 0.11 to 0.53) and neonatal ventilation or neonatal intensive care unit admission. In one of the studies, meconium below the vocal cords was reduced and, in the other, neonatal encephalopathy was reduced.</P>
<P>Perinatal outcomes in these under-resourced settings were worse than in the settings with standard peripartum surveillance (perinatal deaths 22/1000 versus 3.6/1000; meconium aspiration syndrome 6.2% versus 2,2%). Under these conditions, with limited facilities to diagnose fetal distress during labour and intervene effectively, amnioinfusion appears to significantly improve perinatal outcome. It is not possible to be sure whether this improvement is due to dilution of amniotic fluid, or correction of oligohydramnios. Interpretation of the data must take into account methodological shortcomings noted above.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-01-16 12:34:10 +0000" MODIFIED_BY="[Empty name]">
<P>This systematic review is relevant to current day practice of obstetrics and gynaecology, showing the impact of amnioinfusion on meconium aspiration syndrome.</P>
<SUBSECTION>
<HEADING LEVEL="3">Risks</HEADING>
<P>The trials reviewed are too small to address the possibility of rare but serious maternal side-effects of amnioinfusion. Several case reports have been published of cardiac failure or amniotic fluid embolism following amnioinfusion, though a causal relationship has not been established. The benefits shown in the trials reviewed need to be weighed against the theoretical small risk of serious maternal complications (<I>see</I> <LINK REF="REF-Dibble-1992" TYPE="REFERENCE">Dibble 1992</LINK>; <LINK REF="REF-Dragich-1991" TYPE="REFERENCE">Dragich 1991</LINK>; <LINK REF="REF-Hofmeyr-1996" TYPE="REFERENCE">Hofmeyr 1996</LINK>; <LINK REF="REF-Maher-1994" TYPE="REFERENCE">Maher 1994</LINK>; <LINK REF="REF-Wegnelius-1996" TYPE="REFERENCE">Wegnelius 1996</LINK>; <LINK REF="REF-Wenstrom-1994" TYPE="REFERENCE">Wenstrom 1994</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">HIV</HEADING>
<P>The diagnosis of meconium-stained liquor may be limited by a policy of maintaining intact membranes during labour in areas with a high prevalence of HIV infection. Once meconium-stained liquor is diagnosed, whether amnioinfusion would increase the risk of vertical HIV transmission to the fetus because of placement of the intrauterine catheter, or reduce the risk by irrigation of the genital tract and dilution of maternal fluids, is not known.</P>
<P>A simplified method of amnioinfusion was shown to be feasible in an under-resourced labour ward environment.</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-01-13 17:21:12 +0000" MODIFIED_BY="[Empty name]">
<P>The quality of evidence reflects the extent to which the confidence in an estimate of effect is adequate to support recommendations (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>). For systematic reviews, the quality of evidence reflects the extent to which the confidence of an estimate of effect is correct (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>). The GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach for assessing quality of evidence in systematic reviews involves making separate ratings for quality of evidence outcomes, and identifies five factors that can lower the quality of the evidence (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>). Considering these five factors in this systematic review; first, the majority of the trials had limitations with allocation concealment and blinding and in accounting for losses to follow-up (low quality); second, the estimates of treatment effect (heterogeneity) and outcomes across trials were not too different (moderate quality). This suggests similarities in the underlying treatment effects across trials (moderate quality). Third, all trials were randomised trials, comparing amnioinfusion to no intervention (high quality). Fourth, majority of the trials recruited relatively few patients and never reported confidence intervals in their analysis (low quality); and finally, there were no instances of publication bias noted in this systematic review. Therefore, overall, the quality of evidence of this systematic review using the GRADE approach, is of low quality.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-11-25 13:59:17 +0000" MODIFIED_BY="[Empty name]">
<P>There are some potential biases in the review process. Several of the randomised clinical trials that were included did not blind the investigators, especially obstetricians. This is also another potential for bias in this review. Again, while assessing trials for inclusion, we might have omitted some trials that used amnioinfusion for the reduction of meconium aspiration syndrome, as authors may not have included any of the search terms in their title or abstract. Also, the majority of the trials in this review have methodological limitations capable of increasing the risk of bias, hence compromising the strength of evidence.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-01-13 17:21:25 +0000" MODIFIED_BY="[Empty name]">
<P>Evidence concerning the efficacy of amnioinfusion for reducing the impact of meconium aspiration syndrome is in tandem with the findings from another systematic review (<LINK REF="REF-Xu-2007" TYPE="REFERENCE">Xu 2007</LINK>) that was published in the British Journal of Obstetrics and Gynaecology in 2007. In another multicentre, randomised controlled trial with 1998 pregnant women comparing amnioinfusion with standard care, there were no significant differences in composite primary outcome, perinatal death, caesarean delivery, meconium aspiration syndrome (<LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK>). The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion 346 concluded that amnioinfusion does not prevent meconium aspiration syndrome (<LINK REF="REF-ACOG-2006" TYPE="REFERENCE">ACOG 2006</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Units with standard peripartum surveillance</HEADING>
<P>The evidence reviewed does not support the use of amnioinfusion for meconium-stained amniotic fluid (as opposed to oligohydramnios-related fetal heart rate decelerations) in clinical practice, given that it is an invasive procedure and has not been shown to have clear benefits in terms of substantive clinical outcomes, and no benefits were found following sensitivity analysis excluding trials with greater risk of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Units with limited peripartum surveillance</HEADING>
<P>The three studies reviewed showed significant improvements in perinatal outcome with a simplified technique of amnioinfusion. The use of amnioinfusion should be considered for women with meconium-stained liquor in units with limited facilities for peripartum surveillance and high rates of meconium aspiration syndrome. The reduction in the diagnosis of meconium aspiration syndrome after amnioinfusion in these studies may possibly be due to a reduction in fetal distress related to oligohydramnios (<I>see</I> Cochrane review '<I>Amnioinfusion for potential or suspected umbilical cord compression in labour</I>' (<LINK REF="REF-Hofmeyr-2012" TYPE="REFERENCE">Hofmeyr 2012</LINK>)).</P>
</SUBSECTION>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-11-12 01:54:57 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Units with standard peripartum surveillance</HEADING>
<P>Future research should be directed towards the use of amnioinfusion for the correction of oligohydramnios rather than meconium-stained amniotic fluid.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Units with limited peripartum surveillance</HEADING>
<P>Further research is needed to confirm the results of the three included studies, to determine whether the benefits of amnioinfusion for meconium-stained liquor may be limited to women with oligohydramnios, to determine the effect of amnioinfusion in women infected with HIV, and to investigate the possible risks of amnioinfusion to the mother.</P>
</SUBSECTION>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-01-16 11:44:20 +0000" MODIFIED_BY="[Empty name]">
<P>Thanks to Kate Barton for help with translation of <LINK REF="REF-Alvarez-1999" TYPE="REFERENCE">Alvarez 1999</LINK> and Agnieszka Kimball for help with translation of <LINK REF="STD-Engel-2008" TYPE="STUDY">Engel 2008</LINK>.</P>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Pregnancy and Childbirth Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-12-15 16:13:48 +0000" MODIFIED_BY="[Empty name]">
<P>G J Hofmeyr is an author of studies considered for inclusion in the review and has not participated in decisions regarding these studies.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-01-13 17:21:41 +0000" MODIFIED_BY="Sonja L  Henderson">
<P>GJ Hofmeyr prepared the original protocol and review. H Xu updated the review following the release of the results of the <LINK REF="STD-Fraser-2005" TYPE="STUDY">Fraser 2005</LINK> trial, and AC Eke updated the review following the release of the results of the <LINK REF="STD-Choudhary-2010" TYPE="STUDY">Choudhary 2010</LINK> trial. All three review authors checked the data entry and contributed to the writing of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-12-12 12:25:27 +0000" MODIFIED_BY="[Empty name]">
<P>We have added four additional outcomes (perinatal death or severe morbidity; maternal death or severe morbidity; respiratory distress; length of maternal hospital stay) and one sensitivity analysis post hoc and updated <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> references.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2013-11-25 14:01:11 +0000" MODIFIED_BY="[Empty name]">
<P>None.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-01-20 12:33:38 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-12-03 09:59:03 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-12-03 09:59:03 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Choudhary-2010" MODIFIED="2012-04-30 05:38:52 +0100" MODIFIED_BY="[Empty name]" NAME="Choudhary 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-04-30 05:38:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choudhary D, Bano I, Ali SM</AU>
<TI>Does amnioinfusion reduce caesarean section rate in meconium-stained amniotic fluid</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>2010</YR>
<VL>282</VL>
<NO>1</NO>
<PG>17-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cialone-1994" MODIFIED="2009-06-01 12:03:14 +0100" MODIFIED_BY="[Empty name]" NAME="Cialone 1994" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;[7470]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cialone PR, Abramowicz JS, Ryan RM, Sinkin RA, Sherer DM</AU>
<TI>Markedly significant decrease in neonatal morbidity associated with amnioinfusion for labor complicated by particulate meconium</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>168</VL>
<PG>319</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 12:03:14 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[8317]&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:03:14 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cialone PR, Sherer DM, Ryan RM, Sinkin RA, Abramowicz JS</AU>
<TI>Amnioinfusion during labor complicated by particulate meconium-stained amniotic fluid decreases neonatal morbidity</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>842-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eriksen-1994" MODIFIED="2009-06-01 12:03:27 +0100" MODIFIED_BY="[Empty name]" NAME="Eriksen 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;[8436]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eriksen N, Hostetter M, Parisi V</AU>
<TI>Prophylactic amnioinfusion in pregnancies complicated by thick meconium</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>344</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 12:03:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[8572]&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:03:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Eriksen NL, Hostetter M, Parisi VM</AU>
<TI>Prophylactic amnioinfusion in pregnancies complicated by thick meconium</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>171</VL>
<PG>1026-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fraser-2005" MODIFIED="2009-11-10 10:36:45 +0000" MODIFIED_BY="[Empty name]" NAME="Fraser 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 10:36:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fraser W, Hofmeyr J, Lede R, Faron G, Alexander S, Goffinet F et al</AU>
<TI>An international randomised controlled trial of amnioinfusion for thickly meconium stained amniotic fluid</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>191</VL>
<NO>6 Suppl 1</NO>
<PG>S3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 12:03:34 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Fraser WD, Hofmeyr J, Lede R, Faron G, Alexander S, Goffinet F et al. Amnioinfusion for the prevention of the meconium aspiration syndrome [See comment]. New England Journal of Medicine 2005;353(9):909-17&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:03:34 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fraser WD, Hofmeyr J, Lede R, Faron G, Alexander S, Goffinet F et al</AU>
<TI>Amnioinfusion for the prevention of the meconium aspiration syndrome</TI>
<SO>New England Journal of Medicine</SO>
<YR>2005</YR>
<VL>353</VL>
<NO>9</NO>
<PG>909-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hofmeyr-1998a" MODIFIED="2012-02-20 14:26:18 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1998a" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gulmezoglu AM, Nikodem V, Hofmeyr GJ</AU>
<TI>Amniotic fluid index changes after amnioinfusion</TI>
<SO>Proceedings of the 14th Conference on Priorities in Perinatal Care in South Africa; 1995 March 7-10; South Africa</SO>
<YR>1995</YR>
<PG>179-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 12:03:48 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[9791]&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:03:48 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ, Gulmezoglu AM, Buchmann E, Howarth GR, Shaw A, Nikodem VC et al</AU>
<TI>The Collaborative Randomised Amnioinfusion for Meconium Project (CRAMP): 1. South Africa</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1998</YR>
<VL>105</VL>
<PG>304-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hofmeyr GJ, Gulmezoglu AM, Nikodem VC</AU>
<TI>Amnioinfusion for meconium-staining of the amniotic fluid: A randomized trial</TI>
<SO>27th British Congress of Obstetrics And Gynaecology; 1995 July 4-7; Dublin, Ireland</SO>
<YR>1995</YR>
<PG>64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Macri-1992" MODIFIED="2009-06-01 12:03:56 +0100" MODIFIED_BY="[Empty name]" NAME="Macri 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Macri CJ, Schrimmer DB, Leung A, Greenspoon JS, Paul RH</AU>
<TI>Amnioinfusion improves outcome in labor complicated by meconium and oligohydramnios</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>164</VL>
<PG>252</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 12:03:56 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[7335]&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:03:56 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Macri CJ, Schrimmer DB, Leung A, Greenspoon JS, Paul RH</AU>
<TI>Prophylactic amnioinfusion improves outcome of pregnancy complicated by thick meconium and oligohydramnios</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>67</VL>
<PG>117-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mahomed-1998" NAME="Mahomed 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;[9792]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahomed K, Mulambo T, Woelk G, Hofmeyr GJ, Gulmezoglu AM</AU>
<TI>The Collaborative Randomised Amnioinfusion for Meconium Project (CRAMP): 2. Zimbabwe</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1998</YR>
<VL>105</VL>
<PG>309-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moodley-1998" NAME="Moodley 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moodley J, Matchaba P, Payne AJ</AU>
<TI>Intrapartum amnioinfusion for meconium-stained liquor in developing countries</TI>
<SO>Tropical Doctor</SO>
<YR>1998</YR>
<VL>28</VL>
<PG>31-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Puertas-2001" MODIFIED="2009-06-16 11:53:14 +0100" MODIFIED_BY="[Empty name]" NAME="Puertas 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-03-10 14:02:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alvarez M, Puertas A, Suarez AM, Herruzo A, Miranda JA.</AU>
<TI>Transcervical amnioinfusion in deliveries with meconium-stained amniotic fluid</TI>
<TO>Amnioinfusion transcervical en partos con liquido amniotico tenido de meconio</TO>
<SO>Progresos de Obstetricia y Ginecologia</SO>
<YR>1999</YR>
<VL>42</VL>
<PG>365-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Puertas A, Carrillo MP, Alvarez M, Canizares JM, Mino M, Malde J. Meconium concentration and amniotic fluid index influence the outcome of amnioinfusion. Minerva Ginecologica 2001;53:321-30&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Puertas A, Carrillo MP, Alvarez M, Canizares JM, Mino M, Malde J</AU>
<TI>Meconium concentration and amniotic fluid index influence the outcome of amnioinfusion</TI>
<SO>Minerva Ginecologica</SO>
<YR>2001</YR>
<VL>53</VL>
<PG>321-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-16 11:53:14 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Puertas A, Carrillo MP, Molto L, Alvarez M, Sedeno S, Miranda JA . Meconium-stained amniotic fluid in labor: a randomized trial of prophylactic amnioinfusion. European Journal of Obstetrics &amp;amp; Gynecology and Reproductive Biology 2001;99:33-7&lt;/p&gt;" NOTES_MODIFIED="2009-06-16 11:53:14 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Puertas A, Carrillo MP, Molto L, Alvarez M, Sedeno S, Miranda JA</AU>
<TI>Meconium-stained amniotic fluid in labor: a randomized trial of prophylactic amnioinfusion</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>2001</YR>
<VL>99</VL>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rathore-2002" NAME="Rathore 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Rathore AM, Singh R, Ramji S, Tripathi R. Randomised trial of amnioinfusion during labour with meconium stained amniotic fluid. BJOG: an international journal of obstetrics and gynaecology 2002;109:17-20&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rathore AM, Singh R, Ramji S, Tripathi R</AU>
<TI>Randomised trial of amnioinfusion during labour with meconium stained amniotic fluid</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2002</YR>
<VL>109</VL>
<PG>17-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sadovsky-1989" MODIFIED="2009-06-01 12:04:38 +0100" MODIFIED_BY="[Empty name]" NAME="Sadovsky 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-06-01 12:04:38 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[5106]&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:04:38 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sadovsky Y, Amon E, Bade ME, Petrie RH</AU>
<TI>Prophylactic amnioinfusion during labor complicated by meconium: a preliminary report</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1989</YR>
<VL>61</VL>
<PG>613-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sadovsky Y, Amon E, Bade ME, Petrie RH</AU>
<TI>Prophylactic amnioinfusion during labor complicated by meconium: a preliminary report</TI>
<SO>Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 Feb 1-4; New Orleans, Louisiana, USA</SO>
<YR>1999</YR>
<PG>24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sood-2004" NAME="Sood 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;Sood M, Charulata, Dimple D, Aggarwal N, Faridi MM . Amnioinfusion in thick meconium. Indian Journal of Pediatrics 2004;71(8):677-81&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sood M, Charulata, Dimple D, Aggarwal N, Faridi MM</AU>
<TI>Amnioinfusion in thick meconium</TI>
<SO>Indian Journal of Pediatrics</SO>
<YR>2004</YR>
<VL>71</VL>
<NO>8</NO>
<PG>677-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spong-1994" MODIFIED="2009-06-01 12:04:49 +0100" MODIFIED_BY="[Empty name]" NAME="Spong 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;[8445]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spong CY, Ogundipe OA, Ross MG</AU>
<TI>Prophylactic amnioinfusion for meconium stained amniotic fluid</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>285</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 12:04:49 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[8568]&lt;/p&gt;" NOTES_MODIFIED="2009-06-01 12:04:49 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Spong CY, Ogunipe OA, Ross MG</AU>
<TI>Prophylactic amnioinfusion for meconium-stained amniotic fluid</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>171</VL>
<PG>931-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wenstrom-1989" MODIFIED="2013-12-03 09:59:03 +0000" MODIFIED_BY="[Empty name]" NAME="Wenstrom 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-12-03 09:59:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wenstrom KD, Parsons MT</AU>
<TI>The prevention of meconium aspiration in labor using amnioinfusion</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1989</YR>
<VL>73</VL>
<PG>647-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-11-24 15:40:45 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Adam-1989" NAME="Adam 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;[4816]&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Adam K, Cano L, Moise KJ</AU>
<TI>The effect of intrapartum amnioinfusion on the outcome of the fetus with heavy meconium stained amniotic fluid</TI>
<SO>Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 Feb 1-4; New Orleans, Louisiana, USA</SO>
<YR>1989</YR>
<PG>438</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ashfaq-2004" MODIFIED="2009-11-10 10:37:10 +0000" MODIFIED_BY="[Empty name]" NAME="Ashfaq 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-11-10 10:37:10 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Ashfaq F, Shah AA. Effect of amniofusion for meconium stained amniotic fluid on perinatal outcome. Journal of the Pakistan Medical Association  2004;54(6):322-5&lt;/p&gt;" NOTES_MODIFIED="2009-11-10 10:37:10 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ashfaq F, Shah AA</AU>
<TI>Effect of amnioinfusion for meconium stained amniotic fluid on perinatal outcome</TI>
<SO>Journal of the Pakistan Medical Association</SO>
<YR>2004</YR>
<VL>54</VL>
<NO>6</NO>
<PG>322-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Das-2007" MODIFIED="2009-03-10 14:06:02 +0000" MODIFIED_BY="[Empty name]" NAME="Das 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-03-10 14:06:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Das AK, Jana N, Dasgupta S, Samanta B</AU>
<TI>Intrapartum transcervical amnioinfusion for meconium-stained amniotic fluid</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2007</YR>
<VL>93</VL>
<PG>182-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edwards-1999" MODIFIED="2009-03-10 14:06:16 +0000" MODIFIED_BY="[Empty name]" NAME="Edwards 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-03-10 14:06:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edwards RK, Duff P</AU>
<TI>Prophylactic cephazolin in amnioinfusions administered for meconium-stained amniotic fluid</TI>
<SO>Infectious Diseases in Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>7</VL>
<PG>153-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Engel-2008" MODIFIED="2012-04-28 20:29:01 +0100" MODIFIED_BY="[Empty name]" NAME="Engel 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-04-28 20:29:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Engel K, Samborska M, Bilar M, Sipak-Szmigiel O, Ronin-Walknowska E</AU>
<TI>Intrapartum amnioinfusion in patients with meconium-stained amniotic fluid</TI>
<TO>Amnioinfuzja srodporodowa u pacjentek z obecnoscia smolki w plynie owodniowym</TO>
<SO>Ginekologia Polska</SO>
<YR>2008</YR>
<VL>79</VL>
<NO>9</NO>
<PG>621-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-1998" MODIFIED="2009-03-10 14:06:26 +0000" MODIFIED_BY="[Empty name]" NAME="Gonzalez 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-03-10 14:06:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez JL, Martin D, Gardner MO, Mooney S, Curet LB</AU>
<TI>The effects of the amnioinfused solution on the neonatal electrolytes and acid base</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>178</VL>
<NO>1</NO>
<PG>S43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-2002" NAME="Gonzalez 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Gonzalez JL, Mooney S, Gardner MO, Martin D, Curet LB. The effects of amnioinfused solutions for meconium-stained amniotic fluid on neonatal plasma electrolyte concentrations and ph. Journal of Perinatology 2002;22(4):279-81&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez JL, Mooney S, Gardner MO, Martin D, Curet LB</AU>
<TI>The effects of amnioinfused solutions for meconium-stained amniotic fluid on neonatal plasma electrolyte concentrations and ph</TI>
<SO>Journal of Perinatology</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>4</NO>
<PG>279-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-2011" MODIFIED="2013-11-24 15:40:45 +0000" MODIFIED_BY="[Empty name]" NAME="Gupta 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-11-24 15:40:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gupta K, Das B</AU>
<TI>Role of intrapartum amnioinfusion in meconium stained amniotic fluid</TI>
<SO>54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India</SO>
<YR>2011</YR>
<PG>246</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ilagan-1992" NAME="Ilagan 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;[7617]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ilagan NB, Kazzi GM, Shankaran S, Liang KC, Womack SJ, Bronsteen RA et al</AU>
<TI>Transcervical amnioinfusion for the prevention of neonatal meconium aspiration</TI>
<SO>Pediatric Research</SO>
<YR>1992</YR>
<VL>31</VL>
<NO>4</NO>
<PG>205A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khosla-1997" NAME="Khosla 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;study group was 25 consecutive patients who gave consent for amnioinfusion and controls were 25 similar patients of the alternative unit where amnioinfusion was not being carried out&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khosla AH, Sangwan K, Ahuja SD</AU>
<TI>Prophylactic amnioinfusion during labor complicated by meconium</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>37</VL>
<PG>294-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirubamani-2000" MODIFIED="2009-06-16 11:53:36 +0100" MODIFIED_BY="[Empty name]" NAME="Kirubamani 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-06-16 11:53:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kirubamani HN</AU>
<TI>A fetal therapy in labour with meconium stained liquor</TI>
<SO>XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 2); 2000 Sept 3-8; Washington DC, USA</SO>
<YR>2000</YR>
<PG>125</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lembet-1999" NAME="Lembet 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lembet A, Zorlu CG, Yalcin HR, Seckin B, Batioglu S, Gokmen O</AU>
<TI>Prophylactic transabdominal amnioinfusion during labor with thick meconium: does it work?</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1999</YR>
<VL>86</VL>
<PG>S80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lo-1993" NAME="Lo 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;[7814]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lo KWK, Rogers M</AU>
<TI>A controlled trial of amnioinfusion: the prevention of meconium aspiration in labour</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>1993</YR>
<VL>33</VL>
<PG>52-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mukhopadhyay-2006" MODIFIED="2012-04-30 05:37:24 +0100" MODIFIED_BY="[Empty name]" NAME="Mukhopadhyay 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-04-30 05:37:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mukhopadhyay P, Naskar T, Dalui R, Hazra S, Guin K, Bhattacharya D</AU>
<TI>Role of intrapartum amnioinfusion in meconium stained amniotic fluid</TI>
<SO>Journal of Obstetrics and Gynecology of India</SO>
<YR>2006</YR>
<VL>56</VL>
<NO>3</NO>
<PG>230-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nageotte-1991" NAME="Nageotte 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;[6455]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nageotte MP, Bertucci L, Towers CV, Lagrew DL, Modanlou H</AU>
<TI>Prophylactic amnioinfusion in pregnancies complicated by oligohydramnios: a prospective study</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1991</YR>
<VL>77</VL>
<PG>677-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Regi-2009" MODIFIED="2012-04-28 20:49:48 +0100" MODIFIED_BY="[Empty name]" NAME="Regi 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-04-28 20:49:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Regi A, Alexander N, Jose R, Lionel J, Varghese L, Peedicayil A</AU>
<TI>Amnioinfusion for relief of recurrent severe and moderate variable decelerations in labor</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>2009</YR>
<VL>54</VL>
<NO>5</NO>
<PG>295-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-11-24 15:40:45 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-01-20 12:33:38 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-01-20 12:33:38 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abdel_x002d_Aleem-2005" MODIFIED="2014-01-13 10:30:27 +0000" MODIFIED_BY="Heather Maxwell" NAME="Abdel-Aleem 2005" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Aleem H, Amin AF, Shokry M, Radwan RA</AU>
<TI>Therapeutic amnioinfusion for intrapartum fetal distress using a pediatric feeding tube</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2005</YR>
<VL>90</VL>
<NO>2</NO>
<PG>94-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ACOG-2006" MODIFIED="2013-11-24 14:22:41 +0000" MODIFIED_BY="[Empty name]" NAME="ACOG 2006" TYPE="JOURNAL_ARTICLE">
<AU>ACOG Committee Obstetric Practice</AU>
<TI>ACOG Committee Opinion Number 346, October 2006: amnioinfusion does not prevent meconium aspiration syndrome</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>108</VL>
<NO>4</NO>
<PG>1053</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Alvarez-1999" MODIFIED="2009-06-16 11:50:20 +0100" MODIFIED_BY="[Empty name]" NAME="Alvarez 1999" TYPE="JOURNAL_ARTICLE">
<AU>Alvarez M, Puertas A, Suarez AM, Herruzo A, Miranda JA</AU>
<TI>Transcervical amnioinfusion in deliveries with meconium-stained amniotic fluid</TI>
<TO>Amnioinfusion transcervical en partos con liquido amniotico tenido de meconio</TO>
<SO>Progresos de Obstetricia y Ginecologia</SO>
<YR>1999</YR>
<VL>42</VL>
<PG>365-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Benifla-1995" MODIFIED="2009-06-01 12:13:13 +0100" MODIFIED_BY="[Empty name]" NAME="Benifla 1995" TYPE="JOURNAL_ARTICLE">
<AU>Benifla JL, Goffinet F, Bascou V, Darai E, Proust A, Madelenat P</AU>
<TI>Transabdominal amnio-infusion facilitates external version maneouver after initial failure. Six successful attempts</TI>
<SO>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction</SO>
<YR>1995</YR>
<VL>24</VL>
<PG>319-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cialone-1993" MODIFIED="2014-01-13 10:30:55 +0000" MODIFIED_BY="[Empty name]" NAME="Cialone 1993" TYPE="JOURNAL_ARTICLE">
<AU>Cialone PR, Abramowicz JS, Ryan RM, Sinkin RA, Sherer DM</AU>
<TI>Markedly significant decrease in neonatal morbidity associated with amnioinfusion for labor complicated by particulate meconium</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>168</VL>
<PG>319</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-1985" NAME="Davis 1985" TYPE="JOURNAL_ARTICLE">
<AU>Davis RO, Phillips JB, Harris BA, Huddleston JF</AU>
<TI>Fatal meconium aspiration syndrome occurring despite airway management considered appropriate</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1985</YR>
<VL>151</VL>
<PG>731-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dibble-1992" NAME="Dibble 1992" TYPE="JOURNAL_ARTICLE">
<AU>Dibble LA, Elliot JP</AU>
<TI>Possible amniotic fluid embolism associated with amnioinfusion</TI>
<SO>Journal of Maternal-Fetal Medicine</SO>
<YR>1992</YR>
<VL>1</VL>
<PG>263-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dorairajan-2005" MODIFIED="2013-11-25 14:12:54 +0000" MODIFIED_BY="[Empty name]" NAME="Dorairajan 2005" TYPE="JOURNAL_ARTICLE">
<AU>Dorairajan G, Soundararaghavan S</AU>
<TI>Maternal death after intrapartum saline amnioinfusion--report of two cases</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2005</YR>
<VL>11</VL>
<PG>1331-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dragich-1991" NAME="Dragich 1991" TYPE="JOURNAL_ARTICLE">
<AU>Dragich DA, Ross AF, Chestnut DH, Wenstrom KD</AU>
<TI>Respiratory failure associated with amnioinfusion during labor</TI>
<SO>Anesthesia &amp; Analgesia</SO>
<YR>1991</YR>
<VL>72</VL>
<PG>549-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gelfand-2004" MODIFIED="2013-11-25 14:14:17 +0000" MODIFIED_BY="[Empty name]" NAME="Gelfand 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gelfand SL, Fanaroff JM, Walsh MC</AU>
<TI>Controversies in the treatment of meconium aspiration syndrome</TI>
<SO>Clinics in Perinatology</SO>
<YR>2004</YR>
<VL>31</VL>
<PG>445-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ghidini-2001" MODIFIED="2013-11-25 14:14:24 +0000" MODIFIED_BY="[Empty name]" NAME="Ghidini 2001" TYPE="JOURNAL_ARTICLE">
<AU>Ghidini A, Spong CY</AU>
<TI>Severe meconium aspiration syndrome is not caused by aspiration of meconium</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>185</VL>
<PG>931-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gramellini-2003" MODIFIED="2013-11-25 14:14:35 +0000" MODIFIED_BY="[Empty name]" NAME="Gramellini 2003" TYPE="JOURNAL_ARTICLE">
<AU>Gramellini D, Fieni S, Kaihura C, Piantelli G, Verrotti C</AU>
<TI>Antepartum amnioinfusion: a review</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2003</YR>
<VL>14</VL>
<PG>291-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gramellini-2003b" MODIFIED="2009-06-01 12:16:57 +0100" MODIFIED_BY="[Empty name]" NAME="Gramellini 2003b" TYPE="JOURNAL_ARTICLE">
<AU>Gramellini D, Fieni S, Kaihura C, Faiola S, Vadora E</AU>
<TI>Transabdominal antepartum amnioinfusion</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2003</YR>
<VL>83</VL>
<PG>171-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2008" MODIFIED="2014-01-13 10:32:13 +0000" MODIFIED_BY="[Empty name]" NAME="Guyatt 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P et al</AU>
<TI>Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>924-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hicks-2005" MODIFIED="2009-03-10 14:16:59 +0000" MODIFIED_BY="[Empty name]" NAME="Hicks 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hicks P</AU>
<TI>Systematic review of the risk of uterine rupture with the use of amnioinfusion after previous cesarean delivery</TI>
<SO>Southern Medical Journal</SO>
<YR>2005</YR>
<VL>98</VL>
<PG>458-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-10-31 11:33:59 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2003" MODIFIED="2009-06-01 12:22:06 +0100" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2003" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ, Gülmezoglu AM</AU>
<TI>Vaginal misoprostol for cervical ripening and induction of labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2009-06-01 12:22:06 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-06-01 12:22:06 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000941"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2009" MODIFIED="2009-11-05 11:12:46 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2009" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ</AU>
<TI>Routine ultrasound examination in early pregnancy: is it worthwhile in low-income countries? </TI>
<SO>Ultrasound in Obstetrics and Gynecology</SO>
<YR>2009</YR>
<VL>34</VL>
<NO>4</NO>
<PG>367-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2012" MODIFIED="2014-01-20 12:33:38 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2012" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ, Lawrie</AU>
<TI>Amnioinfusion for potential or suspected umbilical cord compression in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2014-01-20 12:33:38 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-01-20 12:33:38 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000013.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lameier-1993" MODIFIED="2009-06-01 12:22:14 +0100" MODIFIED_BY="[Empty name]" NAME="Lameier 1993" TYPE="JOURNAL_ARTICLE">
<AU>Lameier LN, Katz VL</AU>
<TI>Amnioinfusion: a review</TI>
<SO>Obstetrical &amp; Gynecological Survey</SO>
<YR>1993</YR>
<VL>48</VL>
<PG>829-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maher-1994" NAME="Maher 1994" TYPE="JOURNAL_ARTICLE">
<AU>Maher JE, Wenstrom KD, Hauth JC, Meis BJ</AU>
<TI>Amniotic fluid embolism after saline amnioinfusion: two cases and review of the literature</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1994</YR>
<VL>83</VL>
<PG>851-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mahomed-1994" NAME="Mahomed 1994" TYPE="JOURNAL_ARTICLE">
<AU>Mahomed K, Nyoni R, Masona D</AU>
<TI>Meconium-staining of the liquor in a low-risk population</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>1994</YR>
<VL>8</VL>
<PG>292-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mitri-1987" MODIFIED="2009-06-01 12:22:47 +0100" MODIFIED_BY="[Empty name]" NAME="Mitri 1987" TYPE="JOURNAL_ARTICLE">
<AU>Mitri F, Hofmeyr GJ, Van Gelderen CJ</AU>
<TI>Meconium during labour: self-medication and other associations</TI>
<SO>South African Medical Journal</SO>
<YR>1987</YR>
<VL>71</VL>
<PG>431-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miyazaki-1983" NAME="Miyazaki 1983" TYPE="JOURNAL_ARTICLE">
<AU>Miyazaki FS, Taylor NA</AU>
<TI>Saline amnioinfusion for relief of prolonged variable decelerations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1983</YR>
<VL>146</VL>
<PG>670-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nathan-1994" MODIFIED="2009-06-01 12:23:09 +0100" MODIFIED_BY="[Empty name]" NAME="Nathan 1994" TYPE="JOURNAL_ARTICLE">
<AU>Nathan L, Levino KJ, Carmody III TJ, Kelly MA, Sherman ML</AU>
<TI>Meconium: A 1990's perspective on an old obstetric hazard</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1994</YR>
<VL>83</VL>
<PG>329-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Novikova-2012" MODIFIED="2014-01-16 11:36:20 +0000" MODIFIED_BY="Leanne V Jones" NAME="Novikova 2012" TYPE="COCHRANE_REVIEW">
<AU>Novikova N, Hofmeyr GJ, Essilfie-Appiah G</AU>
<TI>Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2014-01-16 11:36:20 +0000" MODIFIED_BY="Leanne V Jones">
<IDENTIFIER MODIFIED="2014-01-16 11:36:20 +0000" MODIFIED_BY="Leanne V Jones" TYPE="DOI" VALUE="10.1002/14651858.CD000176.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pierce-2000" MODIFIED="2014-01-13 10:47:29 +0000" MODIFIED_BY="Heather Maxwell" NAME="Pierce 2000" TYPE="JOURNAL_ARTICLE">
<AU>Pierce J, Gaudier FL, Sanchez-Ramos L</AU>
<TI>Intrapartum amnioinfusion for meconium-stained fluid: meta-analysis of prospective clinical trials</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2000</YR>
<VL>95</VL>
<PG>1051-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2013-10-31 11:34:12 +0000" MODIFIED_BY="[Empty name]" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schrimmer-1991" MODIFIED="2014-01-13 10:47:42 +0000" MODIFIED_BY="Heather Maxwell" NAME="Schrimmer 1991" TYPE="JOURNAL_ARTICLE">
<AU>Schrimmer DB, Macri CJ, Paul RH</AU>
<TI>Prophylactic amnioinfusion as a treatment for oligohydramnios in laboring patients: a prospective, randomized trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>165</VL>
<PG>972-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Velaphi-2006" MODIFIED="2009-11-05 11:12:55 +0000" MODIFIED_BY="[Empty name]" NAME="Velaphi 2006" TYPE="JOURNAL_ARTICLE">
<AU>Velaphi S, Vidyasagar D</AU>
<TI>Intrapartum and postdelivery management of infants born to mothers with meconium-stained amniotic fluid: evidence-based recommendations</TI>
<SO>Clinical Perinatology</SO>
<YR>2006</YR>
<VL>33</VL>
<PG>29-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wax-2004" MODIFIED="2009-06-01 12:23:53 +0100" MODIFIED_BY="[Empty name]" NAME="Wax 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wax JR, Flaherty N, Pinette MG, Blackstone J, Cartin A</AU>
<TI>Small-volume amnioinfusion: a potential stimulus of intrapartum fetal heart rate accelerations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>190</VL>
<PG>380-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wegnelius-1996" NAME="Wegnelius 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wegnelius G, Bergstrom M, Ahlbom L, Thomassen P</AU>
<TI>A case of life-threatening pulmonary edema associated with amnioinfusion during labor</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>65</VL>
<NO>2</NO>
<PG>237-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weismiller-1998" NAME="Weismiller 1998" TYPE="JOURNAL_ARTICLE">
<AU>Weismiller DG</AU>
<TI>Transcervical amnioinfusion</TI>
<SO>American Family Physician</SO>
<YR>1998</YR>
<VL>57</VL>
<PG>504-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wenstrom-1994" NAME="Wenstrom 1994" TYPE="JOURNAL_ARTICLE">
<AU>Wenstrom KD, Andrews WW, Maher JE</AU>
<TI>Prevalence, protocols and complications associated with amnioinfusion</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>341</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woods-1994" MODIFIED="2013-12-03 09:54:57 +0000" MODIFIED_BY="[Empty name]" NAME="Woods 1994" TYPE="BOOK_SECTION">
<AU>Woods JR, Glantz JC</AU>
<TI>Significance of amniotic fluid meconium</TI>
<SO>Maternal Fetal Medicine: Principles and Practice</SO>
<YR>1994</YR>
<PG>413-22</PG>
<EN>3rd</EN>
<ED>Creasy RK, Resnick R</ED>
<PB>WB Saunders</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Xu-2007" MODIFIED="2009-06-01 12:25:16 +0100" MODIFIED_BY="[Empty name]" NAME="Xu 2007" TYPE="JOURNAL_ARTICLE">
<AU>Xu H, Hofmeyr GJ, Roy C, Fraser W</AU>
<TI>Intrapartum amnioinfusion for meconium-stained amniotic fluid:a systematic review of randomised controlled trials</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2007</YR>
<VL>353</VL>
<PG>383-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ziadeh-2000" NAME="Ziadeh 2000" TYPE="JOURNAL_ARTICLE">
<AU>Ziadeh SM, Sunna E</AU>
<TI>Obstetric and perinatal outcomes of pregnancies with term labour and meconium-stained amniotic fluid</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>2000</YR>
<VL>264</VL>
<PG>84-7</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-01-13 10:24:50 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Hofmeyr-1995" MODIFIED="2009-03-14 17:29:50 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1995" TYPE="OTHER">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for meconium-stained liquor in labour. [ revised 07 October 1993]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1996" NAME="Hofmeyr 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ, Gulmezoglu AM, Nikodem VC, de Jager M</AU>
<TI>Amnioinfusion</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>64</VL>
<PG>159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2000" NAME="Hofmeyr 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for meconium-stained liquor</TI>
<SO>Current Opinion in Obstetrics and Gynecology</SO>
<YR>2000</YR>
<VL>12</VL>
<NO>2</NO>
<PG>129-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2002" MODIFIED="2014-01-13 10:24:50 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2002" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for meconium-stained liquor in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-02-20 14:27:01 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-02-20 14:27:01 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000014"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2010" MODIFIED="2014-01-13 10:11:49 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2010" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ, Xu H</AU>
<TI>Amnioinfusion for meconium-stained liquor in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-10-31 11:35:27 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-31 11:35:27 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000014.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-01-13 10:54:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choudhary-2010">
<CHAR_METHODS MODIFIED="2013-11-25 14:01:19 +0000" MODIFIED_BY="[Empty name]">
<P>Randomly generated number using sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-25 14:02:07 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: term pregnancy (&gt; 37 weeks); singleton pregnancy; cephalic presentation; moderate or thick meconium; adequate pelvis.</P>
<P>Exclusion criteria: cord prolapse; persistent fetal bradycardia; presence of chorioamnionitis; antepartum haemorrhage; fetal malpresentation; fetal congenital anomaly; polyhydramnios; maternal cardiac or pulmonary disease; multiple gestations.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 10:53:59 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion &#8211; Transcervical nasogastric tube was passed cephalad to the baby&#8217;s head with infusion of 500 cc&#8217;s of normal saline over a period of 30 minutes, followed by 2 mL/min under gravity until time of delivery (n = 146) compared with standard labour management without amnioinfusion (n = 146). All newborns were managed by standard protocol of immediate oropharyngeal suctioning post delivery; tracheal suctioning if not breathing vigorously.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:03:18 +0000" MODIFIED_BY="[Empty name]">
<P>Outcomes: Incidence of caesarean section; maternal hospital stay; maternal febrile morbidity (temperature of &gt; 38°C, 24 hours after delivery); low Apgar score (at 1 and 5 minutes); MAS; perinatal morbidity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 10:54:27 +0000" MODIFIED_BY="[Empty name]">
<P>Trial was carried out in a single teaching hospital in Northern India.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:07:23 +0000" MODIFIED_BY="Sonja L  Henderson" STUDY_ID="STD-Cialone-1994">
<CHAR_METHODS>
<P>Computerised randomisation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria: labouring term and post-term women; uncomplicated antepartum course; singleton vertex presenting fetus; gestation &gt; 36 weeks; moderate to thick meconium assessed clinically. <BR/>Exclusion criteria: any obstetric risk factor other than meconium.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 10:55:33 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion of room temperature normal saline 600 mL over 1 hour followed by 150 mL per hour (n = 54), compared with control group (n = 59). Pad weight measured hourly. If vaginal effluent &lt; 100 mL per hour, ultrasound examination performed to exclude overdistension of the uterus.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:04:07 +0000" MODIFIED_BY="[Empty name]">
<P>'Meconiumcrit', delivery mode, duration of first and second stage, oxytocin, analgesia, 1-minute Apgar &lt; 7, nuchal cord, maternal infection, meconium below cords, MAS, neonatal ICU admission.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 11:07:23 +0000" MODIFIED_BY="Sonja L  Henderson">
<P>Discrepancy in birthweights not accounted for. Neonatologists but not obstetricians blinded to group allocation. FHR tracings analysed in a blind fashion. 7 withdrawals from the study group because of diabetes (3) and request (4). 1 withdrawal from the control group on request. Meconium below vocal cords in 33/58 controls according to table vs 34/58 according to text, whereas in previous report of same trial (<LINK REF="REF-Cialone-1993" TYPE="REFERENCE">Cialone 1993</LINK>), reported in 36/58 controls.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 10:57:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eriksen-1994">
<CHAR_METHODS>
<P>Computer randomisation using sealed packets.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-10 10:23:58 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: &gt; 36 weeks' gestation; active labour; thick meconium fluid.<BR/>Exclusion criteria: multiple gestation; malpresentation; fetal distress on admission; cervical dilation =/&gt; 7 cm; intra-amniotic infection.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 10:57:08 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion with 800 mL normal saline at room temperature over 1 hour followed by 180 mL per hour (n = 71), compared with control group (n = 24).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:04:13 +0000" MODIFIED_BY="[Empty name]">
<P>Labour characteristics, fetal distress, operative delivery for fetal distress, meconium below the cords, MAS, fetal acid-base status, infectious morbidity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 10:57:34 +0000" MODIFIED_BY="[Empty name]">
<P>Of 139 women who consented to the study, 9 were excluded because of incomplete records and 6 because they were randomised to amnioinfusion but delivered before amnioinfusion could be administered. The latter exclusions could have biased results against the study group by excluding those with more rapid labours. There were also somewhat more primiparous women in the study group (35/65 vs 27/59). This could possibly have been due to exclusion of more multips who had rapid labours. The n value for umbilical artery pH is given as the whole group, yet in the text at least 1 infant with MAS had no cord blood result.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-14 09:00:20 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fraser-2005">
<CHAR_METHODS MODIFIED="2009-06-30 14:13:32 +0100" MODIFIED_BY="[Empty name]">
<P>1998 women allocation by single, centralised computer-randomisation service, stratified by site and presence or absence of 3 or more variable FHR decelerations in 30 minutes prior to randomisation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:06:17 +0100" MODIFIED_BY="[Empty name]">
<P>Women in labour with: thick meconium-stained amniotic fluid; single fetus; cephalic presentation; gestational age 36 weeks or more; ruptured membranes; cervical dilation 2-7 cm; no indication for urgent delivery. Exclusion criteria: suspected major fetal anomaly; chorioamnionitis; placenta praevia; vaginal bleeding; seropositivity for HIV or hepatitis B or C; active genital herpes; polyhydramnios; previous uterine incision other than low transverse; inability to comprehend the consent form.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-14 09:00:20 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion: a sterile catheter was introduced transcervically, and 800 mL saline infused over 40 minutes, followed by 2 mL per minute to a maximum of 1500 mL. The infusion was discontinued if the baseline uterine pressure increased by 15 mmHg, the uterus failed to relax between contractions as assessed by palpation, or ultrasound examination revealed polyhydramnios. Control group: no amnioinfusion. Both groups had continuous electronic FHR monitoring and suctioning of the baby's nasopharynx and oropharynx during and after delivery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:04:24 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: perinatal death and/or moderate or severe MAS, determined by 3 neonatologists blinded to the group allocation. Secondary outcomes included perinatal death or serious morbidity and maternal death or serious morbidity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>56 centres in 13 countries, April 1999 to August 2003.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:00:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hofmeyr-1998a">
<CHAR_METHODS>
<P>Allocation by opaque sealed envelopes in computer-generated random sequence. Blinding not possible.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria: women in labour; moderate or heavy meconium staining of the liquor; gestation 37 weeks or more; singleton cephalic presentation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:00:59 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion via an Intran or Nelaton intrauterine catheter: 800 mL normal saline at 15 mL per minute, then maintenance of 3 mL per minute (n = 176), compared with no amnioinfusion (n = 176). Electronic FHR monitoring in most cases. 1 woman in the control group received amnioinfusion. Analysis was by intention-to-treat.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:04:38 +0000" MODIFIED_BY="[Empty name]">
<P>Primary: caesarean section, MAS diagnosed clinically by paediatrician blind to group allocation, perinatal mortality. Secondary outcomes: assisted delivery; 5-minute Apgar score &lt; 7; cord pH &lt; 7.2; meconium below cords; X-ray diagnosis of MAS (amnioinfusion 2/163 vs control 3/161); neonatal ICU admission; neonatal ventilation (0/164 vs 2/163); postpartum temperature =/&gt; 38 degrees centigrade.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-30 14:07:42 +0100" MODIFIED_BY="[Empty name]">
<P>4 academic hospitals in South Africa.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Macri-1992">
<CHAR_METHODS>
<P>Sealed envelopes randomised by computer.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-10 10:27:56 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: gestation =/&gt; 37 weeks; thick meconium; 4-quadrant amniotic fluid index &lt; 5 cm; normal FHR pattern; vertex presentation; estimated fetal weight =/&gt; 2500 g; cervical dilation =/&lt; 5 cm; ruptured membranes.<BR/>Exclusion criteria: vaginal bleeding, chorioamnionitis, fetal anomalies, uterine anomalies, contraindication to labour.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:01:40 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion with 500 mL warmed saline over 20-30 minutes followed by 250-500 mL as required to maintain a 4-quadrant amniotic fluid index above 10 cm (n = 85), compared with control group (n = 85).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:04:43 +0000" MODIFIED_BY="[Empty name]">
<P>Fetal distress, mode of delivery, Apgar scores, umbilical artery pH, meconium in oropharynx, meconium below cords, MAS, chorioamnionitis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<P>Neonatologists but not obstetricians stated to have been blinded to group allocation. The women in this report are also included in the report of <LINK REF="REF-Schrimmer-1991" TYPE="REFERENCE">Schrimmer 1991</LINK> on amnioinfusion for oligohydramnios (Paul RH, personal communication) (<I>see</I> review 'Amnioinfusion for potential or suspected umbilical cord compression in labour' (<LINK REF="REF-Hofmeyr-2012" TYPE="REFERENCE">Hofmeyr 2012</LINK>)).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:49:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mahomed-1998">
<CHAR_METHODS>
<P>Allocation by opaque sealed envelopes in computer-generated random sequence.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria: moderate or heavy meconium- stained amniotic fluid; singleton cephalic presentation; in labour; gestation 37 weeks or more. Exclusion criteria: indication for immediate delivery; chorioamnionitis; vaginal bleeding; fetal anomaly; maternal cardiac or pulmonary disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:49:56 +0000" MODIFIED_BY="[Empty name]">
<P>Transcervical amnioinfusion using size 8 nasogastric tube. Normal saline 500 mL infused over 30 minutes, then 500 mL at 2 mL per minute (n = 325). Control group received no amnioinfusion (n = 336). Allocation not blinded. Level of intrapartum surveillance limited by number of midwives in a busy labour ward. FHR auscultated every 30 minutes using Pinard stethoscope or hand-held doptone FHR detector. Suctioning of the airways at delivery by attending midwives.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:18:36 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: caesarean section; MAS diagnosed by a paediatrician blind to the group allocation; perinatal mortality. Secondary outcomes: FHR abnormality (amnioinfusion 30/320 vs control 34/334); contractions =/&gt; 40 seconds at 1 hour (206/323 vs 211/324); caesarean section for fetal distress; assisted delivery; 1-minute Apgar score &lt; 4 ( 8/324 vs 18/336); 5-minute Apgar score &lt; 7; X-ray diagnosis of MAS (2/319 vs 9/330); neonatal ICU admission; neonatal ventilation (10/320 vs 34/332); pneumothorax (0/320 vs 3/329); hypoxic ischaemic encephalopathy; &gt; 4 days in neonatal ICU (5/320 vs 10/329); intrapartum and postpartum pyrexia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-30 14:09:24 +0100" MODIFIED_BY="[Empty name]">
<P>4 amnioinfusion allocations early in the study unaccounted for. No electronic FHR monitoring. Neonatologist not usually present at the time of delivery.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:03:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moodley-1998">
<CHAR_METHODS MODIFIED="2009-11-10 10:31:24 +0000" MODIFIED_BY="[Empty name]">
<P>Randomisation using sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:09:35 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: singleton, term, cephalic pregnancies in active labour; meconium-stained amniotic fluid grade 1-3; normal cardiotocograph. Exclusion criteria: medical or surgical conditions; chorioamnionitis; previous caesarean section.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:03:22 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion with normal saline 10-15 mL per minute by gravity via a central venous manometer set and a size 8 nasogastric infant feeding tube (1 litre over 4 hours); versus standard care; continuous FHR monitoring.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean umbilical artery pH; mean Apgar scores; caesarean section; instrumental delivery; hypoxic ischaemic encephalopathy.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Durban, South Africa, January to April 1993.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:03:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Puertas-2001">
<CHAR_METHODS MODIFIED="2009-06-30 14:09:49 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised sequence in sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:14:34 +0100" MODIFIED_BY="[Empty name]">
<P>206 pregnant women admitted for labour and delivery with moderately or thickly stained amniotic fluid; term pregnancy; no uterine scarring; spontaneous labour or induction of labour for meconium staining of the amniotic fluid; single fetus; vertex presentation; no FHR changes suggesting fetal distress; no vaginal bleeding; and no indication of vertically transmitted infectious disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:03:51 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion with 0.9% saline via an infusion pump at 600 mL per hour for 1 hour, then 180 mL per hour until full cervical dilation, or basal uterine pressure increase to 20 mmHg; compared with no amnioinfusion. Continuous FHR monitoring and intrauterine pressure monitoring</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-10 10:31:57 +0000" MODIFIED_BY="[Empty name]">
<P>Amniotic fluid index change after 1 hour; umbilical cord acid base status; meconium below cords &gt; trace by paediatricians blind to the group allocation; umbilical cord complication; mean umbilical artery pH.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-10 10:32:06 +0000" MODIFIED_BY="[Empty name]">
<P>Granada, Southern Spain. Subdivided into thick (meconium concentration &gt; 15%) and moderate meconium staining. Amnioinfusion stopped in 17 women for uterine hypertonia. Confirmed by correspondence with first author that the data from <LINK REF="REF-Alvarez-1999" TYPE="REFERENCE">Alvarez 1999</LINK> are included in the final <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK> report.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:04:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rathore-2002">
<CHAR_METHODS MODIFIED="2009-03-15 12:39:36 +0000" MODIFIED_BY="[Empty name]">
<P>Computer-generated random allocation by sequentially numbered sealed opaque envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:10:35 +0100" MODIFIED_BY="[Empty name]">
<P>Women in labour; 37 or more weeks' gestation; singleton cephalic presentation; moderate or thick meconium-stained fluid, or meconium crit &gt; 10%. exclusions criteria: chorioamnionitis; indication for immediate delivery; fetal congenital anomaly, antepartum haemorrhage; polyhydramnios; and maternal cardiac or respiratory disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:04:47 +0000" MODIFIED_BY="[Empty name]">
<P>Saline amnioinfusion via FG 8 nasogastric tube, 500 mL over 30 minutes, then 3 mL per minute. Maximum dose 1 L. Control group received no amnioinfusion or uterine catheter. No cardiotocography was available.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:05:01 +0000" MODIFIED_BY="[Empty name]">
<P>Caesarean section; meconium at vocal cords; Apgar scores &lt; 7; neonatal ICU admission; respiratory distress, MAS; maternal pyrexia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Tertiary level teaching hospital.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:05:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sadovsky-1989">
<CHAR_METHODS>
<P>'Random allocation' with sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:11:15 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: singleton; more than a trace of meconium-stained liquor; vertex presentation; &gt; 34 weeks; anticipate delivery &gt; 1 hour.<BR/>Exclusion criteria: malformations; chorioamnionitis; malpresentation; polyhydramnios; cord prolapse; urgent delivery needed; maternal cardiac disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:05:12 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion with saline 600 mL over 1 hour then 180 mL per hour (n = 19), compared with control group (n = 21).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-15 12:39:02 +0000" MODIFIED_BY="[Empty name]">
<P>Thick meconium on spectrophotometry, labour duration, labour augmentation, analgesia, mode of delivery, umbilical artery pH, meconium below cords, positive pressure ventilation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Neither obstetricians nor neonatologists stated to have been blinded.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:05:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sood-2004">
<CHAR_METHODS MODIFIED="2009-11-10 10:32:54 +0000" MODIFIED_BY="[Empty name]">
<P>199 women allocated by flip of a coin.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:11:36 +0100" MODIFIED_BY="[Empty name]">
<P>Women in labour with thick staining of the amniotic fluid. singleton, vertex presentation; adequate pelvis, cervical dilation &gt; 5 cm, gestational age &gt; 37 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:05:47 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion via a plastic suction catheter or amnioinfusion catheter with normal saline till the returning fluid was clear. Usually 1000 mL was infused over 30 to 45 minutes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:05:15 +0000" MODIFIED_BY="[Empty name]">
<P>Persistent FHR decelerations; caesarean section; meconium below neonate's vocal cords; MAS diagnosed by X-ray, perinatal mortality, hospital stay; uterine atony (6/96 versus 1/100).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-30 14:14:52 +0100" MODIFIED_BY="[Empty name]">
<P>FHR abnormalities before enrolment were present in 48/96 women in the amnioinfusion versus 60/100 in the control group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:06:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spong-1994">
<CHAR_METHODS MODIFIED="2009-06-30 14:12:12 +0100" MODIFIED_BY="[Empty name]">
<P>'Randomised' by computer-generated random number sequence.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-06-30 14:14:58 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: singleton; vertex presentation; 37 or more weeks; moderate to heavy meconium; no variable FHR decelerations.<BR/>Exclusion criteria: prenatally diagnosed fetal malformations; maternal temperature &gt; 100.4 degrees Fahrenheit; evidence of fetal distress.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:06:12 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion with 600 mL saline bolus followed by 3 mL per minute (n = 43), compared with standard care which included similar amnioinfusion in 8/50 for variable decelerations (n = 50).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-25 14:05:21 +0000" MODIFIED_BY="[Empty name]">
<P>Meconium below cords, MAS, Apgar scores, cord pH, neonatal complications, route of delivery, maternal infection.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Discrepancy in group numbers (43 vs 50), despite use of computer-generated random number sequence to create equal number groups, not accounted for.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 11:06:35 +0000" MODIFIED_BY="Leanne V Jones" STUDY_ID="STD-Wenstrom-1989">
<CHAR_METHODS MODIFIED="2013-12-12 11:58:53 +0000" MODIFIED_BY="Leanne V Jones">
<P>Sealed envelopes randomised by computer.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-12-12 11:59:05 +0000" MODIFIED_BY="Leanne V Jones">
<P>Inclusion criteria: thick meconium-stained amniotic fluid.<BR/>Exclusion criteria: fetal distress, maternal pyrexia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-13 11:06:35 +0000" MODIFIED_BY="Leanne V Jones">
<P>Amnioinfusion of 1000 mL over 20-40 minutes, repeated 6-hourly (n = 41), compared with control group (n = 44).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-12-12 11:59:39 +0000" MODIFIED_BY="Leanne V Jones">
<P>Mode of delivery, Apgar scores, cord arterial pH, meconium below cords, meconium aspiration syndrome, postpartum endometritis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-12-12 11:59:55 +0000" MODIFIED_BY="Leanne V Jones">
<P>5 study women who did not receive amnioinfusion excluded, of which 4 delivered spontaneously after 30, 45, 60 and 180 minutes and 1 required emergency caesarean section for fetal distress. These exclusions have been included in this review with respect to delivery outcomes. Obstetricians not blinded, but neonatologists blinded.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>FHR: fetal heart rate<BR/>ICU: intensive care unit<BR/>MAS: meconium aspiration syndrome<BR/>vs: versus<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-11-10 10:34:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Adam-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-10 10:34:08 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded because inadequate information to confirm acceptable allocation concealment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:15:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ashfaq-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded because the report does not indicated that allocation was by randomisation. 400 patients were 'equally divided in study and control groups'. Amnioinfusion was associated with very large reductions in caesarean section, low Apgar scores, meconium aspiration syndrome and perinatal death (12/200 vs 36/200).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:15:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Das-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:15:20 +0100" MODIFIED_BY="[Empty name]">
<P>Comparative study in a low-resource setting, not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Edwards-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Excluded because comparison was between amnioinfusion with and without antibiotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-25 14:18:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Engel-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-25 14:18:42 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded because not a randomised trial. Amnioinfusion had no statistically significant effects on the measures outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:15:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzalez-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:15:25 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded because no clinically meaningful data. 43 women undergoing amnioinfusion for meconium-stained liquor were randomly allocated to receive normal saline or lactate Ringer's solution. There were no significant differences in the umbilical artery electrolytes or pH.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:15:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzalez-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:15:40 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded because no clinically meaningful data. 40 women undergoing amnioinfusion for meconium-stained liquor were randomly allocated to receive amnioinfusion with normal saline or lactate Ringer's solution. There were no significant differences in the umbilical artery electrolytes or pH, nor were they different from non-randomised normal controls.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-24 15:42:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gupta-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-24 15:42:08 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded because only abstract available.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:15:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ilagan-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:15:45 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded because inadequate information to confirm acceptable allocation concealment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Khosla-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised trial. The study group was 25 consecutive patients who gave consent for amnioinfusion and controls were 25 similar patients of the alternative unit where amnioinfusion was not being carried out.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:15:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kirubamani-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:15:54 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded because only abstract available, with no figures; discrepancy in group numbers (30 vs 20) not accounted for.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-30 14:16:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lembet-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-30 14:16:04 +0100" MODIFIED_BY="[Empty name]">
<P>Excluded because no data given. Women with thick meconium during labour randomised to transabdominal amnioinfusion (19) vs standard care (20).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lo-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Excluded because allocation was not at random. Of 112 women with moderate or thick meconium-stained liquor, 63 chose to undergo amnioinfusion. In the amnioinfusion group, there were fewer operative deliveries for fetal distress but not overall, and neonatal outcomes were improved.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-25 14:11:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mukhopadhyay-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-25 14:11:39 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded because allocation was by alternation, not randomised. This study in a low-resource setting found that with amnioinfusion the rate of caesarean section was one-half and of meconium below the cords was one-fifth of that in the control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nageotte-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-01-20 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Nageotte-1991" TYPE="STUDY">Nageotte 1991</LINK> studied 86 women with oligohydramnios and/or thick meconium-stained liquor. As the reported results relate primarily to problems associated with oligohydramnios, these are considered in the review '<I>Amnioinfusion for potential or suspected umbilical cord compression in labour</I>' (<LINK REF="REF-Hofmeyr-2012" TYPE="REFERENCE">Hofmeyr 2012</LINK>). The authors state that there was no significant difference in meconium below the cords, but no figures are given.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-01-13 11:44:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Regi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-01-13 11:44:22 +0000" MODIFIED_BY="[Empty name]">
<P>The primary indication for amnioinfusion was fetal heart rate decelerations, not meconium-stained liquor. See review: "A<I>mnioinfusion for potential or suspected umbilical cord compression in labour</I>".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-11-24 15:40:45 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-01-17 11:22:23 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-01-17 11:16:59 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:16:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>The authors did not describe how the random sequences were generated (e.g. computer-generated, shuffling envelopes).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 10:56:26 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Computer-generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 10:59:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Computer randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:00:06 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Computer-generated using a centralised computer-randomisation service.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:01:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Computer-generated random sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:02:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Computer-generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-15 15:51:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Computer-generated random sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-15 15:52:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Unclear how the randomisation was carried out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:04:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>'Randomly generated numbers in sealed envelopes.' However, method of randomisation not described (e.g. computer-generated, shuffling envelopes).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-25 14:09:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Computer-generated sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:05:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>'Randomly generated numbers in sealed envelopes.' However, method of randomisation not described (e.g. computer-generated, shuffling envelopes).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-15 16:00:44 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Flip of a coin.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-15 16:04:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Randomised' by computer-generated random number sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:06:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Computer-generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-01-13 11:06:54 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 10:56:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>Allocation by sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-15 15:45:59 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="UNKNOWN" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Unclear. The method of allocation concealment was not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 10:59:15 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-25 14:18:22 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Centralised computer randomisation service.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:01:18 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Allocation by opaque sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:02:02 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Allocation by opaque sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:03:04 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Allocation by opaque sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-15 15:53:01 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Allocation using sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:04:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-11 08:55:32 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Adequate. Sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:05:32 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Allocation adequate with sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:05:57 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:06:26 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-13 11:06:54 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Allocation using sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-01-17 11:20:43 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-11-25 14:05:41 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-17 11:17:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-17 11:17:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-11 08:53:12 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="NO" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Blinding not feasible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-13 11:01:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-17 11:18:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-13 11:03:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-13 11:03:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-11 08:55:21 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="NO" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Blinding not feasible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-11 08:55:36 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="NO" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Blinding not feasible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-13 11:05:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-11 08:55:54 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="NO" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Blinding not feasible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-17 11:20:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-17 11:20:43 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-01-17 11:20:44 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:16:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:17:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:17:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:17:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-13 11:01:22 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:18:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-13 11:03:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-13 11:03:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-12-15 15:57:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Blinding not feasible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:19:47 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-13 11:05:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:20:12 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:20:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 11:20:44 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-01-17 11:20:31 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-11-25 14:05:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>Blinded to outcome assessor (paediatrician).                            </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-13 10:56:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Blinded to outcome assessor (neonatologists).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-17 11:17:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-13 11:00:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>3 neonatologists were blinded to outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-13 11:01:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-17 11:18:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-13 11:03:12 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-14 09:00:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-13 11:04:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Blinded to paediatricians.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-17 11:19:49 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-13 11:05:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Blinding not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-17 11:20:14 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-17 11:20:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-15 16:24:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Neonatologists blinded to outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-01-17 11:22:23 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:16:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:17:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:17:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:22:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Adequately described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:17:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:19:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Adequately described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:19:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:19:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:19:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:19:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:20:00 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:20:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:20:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 11:20:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-01-17 11:20:47 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-25 14:05:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>All outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:17:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:17:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-11 09:02:49 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Protocol published. All predefined outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:18:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:18:51 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Adequately described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:52 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:02 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:47 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-01-17 11:22:06 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:16:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choudhary-2010">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:17:17 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cialone-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:17:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eriksen-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:22:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-2005">
<DESCRIPTION>
<P>Adequately described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:18:22 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hofmeyr-1998a">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:18:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macri-1992">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mahomed-1998">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moodley-1998">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:19:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rathore-2002">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:04 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadovsky-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2004">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spong-1994">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 11:20:49 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenstrom-1989">
<DESCRIPTION>
<P>Not described by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-12-12 16:06:38 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-12-12 16:06:38 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Amnioinfusion for meconium-stained liquor in labour</NAME>
<DICH_OUTCOME CHI2="38.47031163165804" CI_END="0.6891947862876818" CI_START="0.20750517142407232" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3781685897496014" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="150" I2="68.8071151726129" I2_Q="63.73975753716061" ID="CMP-001.01" LOG_CI_END="-0.16165801662019974" LOG_CI_START="-0.6829710753713987" LOG_EFFECT_SIZE="-0.42231454599579915" METHOD="MH" MODIFIED="2013-12-12 14:58:28 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.2860274886450362E-4" P_Q="0.0967788199117483" P_Z="0.001495656831061079" Q="2.757841459622976" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.8615950333151787" TOTALS="SUB" TOTAL_1="2241" TOTAL_2="2277" WEIGHT="200.0" Z="3.175524903527067">
<NAME>Meconium aspiration syndrome</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="20.08094390404239" CI_END="1.0553179998248245" CI_START="0.25609806817882075" DF="9" EFFECT_SIZE="0.519870080952419" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="84" I2="55.18138966471464" ID="CMP-001.01.01" LOG_CI_END="0.02338334566152745" LOG_CI_START="-0.5915936975270506" LOG_EFFECT_SIZE="-0.2841051759327615" MODIFIED="2013-12-12 11:45:25 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.017419403326632388" P_Z="0.07015384082147462" STUDIES="11" TAU2="0.5605668159525523" TOTAL_1="1672" TOTAL_2="1702" WEIGHT="99.99999999999999" Z="1.810916094566733">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="40" O_E="0.0" SE="0.0" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.1080777784770572" CI_START="0.029647862445166522" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3238866303262053" LOG_CI_START="-1.52800661298213" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="60" O_E="0.0" SE="1.0878112581387145" STUDY_ID="STD-Moodley-1998" TOTAL_1="30" TOTAL_2="30" VAR="1.1833333333333331" WEIGHT="7.4829250846809385"/>
<DICH_DATA CI_END="32.31699422911795" CI_START="0.3765430588349484" EFFECT_SIZE="3.488372093023256" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.5094309606912693" LOG_CI_START="-0.42418535373908" LOG_EFFECT_SIZE="0.5426228034760947" ORDER="93" O_E="0.0" SE="1.1358157946515117" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="1.2900775193798448" WEIGHT="7.051313925172094"/>
<DICH_DATA CI_END="1.189831281480707" CI_START="0.019998384524004452" EFFECT_SIZE="0.15425531914893617" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="0.07548538263893022" LOG_CI_START="-1.6990050853683778" LOG_EFFECT_SIZE="-0.8117598513647237" ORDER="105" O_E="0.0" SE="1.0423444847769736" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="1.0864820249449745" WEIGHT="7.922943053200009"/>
<DICH_DATA CI_END="3.7114420468835343" CI_START="0.008907009949792375" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5695426835563069" LOG_CI_START="-2.0502680625447947" LOG_EFFECT_SIZE="-0.7403626894942439" ORDER="124" O_E="0.0" SE="1.5388898005321299" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="2.368181818181818" WEIGHT="4.455648402249149"/>
<DICH_DATA CI_END="3.257383891700545" CI_START="0.009267371118477854" EFFECT_SIZE="0.17374517374517376" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.5128689443869431" LOG_CI_START="-2.0330434449987593" LOG_EFFECT_SIZE="-0.7600872503059081" MODIFIED="2013-12-12 11:45:25 +0000" MODIFIED_BY="Leanne V Jones" ORDER="129" O_E="0.0" SE="1.495481539994739" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="36" TOTAL_2="44" VAR="2.2364650364650362" WEIGHT="4.6654721364688765"/>
<DICH_DATA CI_END="1.6188126849318953" CI_START="0.005105261953309345" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20919659884180564" LOG_CI_START="-2.2919819691582557" LOG_EFFECT_SIZE="-1.041392685158225" ORDER="170" O_E="0.0" SE="1.4692046718768264" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="2.1585623678646932" WEIGHT="4.799137256859088"/>
<DICH_DATA CI_END="0.7446175467319779" CI_START="0.13114954170580534" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="20" LOG_CI_END="-0.12806673395285925" LOG_CI_START="-0.8822332226869527" LOG_EFFECT_SIZE="-0.5051499783199059" ORDER="196" O_E="0.0" SE="0.44300112866673375" STUDY_ID="STD-Sood-2004" TOTAL_1="96" TOTAL_2="100" VAR="0.19625" WEIGHT="17.242579574352778"/>
<DICH_DATA CI_END="3.2678744987864734" CI_START="0.17213023333940294" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5142653693012887" LOG_CI_START="-0.7641428425178886" LOG_EFFECT_SIZE="-0.12493873660829995" ORDER="206" O_E="0.0" SE="0.7509433118452936" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.5639158576051779" WEIGHT="11.604869047010917"/>
<DICH_DATA CI_END="2.332672294551977" CI_START="0.19288965236696626" EFFECT_SIZE="0.6707818930041153" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3678537312222752" LOG_CI_START="-0.7146910696109839" LOG_EFFECT_SIZE="-0.17341866919435434" ORDER="325" O_E="0.0" SE="0.6358921746926443" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="162" TOTAL_2="163" VAR="0.40435885783534037" WEIGHT="13.523812793832539"/>
<DICH_DATA CI_END="2.189215779311479" CI_START="0.8842268676981565" EFFECT_SIZE="1.391317149774259" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="31" LOG_CI_END="0.34028856976610355" LOG_CI_START="-0.05343629296353954" LOG_EFFECT_SIZE="0.14342613840128202" ORDER="1975" O_E="0.0" SE="0.23127593333689545" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.0534885573408521" WEIGHT="21.25129872617361"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.9383271868599534" CI_END="0.5201452107958492" CI_START="0.054126740398393984" DF="2" EFFECT_SIZE="0.16779083644292037" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="66" I2="31.93406068106043" ID="CMP-001.01.02" LOG_CI_END="-0.2838753958967485" LOG_CI_START="-1.2665881260516605" LOG_EFFECT_SIZE="-0.7752317609742044" MODIFIED="2013-11-11 23:52:37 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.23011793152885474" P_Z="0.0019860514975440636" STUDIES="3" TAU2="0.3905246424596259" TOTAL_1="569" TOTAL_2="575" WEIGHT="100.0" Z="3.0923102643465032">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.3177276143489862" CI_START="0.005949621886392381" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="23" LOG_CI_END="-0.4979450381215038" LOG_CI_START="-2.225510633913682" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-11-11 23:52:37 +0000" MODIFIED_BY="[Empty name]" ORDER="137" O_E="0.0" SE="1.0147805825559428" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="1.0297796307325788" WEIGHT="23.461024568380708"/>
<DICH_DATA CI_END="8.085642092978038" CI_START="0.013741779543718032" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9077145135887024" LOG_CI_START="-1.8619570230280276" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="200" O_E="0.0" SE="1.626918770703887" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="2.6468646864686467" WEIGHT="10.97053747130133"/>
<DICH_DATA CI_END="0.4750477622562506" CI_START="0.12380862310926982" EFFECT_SIZE="0.24251805985552116" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="42" LOG_CI_END="-0.3232627233403286" LOG_CI_START="-0.9072491062177295" LOG_EFFECT_SIZE="-0.6152559147790291" ORDER="652" O_E="0.0" SE="0.3430364920814025" STUDY_ID="STD-Mahomed-1998" TOTAL_1="323" TOTAL_2="329" VAR="0.11767403489951413" WEIGHT="65.56843796031797"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.465207771988101" CI_START="0.8788306517930397" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1347552605159097" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="99" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.16589921365248111" LOG_CI_START="-0.05609480419528125" LOG_EFFECT_SIZE="0.054902204728599927" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.3323194086363046" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="986" TOTAL_2="989" WEIGHT="100.00000000000001" Z="0.9694526454644747">
<NAME>Perinatal death or serious morbidity (post hoc)</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.465207771988101" CI_START="0.8788306517930397" DF="0" EFFECT_SIZE="1.1347552605159097" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="99" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="0.16589921365248111" LOG_CI_START="-0.05609480419528125" LOG_EFFECT_SIZE="0.054902204728599927" NO="1" P_CHI2="1.0" P_Z="0.3323194086363046" STUDIES="1" TAU2="0.0" TOTAL_1="986" TOTAL_2="989" WEIGHT="100.00000000000001" Z="0.9694526454644747">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.465207771988101" CI_START="0.8788306517930397" EFFECT_SIZE="1.1347552605159097" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="99" LOG_CI_END="0.16589921365248111" LOG_CI_START="-0.05609480419528125" LOG_EFFECT_SIZE="0.054902204728599927" ORDER="1975" O_E="0.0" SE="0.13040038497188658" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.017004260400816224" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0406314532024608" CI_START="0.49303094319721424" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0030425963488845" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.3097645763509599" LOG_CI_START="-0.3071258230390234" LOG_EFFECT_SIZE="0.0013193766559682393" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.9933108051767243" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="986" TOTAL_2="989" WEIGHT="100.0" Z="0.008383760649534373">
<NAME>Maternal death or serious morbidity (post hoc)</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0406314532024608" CI_START="0.49303094319721424" DF="0" EFFECT_SIZE="1.0030425963488845" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.3097645763509599" LOG_CI_START="-0.3071258230390234" LOG_EFFECT_SIZE="0.0013193766559682393" NO="1" P_CHI2="1.0" P_Z="0.9933108051767243" STUDIES="1" TAU2="0.0" TOTAL_1="986" TOTAL_2="989" WEIGHT="100.0" Z="0.008383760649534373">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="2.0406314532024608" CI_START="0.49303094319721424" EFFECT_SIZE="1.0030425963488845" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.3097645763509599" LOG_CI_START="-0.3071258230390234" LOG_EFFECT_SIZE="0.0013193766559682393" ORDER="1975" O_E="0.0" SE="0.3623644742584019" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.13130801220456803" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4376350400443711" CI_END="0.148746343127789" CI_START="0.006135705391491376" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.030210325047801145" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="55" I2="30.441317014008227" I2_Q="99.99999999999999" ID="CMP-001.04" LOG_CI_END="-0.8275537024326515" LOG_CI_START="-2.212135501393052" LOG_EFFECT_SIZE="-1.5198446019128518" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2305226929676778" P_Q="0.0" P_Z="1.6859655287836674E-5" Q="2.9814532348048994E-31" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="65" TOTAL_2="73" WEIGHT="100.0" Z="4.302874245614724">
<NAME>Heavy meconium staining</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.4376350400443711" CI_END="0.148746343127789" CI_START="0.006135705391491376" DF="1" EFFECT_SIZE="0.030210325047801145" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="55" I2="30.441317014008227" ID="CMP-001.04.01" LOG_CI_END="-0.8275537024326515" LOG_CI_START="-2.212135501393052" LOG_EFFECT_SIZE="-1.5198446019128518" NO="1" P_CHI2="0.2305226929676778" P_Z="1.6859655287836674E-5" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="73" WEIGHT="100.0" Z="4.302874245614724">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="0.20966656848979986" CI_START="8.394386946887503E-4" EFFECT_SIZE="0.013266583229036295" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="42" LOG_CI_END="-0.6784708126337646" LOG_CI_START="-3.076011015464678" LOG_EFFECT_SIZE="-1.8772409140492212" ORDER="1" O_E="0.0" SE="1.4083269831582874" STUDY_ID="STD-Cialone-1994" TOTAL_1="46" TOTAL_2="52" VAR="1.983384891491723" WEIGHT="76.38623326959848"/>
<DICH_DATA CI_END="0.5898438776060756" CI_START="0.012254838915442028" EFFECT_SIZE="0.08502024291497975" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="13" LOG_CI_END="-0.22926292406395316" LOG_CI_START="-1.9116923929875402" LOG_EFFECT_SIZE="-1.0704776585257465" ORDER="2" O_E="0.0" SE="0.9882673982059009" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.9766724503566608" WEIGHT="23.613766730401526"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="20.460652837243074" CI_END="0.9578953952952949" CI_START="0.4705272295244186" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6713537566160578" ESTIMABLE="YES" EVENTS_1="328" EVENTS_2="385" I2="80.45028166100798" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.01868191443548589" LOG_CI_START="-0.32741523878291523" LOG_EFFECT_SIZE="-0.17304857660920053" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="4.049666162456722E-4" P_Q="1.0" P_Z="0.02800868718531082" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10443754612557202" TOTALS="SUB" TOTAL_1="1050" TOTAL_2="1051" WEIGHT="100.0" Z="2.197164678914116">
<NAME>Variable decelerations</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="20.460652837243074" CI_END="0.9578953952952949" CI_START="0.4705272295244186" DF="4" EFFECT_SIZE="0.6713537566160578" ESTIMABLE="YES" EVENTS_1="328" EVENTS_2="385" I2="80.45028166100798" ID="CMP-001.05.01" LOG_CI_END="-0.01868191443548589" LOG_CI_START="-0.32741523878291523" LOG_EFFECT_SIZE="-0.17304857660920053" NO="1" P_CHI2="4.049666162456722E-4" P_Z="0.02800868718531082" STUDIES="5" TAU2="0.10443754612557202" TOTAL_1="1050" TOTAL_2="1051" WEIGHT="100.0" Z="2.197164678914116">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.292578517270638" CI_START="0.32159407727556355" EFFECT_SIZE="0.6447368421052632" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.1114569336473465" LOG_CI_START="-0.492691958151902" LOG_EFFECT_SIZE="-0.1906175122522777" ORDER="40" O_E="0.0" SE="0.3548800496281245" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.12593984962406013" WEIGHT="14.275862556168134"/>
<DICH_DATA CI_END="1.0719717962530997" CI_START="0.056824667529883875" EFFECT_SIZE="0.24680851063829787" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="0.030183359150800265" LOG_CI_START="-1.2454630965683982" LOG_EFFECT_SIZE="-0.607639868708799" ORDER="105" O_E="0.0" SE="0.7493210426412529" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.5614820249449742" WEIGHT="4.938788677561315"/>
<DICH_DATA CI_END="0.657781362626517" CI_START="0.30298588666598514" EFFECT_SIZE="0.44642857142857145" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="56" LOG_CI_END="-0.181918435844437" LOG_CI_START="-0.5185776008238885" LOG_EFFECT_SIZE="-0.3502480183341628" ORDER="196" O_E="0.0" SE="0.19775525999867324" STUDY_ID="STD-Sood-2004" TOTAL_1="96" TOTAL_2="100" VAR="0.039107142857142854" WEIGHT="22.911582874137057"/>
<DICH_DATA CI_END="0.9233622827731014" CI_START="0.5926109456903113" EFFECT_SIZE="0.7397260273972602" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="73" LOG_CI_END="-0.034627869353927594" LOG_CI_START="-0.22723033124104725" LOG_EFFECT_SIZE="-0.13092910029748742" ORDER="206" O_E="0.0" SE="0.1131356395100566" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.01279967292734948" WEIGHT="28.052832234830674"/>
<DICH_DATA CI_END="1.1720725970064028" CI_START="0.8684828046854746" EFFECT_SIZE="1.0089226414067178" ESTIMABLE="YES" EVENTS_1="241" EVENTS_2="234" LOG_CI_END="0.06895451228176638" LOG_CI_START="-0.06123877583995826" LOG_EFFECT_SIZE="0.003857868220904041" ORDER="1554" O_E="0.0" SE="0.07647618190987106" STUDY_ID="STD-Fraser-2005" TOTAL_1="785" TOTAL_2="769" VAR="0.005848606399511689" WEIGHT="29.820933657302817"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="51.6443492054209" CI_END="0.5280195193406743" CI_START="0.2796597224978559" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.38427306990246435" ESTIMABLE="YES" EVENTS_1="196" EVENTS_2="295" I2="80.63679733822585" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-0.2773500225698701" LOG_CI_START="-0.5533700776274513" LOG_EFFECT_SIZE="-0.41536005009866067" METHOD="MH" MODIFIED="2013-12-12 14:59:02 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.3277965804636693E-7" P_Q="0.8868608824352884" P_Z="3.6619994115986304E-9" Q="0.020242867038589338" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.52535455468049" TOTALS="SUB" TOTAL_1="1943" TOTAL_2="1969" WEIGHT="200.0" Z="5.898779627736099">
<NAME>Caesarean for fetal distress</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="24.486656844520013" CI_END="0.8587204346622164" CI_START="0.18991983092172465" DF="7" EFFECT_SIZE="0.4038416023146675" ESTIMABLE="YES" EVENTS_1="151" EVENTS_2="174" I2="71.41300241822695" ID="CMP-001.06.01" LOG_CI_END="-0.06614820222827804" LOG_CI_START="-0.7214296850248815" LOG_EFFECT_SIZE="-0.39378894362657973" MODIFIED="2013-12-12 11:46:09 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="9.352697542729382E-4" P_Z="0.01848953501697291" STUDIES="8" TAU2="0.6981571399713721" TOTAL_1="1376" TOTAL_2="1389" WEIGHT="100.0" Z="2.355665976472396">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="4.311304635056056" CI_START="0.011226300179869031" EFFECT_SIZE="0.22" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6346087110119837" LOG_CI_START="-1.9497633493675712" LOG_EFFECT_SIZE="-0.6575773191777937" ORDER="40" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="2.3045454545454547" WEIGHT="4.934221895560022"/>
<DICH_DATA CI_END="1.5022476497886328" CI_START="0.12226577250002559" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.1767415332480145" LOG_CI_START="-0.9126951038372033" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="60" O_E="0.0" SE="0.6399404734221844" STUDY_ID="STD-Moodley-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.4095238095238095" WEIGHT="13.37569351036696"/>
<DICH_DATA CI_END="2.040411209555538" CI_START="0.029854002290432304" EFFECT_SIZE="0.24680851063829787" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.309717700780901" LOG_CI_START="-1.5249974381984992" LOG_EFFECT_SIZE="-0.607639868708799" ORDER="105" O_E="0.0" SE="1.07772075462291" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="1.1614820249449744" WEIGHT="7.967137478730337"/>
<DICH_DATA CI_END="2.434485915596335" CI_START="0.33843092710682976" EFFECT_SIZE="0.9076923076923077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.3864072663345784" LOG_CI_START="-0.47052995633600114" LOG_EFFECT_SIZE="-0.04206134500071139" ORDER="124" O_E="0.0" SE="0.5033691665043633" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="0.2533805177872974" WEIGHT="15.570588054936938"/>
<DICH_DATA CI_END="1.0392127541169234" CI_START="0.05472781934782827" EFFECT_SIZE="0.23848238482384823" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.016704468134843747" LOG_CI_START="-1.2617918561526271" LOG_EFFECT_SIZE="-0.6225436940088918" MODIFIED="2013-12-12 11:46:09 +0000" MODIFIED_BY="Leanne V Jones" ORDER="130" O_E="0.0" SE="0.7509950695453329" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="41" TOTAL_2="44" VAR="0.5639935944813994" WEIGHT="11.738693710100765"/>
<DICH_DATA CI_END="0.49357419122383506" CI_START="0.028042046557394232" EFFECT_SIZE="0.11764705882352941" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="17" LOG_CI_END="-0.3066475574474942" LOG_CI_START="-1.5521902939810914" LOG_EFFECT_SIZE="-0.9294189257142927" ORDER="170" O_E="0.0" SE="0.7316379689758172" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.5352941176470589" WEIGHT="12.011825190666068"/>
<DICH_DATA CI_END="0.7858226240283176" CI_START="0.06776903112922267" EFFECT_SIZE="0.23076923076923078" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="-0.10467547189833303" LOG_CI_START="-1.1689687232760155" LOG_EFFECT_SIZE="-0.6368220975871743" ORDER="206" O_E="0.0" SE="0.6251711241958117" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.3908389345282549" WEIGHT="13.605192189997087"/>
<DICH_DATA CI_END="1.478876366799121" CI_START="0.9259775634991638" EFFECT_SIZE="1.1702163624070319" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="114" LOG_CI_END="0.16993186874927915" LOG_CI_START="-0.033399536176116316" LOG_EFFECT_SIZE="0.06826616628658143" ORDER="1975" O_E="0.0" SE="0.1194378737598644" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.014265405688277303" WEIGHT="20.79664796964183"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.352612380324638" CI_END="0.5397035656675392" CI_START="0.26780506796490866" DF="2" EFFECT_SIZE="0.380178050503312" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="121" I2="14.988120579216751" ID="CMP-001.06.02" LOG_CI_END="-0.2678447126655234" LOG_CI_START="-0.5721812086221116" LOG_EFFECT_SIZE="-0.42001296064381755" MODIFIED="2013-11-11 23:55:54 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.30841591776887767" P_Z="6.307089473604182E-8" STUDIES="3" TAU2="0.01683582806593374" TOTAL_1="567" TOTAL_2="580" WEIGHT="100.0" Z="5.409868923636076">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.45625606476568" CI_START="0.21507100318252348" EFFECT_SIZE="0.3132530120481928" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="83" LOG_CI_END="-0.3407913496548918" LOG_CI_START="-0.6674181391556201" LOG_EFFECT_SIZE="-0.5041047444052559" MODIFIED="2013-11-11 23:55:54 +0000" MODIFIED_BY="[Empty name]" ORDER="138" O_E="0.0" SE="0.19186219298141177" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.0368111010956365" WEIGHT="59.57148257760533"/>
<DICH_DATA CI_END="0.8625541666089764" CI_START="0.24696159351561947" EFFECT_SIZE="0.46153846153846156" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="26" LOG_CI_END="-0.0642136226074661" LOG_CI_START="-0.6073705812389202" LOG_EFFECT_SIZE="-0.3357921019231931" ORDER="200" O_E="0.0" SE="0.31905308617042366" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.1017948717948718" WEIGHT="26.939292355522717"/>
<DICH_DATA CI_END="1.5222318828969015" CI_START="0.24201129903736804" EFFECT_SIZE="0.606957424714434" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.18248081392726592" LOG_CI_START="-0.6161643571806172" LOG_EFFECT_SIZE="-0.21684177162667562" ORDER="655" O_E="0.0" SE="0.4691281268661265" STUDY_ID="STD-Mahomed-1998" TOTAL_1="321" TOTAL_2="334" VAR="0.22008119941692048" WEIGHT="13.489225066871956"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="59.3979748999129" CI_END="0.8729079682633333" CI_START="0.5706555535487539" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7057830968693076" ESTIMABLE="YES" EVENTS_1="577" EVENTS_2="682" I2="78.11373195482619" I2_Q="34.755775212548826" ID="CMP-001.07" LOG_CI_END="-0.05903154207026485" LOG_CI_START="-0.24362595187756017" LOG_EFFECT_SIZE="-0.15132874697391252" METHOD="MH" MODIFIED="2013-12-12 14:59:19 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="6.72964455272762E-8" P_Q="0.2157077102627517" P_Z="0.0013111876496781116" Q="1.532702707799413" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14754368956959094" TOTALS="SUB" TOTAL_1="2245" TOTAL_2="2272" WEIGHT="200.0" Z="3.213519783227166">
<NAME>Caesarean overall</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnionf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="32.965497311444025" CI_END="1.0156314892006681" CI_START="0.5984065035122004" DF="10" EFFECT_SIZE="0.7795899488253173" ESTIMABLE="YES" EVENTS_1="483" EVENTS_2="516" I2="69.66525362707486" ID="CMP-001.07.01" LOG_CI_END="0.006736157516852803" LOG_CI_START="-0.22300369518351237" LOG_EFFECT_SIZE="-0.10813376883332981" MODIFIED="2013-12-12 11:47:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.760468856138898E-4" P_Z="0.0650333871844418" STUDIES="11" TAU2="0.11065941358670969" TOTAL_1="1682" TOTAL_2="1698" WEIGHT="99.99999999999997" Z="1.8450285393220276">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="2.072993088862818" CI_START="0.3006612522779072" EFFECT_SIZE="0.7894736842105263" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3165978542049341" LOG_CI_START="-0.5219225379992296" LOG_EFFECT_SIZE="-0.10266234189714771" ORDER="40" O_E="0.0" SE="0.4925510291236095" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.24260651629072683" WEIGHT="5.155207207384017"/>
<DICH_DATA CI_END="1.5335466633044796" CI_START="0.4790815272408504" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.18569699538685452" LOG_CI_START="-0.319590574648081" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="60" O_E="0.0" SE="0.29680841985233186" STUDY_ID="STD-Moodley-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.08809523809523812" WEIGHT="9.162850038557298"/>
<DICH_DATA CI_END="2.444312221435798" CI_START="0.43706031397013034" EFFECT_SIZE="1.0335917312661498" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.3881566792244557" LOG_CI_START="-0.3594586266063538" LOG_EFFECT_SIZE="0.014349026309050952" ORDER="93" O_E="0.0" SE="0.4391529314004664" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="0.19285529715762276" WEIGHT="6.000233278186778"/>
<DICH_DATA CI_END="3.1303036677907086" CI_START="0.7880331771699115" EFFECT_SIZE="1.5705996131528046" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" LOG_CI_END="0.49558647008599876" LOG_CI_START="-0.1034554977915332" LOG_EFFECT_SIZE="0.1960654861472328" ORDER="105" O_E="0.0" SE="0.3518802172368271" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.12381968728263665" WEIGHT="7.766828945843417"/>
<DICH_DATA CI_END="1.937501596288934" CI_START="0.5554169573109803" EFFECT_SIZE="1.0373626373626375" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.2872420689895427" LOG_CI_START="-0.2553808650355918" LOG_EFFECT_SIZE="0.01593060197697541" ORDER="124" O_E="0.0" SE="0.3187393974732072" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="0.10159480350158316" WEIGHT="8.580084263154205"/>
<DICH_DATA CI_END="1.1033339040576757" CI_START="0.22732344958302836" EFFECT_SIZE="0.5008130081300813" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.042706963704728644" LOG_CI_START="-0.6433557622546736" LOG_EFFECT_SIZE="-0.30032439927497245" MODIFIED="2013-12-12 11:47:24 +0000" MODIFIED_BY="Leanne V Jones" ORDER="131" O_E="0.0" SE="0.4029966412938174" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="41" TOTAL_2="44" VAR="0.16240629289409775" WEIGHT="6.669307146979216"/>
<DICH_DATA CI_END="0.9465286099248453" CI_START="0.2856754641800736" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.02386625444745958" LOG_CI_START="-0.544127058282942" LOG_EFFECT_SIZE="-0.28399665636520083" ORDER="170" O_E="0.0" SE="0.3056037715054758" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.09339366515837105" WEIGHT="8.924928156082927"/>
<DICH_DATA CI_END="0.5300705918105645" CI_START="0.16710434208982575" EFFECT_SIZE="0.2976190476190476" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="42" LOG_CI_END="-0.27566628965902273" LOG_CI_START="-0.7770122651206652" LOG_EFFECT_SIZE="-0.5263392773898441" ORDER="196" O_E="0.0" SE="0.2944931076887717" STUDY_ID="STD-Sood-2004" TOTAL_1="96" TOTAL_2="100" VAR="0.08672619047619047" WEIGHT="9.226402687639952"/>
<DICH_DATA CI_END="0.9452678270576622" CI_START="0.26447530831359795" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="24" LOG_CI_END="-0.02444512341291181" LOG_CI_START="-0.5776148679150506" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="206" O_E="0.0" SE="0.32493464615495327" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.10558252427184467" WEIGHT="8.421858802516896"/>
<DICH_DATA CI_END="1.262746666265576" CI_START="0.7607173654796694" EFFECT_SIZE="0.9800986262768581" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="68" LOG_CI_END="0.10131623061984496" LOG_CI_START="-0.11877666965806753" LOG_EFFECT_SIZE="-0.008730219519111277" ORDER="326" O_E="0.0" SE="0.129283659100673" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="167" TOTAL_2="159" VAR="0.01671426451045903" WEIGHT="14.297766187124488"/>
<DICH_DATA CI_END="1.2542152611153687" CI_START="0.9602010467742884" EFFECT_SIZE="1.0974054886883264" ESTIMABLE="YES" EVENTS_1="314" EVENTS_2="287" LOG_CI_END="0.09837208090581882" LOG_CI_START="-0.01763782491543725" LOG_EFFECT_SIZE="0.04036712799519079" ORDER="1975" O_E="0.0" SE="0.06814479293770116" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.004643712804522165" WEIGHT="15.794533286530783"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.939871074329556" CI_END="0.8414403514120086" CI_START="0.41204460386380215" DF="2" EFFECT_SIZE="0.5888216676317028" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="166" I2="59.513113401012355" ID="CMP-001.07.02" LOG_CI_END="-0.07497666515551764" LOG_CI_START="-0.38505576900711946" LOG_EFFECT_SIZE="-0.23001621708131856" MODIFIED="2013-11-11 23:57:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0845903710646837" P_Z="0.0036398485032512725" STUDIES="3" TAU2="0.05914381146295329" TOTAL_1="563" TOTAL_2="574" WEIGHT="100.00000000000001" Z="2.9077967250272176">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.611353698846852" CI_START="0.34968618086702186" EFFECT_SIZE="0.46236559139784944" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="93" LOG_CI_END="-0.2137074558565046" LOG_CI_START="-0.45632153009219256" LOG_EFFECT_SIZE="-0.3350144929743486" MODIFIED="2013-11-11 23:57:03 +0000" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.14251270816507938" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.020309871988545086" WEIGHT="41.754777011973275"/>
<DICH_DATA CI_END="0.9252521485815157" CI_START="0.367767616967386" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="36" LOG_CI_END="-0.03373989773135072" LOG_CI_START="-0.4344265143353852" LOG_EFFECT_SIZE="-0.23408320603336796" ORDER="200" O_E="0.0" SE="0.23536530202395042" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.055396825396825396" WEIGHT="28.964138198031982"/>
<DICH_DATA CI_END="1.3238013589835456" CI_START="0.5316739740504376" EFFECT_SIZE="0.838946201722227" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="37" LOG_CI_END="0.12182282258898193" LOG_CI_START="-0.27435459829579184" LOG_EFFECT_SIZE="-0.07626588785340495" ORDER="645" O_E="0.0" SE="0.23271657813757782" STUDY_ID="STD-Mahomed-1998" TOTAL_1="317" TOTAL_2="328" VAR="0.054157005740063366" WEIGHT="29.281084789994747"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.24508816211294662" CI_END="1.4502620215077229" CI_START="0.6671074820063717" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.983605940108887" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="49" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.16144647410710902" LOG_CI_START="-0.17580418844971207" LOG_EFFECT_SIZE="-0.007178857171301544" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6205551189172624" P_Q="1.0" P_Z="0.933500722717141" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="983" TOTAL_2="986" WEIGHT="100.0" Z="0.08344120897635009">
<NAME>1-minute Apgar &lt; 4</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.24508816211294662" CI_END="1.4502620215077229" CI_START="0.6671074820063717" DF="1" EFFECT_SIZE="0.983605940108887" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="49" I2="0.0" ID="CMP-001.08.01" LOG_CI_END="0.16144647410710902" LOG_CI_START="-0.17580418844971207" LOG_EFFECT_SIZE="-0.007178857171301544" NO="1" P_CHI2="0.6205551189172624" P_Z="0.933500722717141" STUDIES="2" TAU2="0.0" TOTAL_1="983" TOTAL_2="986" WEIGHT="100.0" Z="0.08344120897635009">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="5.616953031581328" CI_START="0.05437141103597274" EFFECT_SIZE="0.5526315789473685" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7495007923628191" LOG_CI_START="-1.2646293961286008" LOG_EFFECT_SIZE="-0.25756430188289087" ORDER="40" O_E="0.0" SE="1.183110042825089" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="1.399749373433584" WEIGHT="3.8874175205847195"/>
<DICH_DATA CI_END="1.4849372113554193" CI_START="0.674827027848139" EFFECT_SIZE="1.0010373443983402" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="47" LOG_CI_END="0.17170809046240856" LOG_CI_START="-0.17080753158048492" LOG_EFFECT_SIZE="4.5027944096178926E-4" ORDER="1929" O_E="0.0" SE="0.20119537186766906" STUDY_ID="STD-Fraser-2005" TOTAL_1="964" TOTAL_2="965" VAR="0.040479577660969636" WEIGHT="96.11258247941528"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.252775027522766" CI_END="0.6755896135511068" CI_START="0.3001842952582017" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.45033475551815877" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="137" I2="79.48912540996592" I2_Q="78.26192270649179" ID="CMP-001.09" LOG_CI_END="-0.17031703585075486" LOG_CI_START="-0.5226120324828656" LOG_EFFECT_SIZE="-0.3464645341668103" METHOD="MH" MODIFIED="2013-12-12 15:01:17 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="5.448837875110524E-5" P_Q="0.031967862187529006" P_Z="1.1570437987806039E-4" Q="4.600222855489785" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.49402403684246043" TOTALS="SUB" TOTAL_1="560" TOTAL_2="586" WEIGHT="200.0" Z="3.8550533807127065">
<NAME>1-minute Apgar &lt; 7</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="18.324466031632962" CI_END="1.6011946035827103" CI_START="0.4140179671869538" DF="4" EFFECT_SIZE="0.8142010408038263" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="84" I2="78.17126025339607" ID="CMP-001.09.01" LOG_CI_END="0.20444411775694943" LOG_CI_START="-0.38298081134085965" LOG_EFFECT_SIZE="-0.08926834679195511" MODIFIED="2013-12-12 11:49:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0010663094793014194" P_Z="0.5513796889266555" STUDIES="5" TAU2="0.4470717571796755" TOTAL_1="314" TOTAL_2="340" WEIGHT="100.0" Z="0.5956939721314809">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="5.669770604059163" CI_START="0.9538884734632218" EFFECT_SIZE="2.3255813953488373" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.7535654879217171" LOG_CI_START="-0.020502399080890122" LOG_EFFECT_SIZE="0.3665315444204135" ORDER="93" O_E="0.0" SE="0.45469130852316897" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="0.20674418604651165" WEIGHT="18.210607908788212"/>
<DICH_DATA CI_END="1.861843275331351" CI_START="0.7452644040208806" EFFECT_SIZE="1.1779497098646035" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.269943120510288" LOG_CI_START="-0.12768962143242232" LOG_EFFECT_SIZE="0.07112674953893285" ORDER="105" O_E="0.0" SE="0.23357144093096524" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.05455561801856739" WEIGHT="23.73551838533779"/>
<DICH_DATA CI_END="1.0312020628891903" CI_START="0.33134946718810954" EFFECT_SIZE="0.5845410628019324" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="23" LOG_CI_END="0.013343773139466074" LOG_CI_START="-0.47971372342040147" LOG_EFFECT_SIZE="-0.23318497514046765" MODIFIED="2013-12-12 11:49:31 +0000" MODIFIED_BY="Leanne V Jones" ORDER="132" O_E="0.0" SE="0.2896244141532368" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="36" TOTAL_2="44" VAR="0.08388230127360563" WEIGHT="22.424512247426918"/>
<DICH_DATA CI_END="0.5320009616911497" CI_START="0.10010214586931344" EFFECT_SIZE="0.23076923076923078" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="26" LOG_CI_END="-0.27408758263581245" LOG_CI_START="-0.999556612538536" LOG_EFFECT_SIZE="-0.6368220975871743" ORDER="170" O_E="0.0" SE="0.42614409929447483" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.1815987933634992" WEIGHT="18.93899082169421"/>
<DICH_DATA CI_END="2.749499565581912" CI_START="0.3637025488266833" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4392536553998243" LOG_CI_START="-0.43925365539982436" LOG_EFFECT_SIZE="0.0" ORDER="206" O_E="0.0" SE="0.5160395430450367" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.26629680998613037" WEIGHT="16.690370636752867"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.12233750479564819" CI_END="0.5360383248940155" CI_START="0.19450888685577816" DF="1" EFFECT_SIZE="0.3228997025194834" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="53" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="-0.2708041586375069" LOG_CI_START="-0.7110605515400392" LOG_EFFECT_SIZE="-0.49093235508877314" MODIFIED="2013-11-11 23:58:22 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7265130390549552" P_Z="1.2360318411362813E-5" STUDIES="2" TAU2="0.0" TOTAL_1="246" TOTAL_2="246" WEIGHT="100.0" Z="4.371133504618736">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.5705390535393576" CI_START="0.19474759952334497" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="45" LOG_CI_END="-0.24371462266356628" LOG_CI_START="-0.7105278867757586" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-11 23:58:22 +0000" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="0.2742084221024267" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.07519025875190259" WEIGHT="88.94570191436276"/>
<DICH_DATA CI_END="1.1482049911367633" CI_START="0.054432788990163516" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.060019430372084286" LOG_CI_START="-1.264139413028009" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="200" O_E="0.0" SE="0.7778174593052023" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.605" WEIGHT="11.054298085637244"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.784545246217839" CI_END="0.7863456438469856" CI_START="0.39326574560986205" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5560960402075812" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="87" I2="39.12562172108495" I2_Q="86.06019503020671" ID="CMP-001.10" LOG_CI_END="-0.10438651475017732" LOG_CI_START="-0.4053138800344134" LOG_EFFECT_SIZE="-0.2548501973922954" METHOD="MH" MODIFIED="2013-12-12 16:06:38 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.09702675918335468" P_Q="0.007398019724476068" P_Z="9.010796402294372E-4" Q="7.173701512804089" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1995" TOTAL_2="2025" WEIGHT="100.00000000000001" Z="3.3197194138195485">
<NAME>5-minute Apgar &lt; 7</NAME>
<GROUP_LABEL_1>favours amnioinf.</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.578816809888544" CI_END="1.2226896800530453" CI_START="0.5229726942812214" DF="6" EFFECT_SIZE="0.7996457442187669" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="46" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.08731624661800604" LOG_CI_START="-0.28152098614720267" LOG_EFFECT_SIZE="-0.09710236976459836" MODIFIED="2013-12-12 11:50:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4719823187297473" P_Z="0.30207940870400984" STUDIES="7" TAU2="0.0" TOTAL_1="1425" TOTAL_2="1443" WEIGHT="53.52657078971532" Z="1.031984467106413">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="16.46981283829314" CI_START="0.0741724669365489" EFFECT_SIZE="1.105263157894737" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.216688663908166" LOG_CI_START="-1.129757276345985" LOG_EFFECT_SIZE="0.043465693781090345" ORDER="40" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="1.899749373433584" WEIGHT="1.0898728349359852"/>
<DICH_DATA CI_END="24.76822292846625" CI_START="0.2183575641261216" EFFECT_SIZE="2.3255813953488373" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3938948479242717" LOG_CI_START="-0.6608317590834448" LOG_EFFECT_SIZE="0.3665315444204135" ORDER="93" O_E="0.0" SE="1.206956580017074" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="1.4567441860465116" WEIGHT="1.0608835744707947"/>
<DICH_DATA CI_END="6.470294482593933" CI_START="0.05771866970322788" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.8109240471687218" LOG_CI_START="-1.2386836870588838" LOG_EFFECT_SIZE="-0.21387981994508098" MODIFIED="2013-12-12 11:50:31 +0000" MODIFIED_BY="Leanne V Jones" ORDER="133" O_E="0.0" SE="1.203949728807208" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="36" TOTAL_2="44" VAR="1.4494949494949496" WEIGHT="2.0650222135629193"/>
<DICH_DATA CI_END="1.0032541232022476" CI_START="0.0034489841929702175" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.0014109532853223443" LOG_CI_START="-2.4623087960418704" LOG_EFFECT_SIZE="-1.2304489213782739" ORDER="170" O_E="0.0" SE="1.4472011763642403" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="2.094391244870041" WEIGHT="9.751493786269341"/>
<DICH_DATA CI_END="8.08842446091253" CI_START="0.01373705245663822" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9078639339028167" LOG_CI_START="-1.8621064433421415" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="206" O_E="0.0" SE="1.6270943111681933" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="2.6474358974358974" WEIGHT="1.7208518446357661"/>
<DICH_DATA CI_END="5.186672417947185" CI_START="0.4285933328817639" EFFECT_SIZE="1.4909638554216869" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7148888195049604" LOG_CI_START="-0.36795458904589545" LOG_EFFECT_SIZE="0.17346711522953245" ORDER="331" O_E="0.0" SE="0.6360675783440927" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="166" TOTAL_2="165" VAR="0.4045819642205184" WEIGHT="4.602802114151657"/>
<DICH_DATA CI_END="1.5139184597557411" CI_START="0.5331283364975006" EFFECT_SIZE="0.898394584824751" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="29" LOG_CI_END="0.18010248452218966" LOG_CI_START="-0.2731682335180962" LOG_EFFECT_SIZE="-0.04653287449795324" ORDER="1948" O_E="0.0" SE="0.2662534635031045" STUDY_ID="STD-Fraser-2005" TOTAL_1="973" TOTAL_2="975" VAR="0.07089090682739901" WEIGHT="33.23564442168885"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9386198692780938" CI_END="0.5298657289315964" CI_START="0.14333113452132756" DF="2" EFFECT_SIZE="0.2755834829443447" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="41" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="-0.2758341692141421" LOG_CI_START="-0.8436594615069051" LOG_EFFECT_SIZE="-0.5597468153605236" MODIFIED="2013-11-12 00:00:22 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.37934480433033924" P_Z="1.1147260900282871E-4" STUDIES="3" TAU2="0.0" TOTAL_1="570" TOTAL_2="582" WEIGHT="46.47342921028469" Z="3.8641589709321242">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.6326422100300634" CI_START="0.01097689078336149" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.1988418352284208" LOG_CI_START="-1.9595206568668286" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-11-12 00:00:22 +0000" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="1.0342314553311298" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="1.069634703196347" WEIGHT="13.766814757086129"/>
<DICH_DATA CI_END="5.426269691827724" CI_START="0.046072166368087905" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345013748958881" LOG_CI_START="-1.3365613662238505" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="200" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="2.2944691261810215"/>
<DICH_DATA CI_END="0.7236472658069639" CI_START="0.16512738349537223" EFFECT_SIZE="0.345679012345679" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="27" LOG_CI_END="-0.1404730744701125" LOG_CI_START="-0.7821809006027486" LOG_EFFECT_SIZE="-0.46132698753643053" ORDER="660" O_E="0.0" SE="0.3769423535752798" STUDY_ID="STD-Mahomed-1998" TOTAL_1="324" TOTAL_2="336" VAR="0.14208553791887124" WEIGHT="30.412145327017537"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.952308252471937" CI_END="0.9619253677879608" CI_START="0.3960918259071031" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6172607028748024" ESTIMABLE="YES" EVENTS_1="188" EVENTS_2="226" I2="72.6680222826938" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-0.016858621948887147" LOG_CI_START="-0.4022041199791191" LOG_EFFECT_SIZE="-0.20953137096400312" METHOD="MH" MODIFIED="2013-12-12 12:26:37 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0012352068492177404" P_Q="1.0" P_Z="0.033051399775411924" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.22743093443141973" TOTALS="SUB" TOTAL_1="903" TOTAL_2="885" WEIGHT="100.0" Z="2.1314583552681277">
<NAME>Umbilical artery pH &lt; 7.20</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="21.952308252471937" CI_END="0.9619253677879608" CI_START="0.3960918259071031" DF="6" EFFECT_SIZE="0.6172607028748024" ESTIMABLE="YES" EVENTS_1="188" EVENTS_2="226" I2="72.6680222826938" ID="CMP-001.11.01" LOG_CI_END="-0.016858621948887147" LOG_CI_START="-0.4022041199791191" LOG_EFFECT_SIZE="-0.20953137096400312" NO="1" P_CHI2="0.0012352068492177404" P_Z="0.033051399775411924" STUDIES="7" TAU2="0.22743093443141973" TOTAL_1="903" TOTAL_2="885" WEIGHT="100.0" Z="2.1314583552681277">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.3392327753079343" CI_START="0.12827376843696736" EFFECT_SIZE="0.4144736842105263" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.12685606935378432" LOG_CI_START="-0.891862146336166" LOG_EFFECT_SIZE="-0.3825030384911908" ORDER="40" O_E="0.0" SE="0.5984001226327726" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.3580827067669173" WEIGHT="8.750618803423144"/>
<DICH_DATA CI_END="1.9093539112628792" CI_START="0.3745512631125588" EFFECT_SIZE="0.8456659619450317" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.28088643518406076" LOG_CI_START="-0.42648873400375903" LOG_EFFECT_SIZE="-0.07280114940984916" ORDER="93" O_E="0.0" SE="0.4155156759444853" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="0.17265327695560254" WEIGHT="12.806320600776191"/>
<DICH_DATA CI_END="1.0663495498912077" CI_START="0.12863906705102493" EFFECT_SIZE="0.37037037037037035" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="0.027899589967178406" LOG_CI_START="-0.8906271182851531" LOG_EFFECT_SIZE="-0.43136376415898736" ORDER="95" O_E="0.0" SE="0.5395471352079548" STUDY_ID="STD-Cialone-1994" TOTAL_1="45" TOTAL_2="50" VAR="0.2911111111111111" WEIGHT="9.88079312444237"/>
<DICH_DATA CI_END="0.4843321850471216" CI_START="0.10527599685544253" EFFECT_SIZE="0.22580645161290322" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="31" LOG_CI_END="-0.3148566700739944" LOG_CI_START="-0.9776706375660374" LOG_EFFECT_SIZE="-0.6462636538200158" ORDER="170" O_E="0.0" SE="0.3893402054868801" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.151585795608566" WEIGHT="13.518154403871268"/>
<DICH_DATA CI_END="1.7467172593663522" CI_START="0.554751569224499" EFFECT_SIZE="0.984375" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.24222261154579494" LOG_CI_START="-0.25590146060640584" LOG_EFFECT_SIZE="-0.006839424530305466" ORDER="201" O_E="0.0" SE="0.29260054573612704" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="96" TOTAL_2="105" VAR="0.08561507936507937" WEIGHT="16.366944322956968"/>
<DICH_DATA CI_END="0.9694437770737163" CI_START="0.34777550932097834" EFFECT_SIZE="0.5806451612903226" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="31" LOG_CI_END="-0.013477372778848841" LOG_CI_START="-0.45870100468308445" LOG_EFFECT_SIZE="-0.23608918873096657" ORDER="206" O_E="0.0" SE="0.26152656527306983" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.06839614434352925" WEIGHT="17.31960001615915"/>
<DICH_DATA CI_END="1.3172009417779278" CI_START="0.8503146810035935" EFFECT_SIZE="1.0583172013274336" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="113" LOG_CI_END="0.1196520325536957" LOG_CI_START="-0.0704203226007308" LOG_EFFECT_SIZE="0.024615854976482436" ORDER="983" O_E="0.0" SE="0.11164944229104237" STUDY_ID="STD-Fraser-2005" TOTAL_1="512" TOTAL_2="471" VAR="0.012465597963900801" WEIGHT="21.357568728370925"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="33.071416197471656" CI_END="0.5307902393400736" CI_START="0.2244836159995744" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.34518648911036376" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="282" I2="69.76240769282657" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="-0.27507707194121334" LOG_CI_START="-0.6488153506100243" LOG_EFFECT_SIZE="-0.4619462112756188" METHOD="MH" MODIFIED="2013-12-12 15:02:52 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="2.649602893057823E-4" P_Q="0.4874748551839039" P_Z="1.265538250148737E-6" Q="0.48209518535199114" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3707012712397054" TOTALS="SUB" TOTAL_1="1734" TOTAL_2="1764" WEIGHT="200.0" Z="4.845090741680566">
<NAME>Meconium below vocal cords</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="33.13289688161321" CI_END="0.5307738879126473" CI_START="0.1753733874812969" DF="9" EFFECT_SIZE="0.3050960745566209" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="258" I2="72.83666432139091" ID="CMP-001.12.01" LOG_CI_END="-0.27509045094398993" LOG_CI_START="-0.7560363091849339" LOG_EFFECT_SIZE="-0.5155633800644619" MODIFIED="2013-12-12 11:51:27 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.2662060155732568E-4" P_Z="2.6447766003286245E-5" STUDIES="10" TAU2="0.4567538222982979" TOTAL_1="1634" TOTAL_2="1664" WEIGHT="99.99999999999999" Z="4.202076551277208">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.408238943505249" CI_START="0.005084196362151506" EFFECT_SIZE="0.08461538461538462" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.14867635014810587" LOG_CI_START="-2.2937776844453293" LOG_EFFECT_SIZE="-1.0725506671486118" ORDER="40" O_E="0.0" SE="1.4347095902626457" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="2.0583916083916085" WEIGHT="3.1732513997630094"/>
<DICH_DATA CI_END="9.958510981017625" CI_START="0.3054859276296135" EFFECT_SIZE="1.744186046511628" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9981944065892543" LOG_CI_START="-0.5150087909650274" LOG_EFFECT_SIZE="0.2415928078121135" ORDER="93" O_E="0.0" SE="0.8888630487200179" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="0.7900775193798448" WEIGHT="6.401177522376197"/>
<DICH_DATA CI_END="0.2956457229840206" CI_START="0.018919984760361316" EFFECT_SIZE="0.07479045776918117" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="33" LOG_CI_END="-0.5292283994244719" LOG_CI_START="-1.7230792177489012" LOG_EFFECT_SIZE="-1.1261538085866865" ORDER="105" O_E="0.0" SE="0.7012738803406302" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.4917850552480046" WEIGHT="8.41419255180153"/>
<DICH_DATA CI_END="0.8802689824848843" CI_START="0.014624530644847785" EFFECT_SIZE="0.11346153846153846" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.05538460085073582" LOG_CI_START="-1.8349180631345743" LOG_EFFECT_SIZE="-0.945151331992655" ORDER="124" O_E="0.0" SE="1.0453067645782321" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="1.0926662320730118" WEIGHT="5.151081358491076"/>
<DICH_DATA CI_END="0.6210512338271941" CI_START="0.03758313020147809" EFFECT_SIZE="0.1527777777777778" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.2068725710784473" LOG_CI_START="-1.4250070514676396" LOG_EFFECT_SIZE="-0.8159398112730434" MODIFIED="2013-12-12 11:51:27 +0000" MODIFIED_BY="Leanne V Jones" ORDER="134" O_E="0.0" SE="0.7155382236435378" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="36" TOTAL_2="44" VAR="0.5119949494949495" WEIGHT="8.238656905618917"/>
<DICH_DATA CI_END="0.32724574107268856" CI_START="0.04489708034268494" EFFECT_SIZE="0.12121212121212122" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="33" LOG_CI_END="-0.4851259968495247" LOG_CI_START="-1.3477819002503253" LOG_EFFECT_SIZE="-0.9164539485499251" ORDER="170" O_E="0.0" SE="0.5067283478732213" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.25677361853832437" WEIGHT="11.185538637709872"/>
<DICH_DATA CI_END="0.5676962878088593" CI_START="0.21237283771975515" EFFECT_SIZE="0.3472222222222222" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="48" LOG_CI_END="-0.2458839456361324" LOG_CI_START="-0.6729010298823292" LOG_EFFECT_SIZE="-0.45939248775923086" ORDER="196" O_E="0.0" SE="0.2508319490548735" STUDY_ID="STD-Sood-2004" TOTAL_1="96" TOTAL_2="100" VAR="0.06291666666666666" WEIGHT="15.358172010961281"/>
<DICH_DATA CI_END="0.6916115547285531" CI_START="0.19439299925694825" EFFECT_SIZE="0.36666666666666664" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="30" LOG_CI_END="-0.16013775959572754" LOG_CI_START="-0.7113193795271473" LOG_EFFECT_SIZE="-0.4357285695614374" ORDER="206" O_E="0.0" SE="0.32376681194073753" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.1048249485142689" WEIGHT="14.212055678308564"/>
<DICH_DATA CI_END="1.3491030239383297" CI_START="0.1996495865330125" EFFECT_SIZE="0.5189873417721519" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.13004511573527938" LOG_CI_START="-0.6997315848766912" LOG_EFFECT_SIZE="-0.2848432345707059" ORDER="322" O_E="0.0" SE="0.4874149414003838" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="158" TOTAL_2="164" VAR="0.2375733251003396" WEIGHT="11.494853382078698"/>
<DICH_DATA CI_END="1.0857050816040719" CI_START="0.5458945329008114" EFFECT_SIZE="0.769857433808554" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="70" LOG_CI_END="0.03571187053251585" LOG_CI_START="-0.2628912551040021" LOG_EFFECT_SIZE="-0.11358969228574313" ORDER="1962" O_E="0.0" SE="0.17540095410820117" STUDY_ID="STD-Fraser-2005" TOTAL_1="982" TOTAL_2="980" VAR="0.03076549470206729" WEIGHT="16.37102055289084"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8254565803895365" CI_START="0.21032131215088662" DF="0" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" I2="0.0" ID="CMP-001.12.02" LOG_CI_END="-0.08330576600284131" LOG_CI_START="-0.6771167174203706" LOG_EFFECT_SIZE="-0.38021124171160603" NO="2" P_CHI2="1.0" P_Z="0.012076848037806304" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="100.0" Z="2.509890861706336">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.8254565803895365" CI_START="0.21032131215088662" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.08330576600284131" LOG_CI_START="-0.6771167174203706" LOG_EFFECT_SIZE="-0.38021124171160603" ORDER="200" O_E="0.0" SE="0.3488074922742725" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.12166666666666666" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.094786915920827" CI_END="0.6837261520392628" CI_START="0.37523523201112124" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5065156871139569" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="112" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="-0.16511780832706766" LOG_CI_START="-0.4256963911094411" LOG_EFFECT_SIZE="-0.2954070997182544" METHOD="MH" MODIFIED="2013-12-12 12:26:42 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.718330347599135" P_Q="0.7131736498324077" P_Z="8.835940986731293E-6" Q="0.13512775175626218" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="651" TOTAL_2="674" WEIGHT="100.0" Z="4.443859276867446">
<NAME>Neonatal ventilation/neonatal intensive care unit admission</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7265985296911784" CI_END="0.8952267868456792" CI_START="0.2282675581269988" DF="2" EFFECT_SIZE="0.4520522454353506" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="25" I2="0.0" ID="CMP-001.13.01" LOG_CI_END="-0.048066931388980036" LOG_CI_START="-0.6415558069836245" LOG_EFFECT_SIZE="-0.34481136918630223" NO="1" P_CHI2="0.6953784207808886" P_Z="0.02275992100335613" STUDIES="3" TAU2="0.0" TOTAL_1="230" TOTAL_2="242" WEIGHT="21.415415975352452" Z="2.2774407166030297">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.3184814570054018" CI_START="0.1527287710947513" EFFECT_SIZE="0.44874274661508706" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.12007402629717338" LOG_CI_START="-0.8160791427032591" LOG_EFFECT_SIZE="-0.3480025582030428" ORDER="79" O_E="0.0" SE="0.5499010055037773" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.3023911158540653" WEIGHT="9.027919488310696"/>
<DICH_DATA CI_END="3.2784483012156382" CI_START="0.16948907127403626" EFFECT_SIZE="0.7454268292682927" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5156683395432392" LOG_CI_START="-0.7708583000473193" LOG_EFFECT_SIZE="-0.12759498025204" ORDER="80" O_E="0.0" SE="0.7557121165050684" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="164" TOTAL_2="163" VAR="0.5711008030325702" WEIGHT="3.6782608104557615"/>
<DICH_DATA CI_END="1.02764615454872" CI_START="0.10698682406516777" EFFECT_SIZE="0.33157894736842103" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.01184360144842037" LOG_CI_START="-0.9706697044469149" LOG_EFFECT_SIZE="-0.4794130514992473" ORDER="81" O_E="0.0" SE="0.577133179402222" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.3330827067669173" WEIGHT="8.709235676585994"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1851491559079654" CI_END="0.728066829403246" CI_START="0.37333647332898595" DF="1" EFFECT_SIZE="0.5213577489950871" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="87" I2="15.62243494711171" ID="CMP-001.13.02" LOG_CI_END="-0.1378287548779314" LOG_CI_START="-0.4278995793430958" LOG_EFFECT_SIZE="-0.28286416711051365" NO="2" P_CHI2="0.2763102751185731" P_Z="1.3208435650116372E-4" STUDIES="2" TAU2="0.0" TOTAL_1="421" TOTAL_2="432" WEIGHT="78.58458402464755" Z="3.822539416542433">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.9482504024702177" CI_START="0.0784393711782182" EFFECT_SIZE="0.2727272727272727" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.023076964295556657" LOG_CI_START="-1.1054658965815685" LOG_EFFECT_SIZE="-0.5642714304385626" ORDER="200" O_E="0.0" SE="0.6358006167364295" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.4042424242424242" WEIGHT="10.084378151836415"/>
<DICH_DATA CI_END="0.7897445259728648" CI_START="0.3942030745110746" EFFECT_SIZE="0.5579603213641581" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="76" LOG_CI_END="-0.10251337567671368" LOG_CI_START="-0.4042799928470696" LOG_EFFECT_SIZE="-0.2533966842618916" ORDER="653" O_E="0.0" SE="0.17725920469471326" STUDY_ID="STD-Mahomed-1998" TOTAL_1="321" TOTAL_2="332" VAR="0.031420825649002254" WEIGHT="68.50020587281114"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3037721628519295" CI_END="0.4911012894156071" CI_START="0.017551631385894276" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.09284195605953226" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-0.3088289256009396" LOG_CI_START="-1.7556825105962275" LOG_EFFECT_SIZE="-1.0322557180985836" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.5815273167922296" P_Q="0.5869320145816668" P_Z="0.005163267680582368" Q="0.295161208615177" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="350" TOTAL_2="359" WEIGHT="100.00000000000001" Z="2.7966672665297283">
<NAME>Neonatal encephalopathy</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.9981665126016623" CI_START="0.010004585820506876" DF="0" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-001.14.01" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" NO="1" P_CHI2="1.0" P_Z="0.2922772002054833" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="15.33191589888968" Z="1.053139231306288">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="84" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Moodley-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="15.33191589888968"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5552094784419342" CI_START="0.009713570491239417" DF="0" EFFECT_SIZE="0.0734375" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="14" I2="0.0" ID="CMP-001.14.02" LOG_CI_END="-0.25554312828826753" LOG_CI_START="-2.012621103808072" LOG_EFFECT_SIZE="-1.1340821160481698" NO="2" P_CHI2="1.0" P_Z="0.011404163479660008" STUDIES="1" TAU2="0.0" TOTAL_1="320" TOTAL_2="329" WEIGHT="84.66808410111034" Z="2.5300642702641785">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.5552094784419342" CI_START="0.009713570491239417" EFFECT_SIZE="0.0734375" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="14" LOG_CI_END="-0.25554312828826753" LOG_CI_START="-2.012621103808072" LOG_EFFECT_SIZE="-1.1340821160481698" ORDER="85" O_E="0.0" SE="1.0321163004965863" STUDY_ID="STD-Mahomed-1998" TOTAL_1="320" TOTAL_2="329" VAR="1.0652640577507597" WEIGHT="84.66808410111034"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.820691780210598" CI_END="0.664642741990864" CI_START="0.18120861791370638" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3470432144309129" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="35" I2="37.76826777610451" I2_Q="72.59295343320976" ID="CMP-001.15" LOG_CI_END="-0.17741173345468844" LOG_CI_START="-0.741821152004852" LOG_EFFECT_SIZE="-0.45961644272977026" METHOD="MH" MODIFIED="2013-12-12 11:53:55 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.18540788992595658" P_Q="0.05611330534466619" P_Z="0.0014123198923804666" Q="3.6486966866824817" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1942" TOTAL_2="1971" WEIGHT="100.0" Z="3.1921213390336156">
<NAME>Perinatal death</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.4538372149270877" CI_START="0.2912975880108323" DF="0" EFFECT_SIZE="1.0030425963488845" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-001.15.01" LOG_CI_END="0.5383018646949891" LOG_CI_START="-0.5356631113830527" LOG_EFFECT_SIZE="0.0013193766559682393" MODIFIED="2013-12-12 11:53:55 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9961576657071963" STUDIES="7" TAU2="0.0" TOTAL_1="1372" TOTAL_2="1390" WEIGHT="14.34924835682607" Z="0.004815670502001046">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="40" O_E="0.0" SE="0.0" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Moodley-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="105" O_E="0.0" SE="0.0" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-12-12 11:53:55 +0000" MODIFIED_BY="Leanne V Jones" ORDER="135" O_E="0.0" SE="0.0" STUDY_ID="STD-Wenstrom-1989" TOTAL_1="41" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="170" O_E="0.0" SE="0.0" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="327" O_E="0.0" SE="0.0" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="164" TOTAL_2="163" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.4538372149270877" CI_START="0.2912975880108323" EFFECT_SIZE="1.0030425963488845" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5383018646949891" LOG_CI_START="-0.5356631113830527" LOG_EFFECT_SIZE="0.0013193766559682393" ORDER="1975" O_E="0.0" SE="0.6308523431606121" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.3979746788712347" WEIGHT="14.34924835682607"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.5502494281432941" CI_END="0.5346260151813036" CI_START="0.10518840662634406" DF="2" EFFECT_SIZE="0.23714227518077197" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="30" I2="0.0" ID="CMP-001.15.02" LOG_CI_END="-0.2719499120688343" LOG_CI_START="-0.9780321234489991" LOG_EFFECT_SIZE="-0.6249910177589166" MODIFIED="2013-11-12 00:02:39 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4606464672421253" P_Z="5.209676774935224E-4" STUDIES="3" TAU2="0.0" TOTAL_1="570" TOTAL_2="581" WEIGHT="85.65075164317393" Z="3.4697372791026857">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.533936644312774" CI_START="0.029263771584943064" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.27251027229303443" LOG_CI_START="-1.5336697016908525" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-11-12 00:02:39 +0000" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.7408112916681371" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.5488013698630136" WEIGHT="45.98744909489897"/>
<DICH_DATA CI_END="5.426269691827724" CI_START="0.046072166368087905" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345013748958881" LOG_CI_START="-1.3365613662238505" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="200" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="5.748431136862371"/>
<DICH_DATA CI_END="1.0576055909850415" CI_START="0.11231385815640806" EFFECT_SIZE="0.3446502057613169" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="0.024323738026146895" LOG_CI_START="-0.9495666538050056" LOG_EFFECT_SIZE="-0.4626214578894293" ORDER="659" O_E="0.0" SE="0.572068036996808" STUDY_ID="STD-Mahomed-1998" TOTAL_1="324" TOTAL_2="335" VAR="0.32726183895338123" WEIGHT="33.91487141141259"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.657436900051199" CI_END="1.3413991169909956" CI_START="0.6460791845008692" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9309404103355534" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="56" I2="27.516999878478213" I2_Q="63.757760781171605" ID="CMP-001.16" LOG_CI_END="0.1275580161196884" LOG_CI_START="-0.18971425091469277" LOG_EFFECT_SIZE="-0.031078117397502155" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.20883152248789183" P_Q="0.0966959746026601" P_Z="0.7009984661915101" Q="2.759211410647289" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1920" TOTAL_2="1939" WEIGHT="100.0" Z="0.38397299187710715">
<NAME>Puerperal pyrexia</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.659763965898575" CI_END="1.7767883224517194" CI_START="0.7391121769430502" DF="4" EFFECT_SIZE="1.1459694083937322" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="35" I2="29.325674637653588" ID="CMP-001.16.01" LOG_CI_END="0.24963569124536686" LOG_CI_START="-0.1312896426198402" LOG_EFFECT_SIZE="0.059173024312763334" MODIFIED="2013-11-12 00:04:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.22603899703109143" P_Z="0.542575836639583" STUDIES="5" TAU2="0.0" TOTAL_1="1353" TOTAL_2="1358" WEIGHT="62.40258402308039" Z="0.6089224643187862">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="2.0170926395498863" CI_START="0.0969003901355406" EFFECT_SIZE="0.4421052631578947" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3047258446289356" LOG_CI_START="-1.0136744744108301" LOG_EFFECT_SIZE="-0.35447431489094733" ORDER="40" O_E="0.0" SE="0.7744348735907907" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="0.5997493734335839" WEIGHT="8.512828672001273"/>
<DICH_DATA CI_END="1.6783621410610268" CI_START="0.07183388415131946" EFFECT_SIZE="0.3472222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.22488567454721484" LOG_CI_START="-1.1436706500656766" LOG_EFFECT_SIZE="-0.45939248775923086" ORDER="196" O_E="0.0" SE="0.8038967595406763" STUDY_ID="STD-Sood-2004" TOTAL_1="96" TOTAL_2="100" VAR="0.64625" WEIGHT="10.533596810038096"/>
<DICH_DATA CI_END="35.18128420461223" CI_START="0.4547872643575193" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.546311688242462" LOG_CI_START="-0.34219170558653705" LOG_EFFECT_SIZE="0.6020599913279624" ORDER="206" O_E="0.0" SE="1.1093162417777198" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="1.2305825242718447" WEIGHT="1.792174457263426"/>
<DICH_DATA CI_END="2.3311491265185786" CI_START="0.6518056109203711" EFFECT_SIZE="1.232662192393736" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="15" LOG_CI_END="0.3675700567691982" LOG_CI_START="-0.18588190532950108" LOG_EFFECT_SIZE="0.09084407571984857" ORDER="294" O_E="0.0" SE="0.32510042216817253" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="149" TOTAL_2="145" VAR="0.105690284493924" WEIGHT="27.248366748188822"/>
<DICH_DATA CI_END="3.9151132505156436" CI_START="0.6785801552279036" EFFECT_SIZE="1.629944219066937" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="8" LOG_CI_END="0.5927443291941278" LOG_CI_START="-0.16839884525240503" LOG_EFFECT_SIZE="0.21217274197086136" ORDER="1975" O_E="0.0" SE="0.4470992683893719" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.19989775579431163" WEIGHT="14.315617335588763"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2511626787580343" CI_END="1.1419157510570137" CI_START="0.2885738755723206" DF="2" EFFECT_SIZE="0.5740444702804824" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" I2="0.0" ID="CMP-001.16.02" LOG_CI_END="0.057634063453831874" LOG_CI_START="-0.5397429878936963" LOG_EFFECT_SIZE="-0.24105446221993226" MODIFIED="2013-11-12 00:04:20 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5349506846860594" P_Z="0.11370092762530538" STUDIES="3" TAU2="0.0" TOTAL_1="567" TOTAL_2="581" WEIGHT="37.59741597691962" Z="1.581775072202707">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="1.6241016374889075" CI_START="0.15393125296427607" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.2106132042274363" LOG_CI_START="-0.8126731955553987" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-12 00:04:20 +0000" MODIFIED_BY="[Empty name]" ORDER="143" O_E="0.0" SE="0.601083496581809" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.36130136986301364" WEIGHT="14.337395658107408"/>
<DICH_DATA CI_END="1.2799468141226171" CI_START="0.1953206158580667" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.10719192370024284" LOG_CI_START="-0.7092519150282052" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="200" O_E="0.0" SE="0.4795831523312719" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.22999999999999998" WEIGHT="21.50609348716111"/>
<DICH_DATA CI_END="22.90616884188946" CI_START="0.1901897392445943" EFFECT_SIZE="2.087227414330218" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3599524575891289" LOG_CI_START="-0.7208129169972202" LOG_EFFECT_SIZE="0.31956977029595435" ORDER="656" O_E="0.0" SE="1.222251880986741" STUDY_ID="STD-Mahomed-1998" TOTAL_1="321" TOTAL_2="335" VAR="1.4938996605756267" WEIGHT="1.7539268316510968"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.411728366924039" CI_END="1.6021209057307342" CI_START="0.5257586865659285" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9177848239739022" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="24" I2="9.332586521211992" I2_Q="100.0" ID="CMP-001.17" LOG_CI_END="0.20469528747251772" LOG_CI_START="-0.2792135431847046" LOG_EFFECT_SIZE="-0.037259127856093414" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.3531429936261802" P_Q="0.0" P_Z="0.7627897029585161" Q="2.3836263993255627E-33" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="259" TOTAL_2="273" WEIGHT="100.0" Z="0.30181945055284465">
<NAME>Puerperal endometritis</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.411728366924039" CI_END="1.6021209057307342" CI_START="0.5257586865659285" DF="4" EFFECT_SIZE="0.9177848239739022" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="24" I2="9.332586521211992" ID="CMP-001.17.01" LOG_CI_END="0.20469528747251772" LOG_CI_START="-0.2792135431847046" LOG_EFFECT_SIZE="-0.037259127856093414" MODIFIED="2013-11-24 15:42:33 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3531429936261802" P_Z="0.7627897029585161" STUDIES="5" TAU2="0.0" TOTAL_1="259" TOTAL_2="273" WEIGHT="100.0" Z="0.30181945055284465">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="2.6678725362794693" CI_START="0.0356759225370242" EFFECT_SIZE="0.30851063829787234" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.4261650763266527" LOG_CI_START="-1.4476247877281376" LOG_EFFECT_SIZE="-0.5107298557007426" ORDER="102" O_E="0.0" SE="1.1006734415552029" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="1.2114820249449745" WEIGHT="15.22500840863003"/>
<DICH_DATA CI_END="1.7338536014700268" CI_START="0.11879684143246712" EFFECT_SIZE="0.45384615384615384" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2390124248830673" LOG_CI_START="-0.9251951062124523" LOG_EFFECT_SIZE="-0.3430913406646926" ORDER="103" O_E="0.0" SE="0.6838612666857304" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="0.4676662320730117" WEIGHT="26.74434172672442"/>
<DICH_DATA CI_END="2.194357702204475" CI_START="0.36007049169620653" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.34130742334408676" LOG_CI_START="-0.4436124682388494" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="104" O_E="0.0" SE="0.46106582973194316" STUDY_ID="STD-Macri-1992" TOTAL_1="85" TOTAL_2="85" VAR="0.2125816993464052" WEIGHT="38.26498123977494"/>
<DICH_DATA CI_END="22.467812126325306" CI_START="0.21748564414389093" EFFECT_SIZE="2.210526315789474" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3515607836907813" LOG_CI_START="-0.6625694048006384" LOG_EFFECT_SIZE="0.34449568944507153" ORDER="105" O_E="0.0" SE="1.183110042825089" STUDY_ID="STD-Sadovsky-1989" TOTAL_1="19" TOTAL_2="21" VAR="1.399749373433584" WEIGHT="4.039081353087354"/>
<DICH_DATA CI_END="6.483810855527622" CI_START="0.6386293261742462" EFFECT_SIZE="2.0348837209302326" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.8118303372068946" LOG_CI_START="-0.19475114232144117" LOG_EFFECT_SIZE="0.30853959744272674" ORDER="106" O_E="0.0" SE="0.5912709437336274" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="0.3496013289036545" WEIGHT="15.726587271783249"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.17.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.088596095327178" CI_END="5.122753351768596" CI_START="0.6695635648760114" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.8520283464868232" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="36" I2="80.34821429591763" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.7095034461467755" LOG_CI_START="-0.17420818703961344" LOG_EFFECT_SIZE="0.26764762955358096" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.02408371528412312" P_Q="1.0" P_Z="0.23514118585483046" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.4428936088515885" TOTALS="SUB" TOTAL_1="112" TOTAL_2="117" WEIGHT="100.0" Z="1.1872192121791265">
<NAME>Oxytocin augmentation</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.088596095327178" CI_END="5.122753351768596" CI_START="0.6695635648760114" DF="1" EFFECT_SIZE="1.8520283464868232" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="36" I2="80.34821429591763" ID="CMP-001.18.01" LOG_CI_END="0.7095034461467755" LOG_CI_START="-0.17420818703961344" LOG_EFFECT_SIZE="0.26764762955358096" NO="1" P_CHI2="0.02408371528412312" P_Z="0.23514118585483046" STUDIES="2" TAU2="0.4428936088515885" TOTAL_1="112" TOTAL_2="117" WEIGHT="100.0" Z="1.1872192121791265">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="7.743937840320397" CI_START="1.3984143681487222" EFFECT_SIZE="3.2907801418439715" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.8889618582835251" LOG_CI_START="0.1456358775154768" LOG_EFFECT_SIZE="0.517298867899501" ORDER="108" O_E="0.0" SE="0.4366333606260989" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.19064869161164097" WEIGHT="42.53248240007243"/>
<DICH_DATA CI_END="1.6600775225071196" CI_START="0.8823205896762273" EFFECT_SIZE="1.2102564102564102" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="30" LOG_CI_END="0.22012836925146853" LOG_CI_START="-0.05437358603629144" LOG_EFFECT_SIZE="0.08287739160758854" ORDER="109" O_E="0.0" SE="0.16124380734262345" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="0.025999565406345067" WEIGHT="57.467517599927575"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.18.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7195321559973056" CI_START="0.6605592976025263" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0657640232108316" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.2354103017291935" LOG_CI_START="-0.18008819021350855" LOG_EFFECT_SIZE="0.027661055757842508" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Q="1.0" P_Z="0.7941217587682939" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="47" TOTAL_2="58" WEIGHT="100.0" Z="0.26096206898966035">
<NAME>Narcotic analgesic</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7195321559973056" CI_START="0.6605592976025263" DF="0" EFFECT_SIZE="1.0657640232108316" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" I2="0.0" ID="CMP-001.19.01" LOG_CI_END="0.2354103017291935" LOG_CI_START="-0.18008819021350855" LOG_EFFECT_SIZE="0.027661055757842508" NO="1" P_CHI2="1.0" P_Z="0.7941217587682939" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="58" WEIGHT="100.0" Z="0.26096206898966035">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.7195321559973056" CI_START="0.6605592976025263" EFFECT_SIZE="1.0657640232108316" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.2354103017291935" LOG_CI_START="-0.18008819021350855" LOG_EFFECT_SIZE="0.027661055757842508" ORDER="110" O_E="0.0" SE="0.24406587091784912" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.05956814934688819" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.19.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9940007559036834" CI_START="0.896311905640873" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3368794326241136" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="0.2997253186119139" LOG_CI_START="-0.04754083483905033" LOG_EFFECT_SIZE="0.12609224188643178" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="1.0" P_Z="0.15464203992005837" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="47" TOTAL_2="58" WEIGHT="100.0" Z="1.4233247344804432">
<NAME>Epidural analgesia</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9940007559036834" CI_START="0.896311905640873" DF="0" EFFECT_SIZE="1.3368794326241136" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" I2="0.0" ID="CMP-001.20.01" LOG_CI_END="0.2997253186119139" LOG_CI_START="-0.04754083483905033" LOG_EFFECT_SIZE="0.12609224188643178" NO="1" P_CHI2="1.0" P_Z="0.15464203992005837" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="58" WEIGHT="100.0" Z="1.4233247344804432">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="1.9940007559036832" CI_START="0.8963119056408732" EFFECT_SIZE="1.3368794326241136" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" LOG_CI_END="0.29972531861191387" LOG_CI_START="-0.04754083483905028" LOG_EFFECT_SIZE="0.12609224188643178" ORDER="111" O_E="0.0" SE="0.20398585753227952" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.04161023007317944" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.20.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.5424104255518625" CI_END="133.70340662526309" CI_START="-68.7764936093438" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="32.463456507959634" ESTIMABLE="YES" I2="35.166413333713834" I2_Q="0.0" ID="CMP-001.21" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.21425983776615265" P_Q="1.0" P_Z="0.5296900544005618" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="112" TOTAL_2="117" UNITS="" WEIGHT="100.00000000000001" Z="0.6284792267831083">
<NAME>First stage labour (minutes)</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5424104255518625" CI_END="133.70340662526309" CI_START="-68.7764936093438" DF="1" EFFECT_SIZE="32.463456507959634" ESTIMABLE="YES" I2="35.166413333713834" ID="CMP-001.21.01" NO="1" P_CHI2="0.21425983776615265" P_Z="0.5296900544005618" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="117" WEIGHT="100.00000000000001" Z="0.6284792267831083">
<NAME>Standard peripartum surveillance</NAME>
<CONT_DATA CI_END="114.10745065010605" CI_START="-109.907450650106" EFFECT_SIZE="2.1000000000000227" ESTIMABLE="YES" MEAN_1="401.5" MEAN_2="399.4" ORDER="112" SD_1="296.8" SD_2="284.1" SE="57.147708597508164" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" WEIGHT="81.69773567934925"/>
<CONT_DATA CI_END="404.6461868467582" CI_START="-68.64618684675821" EFFECT_SIZE="168.0" ESTIMABLE="YES" MEAN_1="884.0" MEAN_2="716.0" ORDER="113" SD_1="850.0" SD_2="452.0" SE="120.74006905912206" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" WEIGHT="18.302264320650764"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.21.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.812283047985935" CI_END="1.5510448527739824" CI_START="0.7606170265886868" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0861634886252778" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="56" I2="28.883403061710506" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="0.19062435682752285" LOG_CI_START="-0.11883395703284116" LOG_EFFECT_SIZE="0.035895199897340836" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.24508741902791997" P_Q="1.0" P_Z="0.6493346089183613" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1136" TOTAL_2="1150" WEIGHT="100.0" Z="0.45468675983544077">
<NAME>Instrumental vaginal delivery for fetal distress</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.812283047985935" CI_END="1.5510448527739824" CI_START="0.7606170265886868" DF="2" EFFECT_SIZE="1.0861634886252778" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="56" I2="28.883403061710506" ID="CMP-001.22.01" LOG_CI_END="0.19062435682752285" LOG_CI_START="-0.11883395703284116" LOG_EFFECT_SIZE="0.035895199897340836" NO="1" P_CHI2="0.24508741902791997" P_Z="0.6493346089183613" STUDIES="3" TAU2="0.0" TOTAL_1="1136" TOTAL_2="1150" WEIGHT="100.0" Z="0.45468675983544077">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="2.040411209555538" CI_START="0.029854002290432304" EFFECT_SIZE="0.24680851063829787" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.309717700780901" LOG_CI_START="-1.5249974381984992" LOG_EFFECT_SIZE="-0.607639868708799" ORDER="105" O_E="0.0" SE="1.07772075462291" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="1.1614820249449744" WEIGHT="8.078180601401293"/>
<DICH_DATA CI_END="2.0854365530527716" CI_START="0.26972769762598775" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.3191969814855042" LOG_CI_START="-0.5690744547021039" LOG_EFFECT_SIZE="-0.12493873660829995" ORDER="206" O_E="0.0" SE="0.5217750386311243" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.2722491909385113" WEIGHT="14.437599372717203"/>
<DICH_DATA CI_END="1.8305281132431217" CI_START="0.8349821246755302" EFFECT_SIZE="1.2363083164300204" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="43" LOG_CI_END="0.26257640316160863" LOG_CI_START="-0.07832282180726713" LOG_EFFECT_SIZE="0.09212679067717075" ORDER="1775" O_E="0.0" SE="0.20024589222509648" STUDY_ID="STD-Fraser-2005" TOTAL_1="986" TOTAL_2="989" VAR="0.040098417353024954" WEIGHT="77.48422002588151"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.22.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.939135668300745" CI_END="0.9142401154855762" CI_START="0.5033910844830354" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6783954032952904" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="95" I2="45.90055951612657" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="-0.03893972643785538" LOG_CI_START="-0.2980944804724174" LOG_EFFECT_SIZE="-0.1685171034551364" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.07360534753265924" P_Q="0.5001744160784964" P_Z="0.010804492472646489" Q="0.45456639082077105" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1021" TOTAL_2="1038" WEIGHT="100.00000000000001" Z="2.5489592485502244">
<NAME>Instrumental vaginal delivery</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.337270473782118" CI_END="1.037789971812943" CI_START="0.5118626813248912" DF="4" EFFECT_SIZE="0.7288387734089457" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="63" I2="36.881343213164484" ID="CMP-001.23.01" LOG_CI_END="0.016109469782164963" LOG_CI_START="-0.29084653266009786" LOG_EFFECT_SIZE="-0.1373685314389664" MODIFIED="2013-11-12 00:06:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1753370627360693" P_Z="0.07938925198995875" STUDIES="6" TAU2="0.0" TOTAL_1="455" TOTAL_2="459" WEIGHT="65.85415596964299" Z="1.7542408168426338">
<NAME>Standard peripartum surveillance</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Moodley-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.7717988570362735" CI_START="0.7589915133715326" EFFECT_SIZE="2.0930232558139537" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.7613111878404906" LOG_CI_START="-0.11976308012101372" LOG_EFFECT_SIZE="0.3207740538597384" ORDER="93" O_E="0.0" SE="0.5175473863885536" STUDY_ID="STD-Spong-1994" TOTAL_1="43" TOTAL_2="50" VAR="0.26785529715762274" WEIGHT="4.890758689663045"/>
<DICH_DATA CI_END="1.0719717962530997" CI_START="0.056824667529883875" EFFECT_SIZE="0.24680851063829787" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="0.030183359150800265" LOG_CI_START="-1.2454630965683982" LOG_EFFECT_SIZE="-0.607639868708799" ORDER="105" O_E="0.0" SE="0.7493210426412529" STUDY_ID="STD-Cialone-1994" TOTAL_1="47" TOTAL_2="58" VAR="0.5614820249449742" WEIGHT="9.469548718722997"/>
<DICH_DATA CI_END="1.8470220411444935" CI_START="0.2509156551672544" EFFECT_SIZE="0.6807692307692308" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.26647207805546236" LOG_CI_START="-0.6004722412734851" LOG_EFFECT_SIZE="-0.1670000816090113" ORDER="124" O_E="0.0" SE="0.5092473846174159" STUDY_ID="STD-Eriksen-1994" TOTAL_1="65" TOTAL_2="59" VAR="0.25933289873967835" WEIGHT="8.871608785900406"/>
<DICH_DATA CI_END="1.1351986513052224" CI_START="0.4056199178390894" EFFECT_SIZE="0.6785714285714286" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="28" LOG_CI_END="0.055071866477740664" LOG_CI_START="-0.3918807272565212" LOG_EFFECT_SIZE="-0.16840443038939024" ORDER="206" O_E="0.0" SE="0.2625421660105264" STUDY_ID="STD-Puertas-2001" TOTAL_1="103" TOTAL_2="103" VAR="0.0689283889334988" WEIGHT="29.61752471600597"/>
<DICH_DATA CI_END="1.6483277968538472" CI_START="0.30934296983586" EFFECT_SIZE="0.7140718562874252" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.217043582487634" LOG_CI_START="-0.5095597493584975" LOG_EFFECT_SIZE="-0.14625808343543173" ORDER="326" O_E="0.0" SE="0.4268103938709178" STUDY_ID="STD-Hofmeyr-1998a" TOTAL_1="167" TOTAL_2="159" VAR="0.182167112316248" WEIGHT="13.004715059350563"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.629955675641661" CI_END="1.0128809784351611" CI_START="0.33339393739340883" DF="2" EFFECT_SIZE="0.5811096088616904" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" I2="69.83388580789516" ID="CMP-001.23.02" LOG_CI_END="0.005558415305260695" LOG_CI_START="-0.47704230187012464" LOG_EFFECT_SIZE="-0.23574194328243198" MODIFIED="2013-11-12 00:06:11 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.036334941874866744" P_Z="0.05551600971625315" STUDIES="3" TAU2="0.0" TOTAL_1="566" TOTAL_2="579" WEIGHT="34.145844030357026" Z="1.914815714254878">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="1.156637728354676" CI_START="0.003842555309661819" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.06319735444605548" LOG_CI_START="-2.415379872557418" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-11-12 00:06:11 +0000" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="1.4559285322969884" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="2.119727891156463" WEIGHT="7.933265548930171"/>
<DICH_DATA CI_END="0.9542386659211578" CI_START="0.1336678390463607" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" LOG_CI_END="-0.0203429897305862" LOG_CI_START="-0.8739730729538522" LOG_EFFECT_SIZE="-0.4471580313422192" ORDER="200" O_E="0.0" SE="0.501426536422407" STUDY_ID="STD-Rathore-2002" TOTAL_1="100" TOTAL_2="100" VAR="0.25142857142857145" WEIGHT="14.808762358002985"/>
<DICH_DATA CI_END="2.7047926127377298" CI_START="0.5591854635176762" EFFECT_SIZE="1.2298295454545454" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.43213397162505157" LOG_CI_START="-0.25244412695500035" LOG_EFFECT_SIZE="0.0898449223350256" ORDER="653" O_E="0.0" SE="0.402124563822163" STUDY_ID="STD-Mahomed-1998" TOTAL_1="320" TOTAL_2="333" VAR="0.16170416482916486" WEIGHT="11.403816123423871"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.24" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-24 15:50:26 +0000" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Second stage labour (minutes)</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours amnioinf.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.24.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Standard peripartum surveillance</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.24.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Limited peripartum surveillance</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.3231119963017215" CI_START="0.04283601540099566" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.11764705882352941" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-001.25" LOG_CI_END="-0.4906469174669607" LOG_CI_START="-1.3681909339616247" LOG_EFFECT_SIZE="-0.9294189257142927" METHOD="MH" MODIFIED="2013-12-12 12:27:04 +0000" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="1.0" P_Q="1.0" P_Z="3.3008742194789656E-5" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="146" TOTAL_2="146" WEIGHT="100.0" Z="4.151649573605174">
<NAME>Respiratory Distress (post hoc)</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.25.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-12 00:08:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Standard peripartum surveillance</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.3231119963017215" CI_START="0.04283601540099566" DF="0" EFFECT_SIZE="0.11764705882352941" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="34" I2="0.0" ID="CMP-001.25.02" LOG_CI_END="-0.4906469174669607" LOG_CI_START="-1.3681909339616247" LOG_EFFECT_SIZE="-0.9294189257142927" MODIFIED="2013-11-12 00:08:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="3.3008742194789656E-5" STUDIES="1" TAU2="0.0" TOTAL_1="146" TOTAL_2="146" WEIGHT="100.0" Z="4.151649573605174">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="0.3231119963017215" CI_START="0.04283601540099566" EFFECT_SIZE="0.11764705882352941" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="34" LOG_CI_END="-0.4906469174669607" LOG_CI_START="-1.3681909339616247" LOG_EFFECT_SIZE="-0.9294189257142927" MODIFIED="2013-11-12 00:08:03 +0000" MODIFIED_BY="[Empty name]" ORDER="145" O_E="0.0" SE="0.515473699201905" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.265713134568896" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.910277782266072" CI_START="0.1709335758789751" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="0.28109652459513207" LOG_CI_START="-0.7671726219677211" LOG_EFFECT_SIZE="-0.24303804868629447" METHOD="MH" MODIFIED="2013-12-12 12:27:16 +0000" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="1.0" P_Q="1.0" P_Z="0.36344330519043855" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="146" TOTAL_2="146" WEIGHT="100.0" Z="0.9088235094200938">
<NAME>Mean maternal hospital stay (post hoc)</NAME>
<GROUP_LABEL_1>Amnioinfusion Group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.26.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-12 00:09:12 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Standard peripartum surveillance</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.910277782266072" CI_START="0.1709335758789751" DF="0" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-001.26.02" LOG_CI_END="0.28109652459513207" LOG_CI_START="-0.7671726219677211" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-11-12 00:08:54 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.36344330519043855" STUDIES="1" TAU2="0.0" TOTAL_1="146" TOTAL_2="146" WEIGHT="100.0" Z="0.9088235094200938">
<NAME>Limited peripartum surveillance</NAME>
<DICH_DATA CI_END="1.910277782266072" CI_START="0.1709335758789751" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.28109652459513207" LOG_CI_START="-0.7671726219677211" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-11-12 00:08:54 +0000" MODIFIED_BY="[Empty name]" ORDER="146" O_E="0.0" SE="0.6157584857069828" STUDY_ID="STD-Choudhary-2010" TOTAL_1="146" TOTAL_2="146" VAR="0.37915851272015655" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-01-17 11:22:24 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-01-17 11:22:24 +0000" MODIFIED_BY="Leanne V Jones" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEZCAMAAABxStv9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAAgGUlEQVR42u1dfXAcZ3l/ZGu/7k6625U0sTBjbEvQP8wfQJo0diwD
pziJSyHATKYZQgJkpqKBDDTTDpC0Q8N0BodAmElTGHDTSQOEwoShOAFsEvuAnM2H0nGHac0w4WQL
B+ucStqVLJ327vYk9f3ar/uQTtLd+eQ8P3/c7rvv8z7v7j33vs/uvb/7ASAQTUMH6HgREE2CtQWv
AaJ5wPBCYHghMLwQCAwvBIYXAsMLgcDwQlwxdOIlaCwsvASBJ/UYXjgfNLrjJZwcEfhZQ2B4IRAY
XggMLwSG16aB2XJDRJPCK0kgR7JVD12pc9tew7ceW6WHNQyT1WsvGxhGTR+9UqnUJWmgrc5tL+lV
tbHJ/sP6DN0zLdsv2TjatWJyNM6XAPo0WSEf52RClcnLaEShj3CdqBx1aKEiP2mrUppVtyVFTdNj
UsyhNVU9yYcG8s+MKFGTGSg2OabSJkUZsFYTpJIT463GD8m2104yroo+JNkfWs5ruX6fsXvAlhWN
+ZapDXhtOeqwbxhRIn4fmF+NtQTQq8kqOa+0LKu9IC0MYBy1IvfaLQHMRYvRHNlemoiRl6SaXSQ7
PUeLcg8tzJ78WP/E5WFWuztWeOEmcizj0GPJn0wEBoEds4XjOjOYiQO8Uxu3/TKA6+TsEm3VKiq0
VXj6ZLfXDmydgPlocSZHRhk2zvQc5eXg+r3/FPP9PPU9w/vF2qJbCe03C66hrhTUHV4fmN+LGV47
ZxYjCwDDseIL8wCnihhHzQ4vmnuVZgDyU2DeSPbHDfpSyhjTZKfwNhjLk9dpY2jvOUPbzywUJ72n
QI71g0lenD1G4MuEkgRDGmuFVi6N9dt+GYB2jrcqMUs4bwwNee1AxgB7CrQb3abuEL7Pu34X9xDf
Re5btMC2rAL1NJX3+jAGmZLXBwrL6Oe1bY2dpFTo3UOq7ylhHNVAo5hCyRTYxmUyek3vLi3tTdF9
+k8ushe6RzZFIftHAipx51Pdk2w6JJ9/yfFq0hde6O6l3JSaDxQjR7xK8vEqJtO7Fxd5H4SxUgj4
pX2ivrumAjYBawgYBjoNgZbMXYulfSmY3uF0jPfz/riw8DvHkt6Mi6Epf0v+/yBMXQ5Erwk0tzlt
VrnZl3IPR+bIm0puCsgbfoDXFI8FTvNCgdPM2C/7Bq9LLY97lU75Jh+ESf/m8BTxvRz0O2Ry3/PB
JoV1R6CbtNNDoR47YH5I3FrKL9IZNXdJ+yDp8FM4TLUg95p5gmTLJ1+we/yi/AD00nlwEAbU8upq
2niWJGZqH+hRgJc0VvO0bdLYJ2PZk5pXs3Mwq7Eymzdi74YekkCpDpyI+M3xdihOTtkFLyrVct+/
OksKbeZbybo2pC2dtPWrgT6VRSTtgwaDvw71OA7ad9jG0u8yN/EzeI6c8llcdtKS1H72oAmzB/oD
bb5UVDtozlWQi9PltbsOymwms+U8CZ7xXoXWnIlv+3d68x+X7/UHwZmFXeQNTyVkfY6PuQWF+phO
SI9GvUqiHdaPLtaHzm1QzbdMMqkug/t+o2tD2rqBtPVT+zIJMvka9gCiR7bDDyFm1T7eUuQe5iB2
UBmeBdgvYxw1OfdqVAJX90MQ216vF/POb/U0stfOe542MPeqnnttBa19TnBisb56f/dfWxd//q/r
9fKF6dwvGtnrePZzgb18x+YdaRqEJS1wMfA3JhoKXAwdWAxtYVbarEuLAFyQg8DwQmB4IRAYXohW
AlN7vHNs4u0NhhfOB40+FaTRIvCzhsDwQiAwvBAYXggMr2bDvPJNI7Fs84aXkaQrtZI16bXbN0a8
Xcn2s/zFfmwVm8+uiUYbszGM2ie8iqO9Kx5fmcO6IfyWj0363tXrrYFGe0HH0a5twst0rJL3dpic
qepolAeb1WT1hMthNSOyZnpsXGD0XNvn48Y1Oe3aibI+TVF41aSujNi2KtkBpi2tn+QDzxnlejAU
WbMZHzfCO2NGZbqV1RTb59/Kgpcrc/4t9EVYnzxftixpaTBkpNHWQstXqz4UW1T/XoJd5+nfryjz
XV8qQlyeiZfgt2e2dH2jdH5Xih55uCvXTY7suvjK13JsDesWVkeXclGtALuyFw4ll4SdbkHXJ34B
S7G5+S2LrOGLf/xYZ+LCn393ET79AsTIMV6fNk3w/R8/CUuRXPfBDPzHT792+dEO5m8BUn/SAV+K
RToWRReIrwjz9Qr1RbDrlQtHPstqC1/RyMLcMyU48ZTjn9/mXa1aiXWeSmC1astHryMyyB4t0MlA
hrw1xXNSHuCYBtY+94g6xo4INi7BB1idwhic85mz3I5yYR9n/F2X7jptTO09ZwyRvcclsB736nN8
YA9Ap2lnjhH/14PGWUQa5+h+9Nxkwa0X9gVsa5LXFr6+WLJtSqN1cJiqGaCtXV5p3r4McDprVDBV
yaGdHz6yL7UShxXKikP0Wqe3dKCQClBxa9FxKY3WfP3icnyyjEabdlan0fIC4Wv0HSVI7WfcWg8W
fufYHBptXdB+mUqltp4Ve5Sp2uESErdv+dacV08cgWABcE5sRRlnwMZh6tkKd6dCdFz/uYOxkI1d
DtJo6ZbjMhyFbQX3t9ftk/B1/cKl6DA+x2ij1J6yVEE9I/YeOQuDEoC02yHFS1KGrt9Ij9IjlMMq
BQ15HXUQdqvlZZxNWwrxd9051vG4tTRg2Cwmk0nwkMHuAqRRMMR0x3m78oCjuPU+EfLFnmjAm/gv
UAhfmmFMkMFYw2Un7RJepQz5L/Np8YG/6xYlfwHg94XYCwDR+c/Q91xhCdSFHnbEB69zvjDiTJeV
TSekd5MQmv1G//cr3E0nRvI+kVtiPw3wg2sAXrKl3Azx8k7lA4KZG1cob9eyPz7j1jtckJww9zej
2Xw5l/D1vC0nSNVrjmIctUnu1QYw+9PXN7I9J5a9Kmi0zci9Xos8R6OQa2Rzj30umHxheL3Ww6up
wMXQSKNtxaVFAC7IQWB4ITC8EAgML0Qrgak93jk28fYGw+u1+YFdbGLbyzg5IjD3QmB4IRAYXggM
LwSG19UHc5V9xBUOL6qHRgUSK9ixteiy+nKVwrTcvS7noZf6Koe27iyrc+faaLT4LXbTR69U6tJz
N/OtikPVxot8NZG64ZOXN9KFdVsWKvfXQKO18jjaNX9yNG5a9Mar+CGZa70aokBnbFhTUxP8sz8g
SZA0FG00qCmb3P+PAe1YJgMrtGvTEVlNeO32afKTnh2FowqVWFEvLSkap4K72riuf0WMNKMROQFu
G5Q062ri0hqCRkvq0P4J29p+JAlptC3IvXR/UTs8ffKbAD3HLrlj1OJEbB7gu8rEEt8vUpWnUla9
DqDTKh5jKrJPUxVYVzt26wSVgT0htGtv/klRs7127efi9/p2BE9MaHxL1PtmrPD8+1nBXwptXOFf
y4qn1depl4SeLWmD+b3A/L5THbddNdrr1CLtn9DVXcGP/BDGUZPDiyRfb/XTqfPGUIbMMW82xkXB
uGHuB/geV5EluOFloGzXMUr0keCAUJElyAvtWLrna9faQ2Dd6LVbfNtk3rcjuNYQGrKi3rcdew+n
6v6Lr41Lmrk/4/pXM66erWjjjh6mS3vDWL+nRqtmgPaPOBVM3lp+Xv4UxlENNGgxNGWYZnflAwRU
8o+yS0MFQpsWwNWepa+VTNeAdqz4N3rQlZetJk7r24h6TqK4pWuKTWd9TqU2ru8/TKM9Xaig0UpO
VTXaMj9ygEpp4XeOy02h0fYvVd7wj4Zj2SOmbjHZYXNrOdP1dLl2LMOBDjmQ9J8KsmdZhuU2K+pJ
uVep1ixBfHkqFhiqPf9bfT1bn0ZbcIm5flfCl6eGH7MDh6nm514npLIC5QzcFCrI74ad/MdmOilP
excMyIzp+qKfteX/t4puLSxzhq2AfKZPDdnl4KwSrEe1Zu9mBSWuSytgD8BO0QRXyS3wNtImKNMs
d3xkMKuyfRo8Z2EgH+pGDT9nH8E4anruJb8nUlY2/V5la6jgpaKyhTv8MuXKdijFccaCPewTqUuH
qujWQvRPtwXU0LVHL1shu5+pt04H63Xp8vBdrGC26/YtYf8iFyyodKuUkGkbyjaYfoNsk/5/bGGX
xfbpyH6LUgiv3qrhZz+m9k3Ovep/fJFfYNPm9stSMnV1XEKn+6KBuVf13Kul4dWd79hymU+hujOv
FK6O8FruCdFoMbyWrxDPkaXDwnHls/JNOwGEH9qXcEr0gYuhGwz8ArJJd44IBIYXAsMLgeGFQGBq
31ogjRZptPiBbSZQjRaBuRcCwwuBwPBCYHghMLzqhtmgOoirI7ySyaRECVx1c2E5DGW5avnrAla1
zLev3LsNyNIKUyNa5Zhdo8f1NVneqccMDKO6Rq9U6lWVr1GviwsrkJupvtZ8X8CqlvneJp+eufBK
ldJ4dCOr48vPZe8CjsF1To6Gdbc3XiXUEab1OuJyYROKYlOdWPUE/wBzLdnkje9iFvZIdBqg7z7O
W02MCDIq03dl5jZTfk0zzVlInlCFPqwty/fxBfh99yncVvhRXhTDxYtcszY6EuUCtcTmVmozHZWp
T96WZxd1FWYJzsgGcSxHHK+cmCf3v4Wq3fK9EUjqI4qRHqHCtr2aMqKzOrQjDvs/0F5Wi3A1WlGP
a9peL5/BOKoz9zrxjLe5PHFXHOAB+WF37ftSdoYU7JQnjvP9HWpB2eGSTkF9WDoMMPedYpQOgB0P
i/LDSrf4jkDNqmTr888XNVIPjk/MDjPbeLR47UFWYe47BWbL/ehq1hXQ+4ssZVf3zBxRdtIuTxCb
49Rml1yUvLY8u5nCV3a653DbqzRsLymdfnnHBPW64ytF0nfaTxJAD8/k3/XwLLGdf76wl1JmlyYo
+TbxWPdCqL1HL0Z2sA1RLxcpmu8HePW9GEf1hBdJvj4f4sJSPdcxw/0abZxRWovnjMN838nAmC/E
ahnnuCYsJazCmJuQfP3cpKDblIyMCnBsCCzq40FDaMfKD6Vv4zVcW+5HyxgPijY43/YOCcw7gDFs
JW5D9WIf99sSdhJ8xCO2OTbr2Zjil/OeObfxvtM9y9Bu4Lb5IfgIb4kyZ0u3064H2jtsTPHzFfU6
TcM+RlI5VKOtheBae8qt6J3PV6W++gUuAxbCWrJix+lzhCZswAoCrFRz58i/7AtWcBJOx3g/e8s9
PdnqfsBjujp6saNrqoo2bbmurGDyMvarX14pNSv+OX2l0r4qdN20Ez5fUc/cvgTdk5uSRttMrKBG
O3V3WcGHyzVZt3AGKpQrxpKdDzPealgT1td35azU7R3/9GKogpS79KNdPOMO2fp+yCu1FExXZjN/
6UdkGh00qzzZELqyHB8SdN3y8kq1W4bu5cnzEKwTtsu6vFpRz7Czkffh05U15F6Jp8uv+G7YGSpQ
dsMDp/ibfBQGfOrsTjjTHdKEFdqvA32KW+Eo2VqS7esCwedQLqrC+d2lE0E9WeUZeEBsPgADNhOM
dX8lRdh0a+V6seDpynI8PQh0fciAUlZe1ncXi1P2o/5e51FK1w3YDcJZO1jvkG10PEWKZYyj+nIv
yZkpq3DYGQlzYccLyhP8c3/h43LBV4zdKr2X5EqzBzxNWK7pquXfJ5r8vnLfONWc3RZ4TkTqUC7q
SbYz+/agnuz4/eoTYvPflKLFOK/5MV7QpSvU5nBfuV4seLqyHEfp4hBDprVC5bTvYbVbhpNd/U/4
ezP3zkVCdhHtFitY70FDykVJxySMozpyr7ph2HblM8fVSLHrZ81ugG9rvm6u6XTd0QMTm49G26Lc
a+3htfzRp1wubBAjR1axWz9rdiN8W/vIJ4OJdzMQm9QAw6tR4YVYEbgYGtVoW3FpEYALchAYXggM
LwQCwwvRSmBqj3eOTby9wfDaVPPBpphskEaLwNwLgeGFQGB4ITC8EBheTYB5hf2gGm2zsP4VE0mA
U1u6Jv1F6d6B1EortOzuT36pvEyzW3Oywo/uzIt+1vBP9qudgSgrP1T2u/b4YKLUEMmqVOqSNse3
Kg7Vtvrk5YroajqZNuzHtP+wiv+9a1KjLdk42jXl42BYS+5AlkwwzVYnwvReRQFTpFW+zkm3TpQp
v2YY6daJKIKRKrRf+w7JtluHEmLlJ9Pc3tOc7dVkypNMy7La6zJYKdeWUmttWTqU9o4ldUUxnuT6
s/w4Z9gmOX//GbnH7SfxFxNqtNyPow4bvhqt4N0ydi7FqCbUaElfhr2+SAuoRtuc0dbw12lyzVZd
dfVeYXni5DBAj5Qd4fs9R4tyj0u61ZWCusMfDlJg/zKXcOtQQuzJj72b21tFhfM7cmYxsgAwHCu+
MM8YrBoJnx2zhePkfY7/2Pn+Qe8YmNlo/m9Yf8RxyrBNuL7vl71+9mTcPgk/Ce03C269pOgjZ+dS
XHdxyuvLf9uev74ixlHjwyuZTL7FNxfMU0/vVbBwC+eMl/h+QejM8gllDDIh8qlzTir4WrRch5bZ
S0wlliZtGhOWlQrpPaRKp2NkbMaiGCIh3jls23nvGFiGeQPXkBXHKcP2RtfV4stePwv9buvCT2ls
qqKP4y7hl/Jt/b7s8/y9jDovTUjtKel2rrAK6dblsVYn3VZh25Zp0fqas+auRUpdnd7BWLfm6xc/
9J+T7mGytxyfdI9Vmod4sbSPbj8hqEZ7qlihRhtg2gZ7F+4LY/xiat/g1J5gqvyHjDp87qvAqHub
fzrIeaU7Q+I4g1CYrdCi9fVit4NM+bc9uUvaB8m0vJB95jLnuBbZ3tcve8cCOB2SuuUYMr1++q2L
rY4yNdqhkKXjnkG4LyY+PGzOx0HfWlaQ5yqvPpSbQeekW2UwoDMraTD4a/KmGuZNPKrk3Y4CoA6W
a9GqDpzg3Nml32VoXTVtZEkWrxkGJVuSccNW2d4dJCy1tPFcOmQujkMwht+jef1Us4yZS8qFn18N
UOYsr/cI72MAcdAUty+UCyz8ncVlJ03JveT8z8vKXiqqYWr9tCMLEuB0IaAzm+qRbTLVxHL9NEDl
bWDlYyfK6nCrhPQo/wW4yD39tLOxg0r8JMDzNmOwphKyPkf2/kyOxwCiB5Xh2fBDBH5cQGYqsw+p
Xj+n38iYuaRc+PmpfTni1tvbI+fDDyFm1b5xthG9p59OAMLffmRpNz73qn+IK+ba6pQptbaR7U1v
D9FoMfdqIc9x+aZ052ybkeR1s6ORzcWk4ApVDC+k0TYRuBgaabStuLQIwAU5CAwvBIYXAoHhhWgl
MLXHO8cm3t5geF2R+eCqnjSQRovA3AuB4YVAYHghMLwQGF6thrmuQ2s1MYOHkFjWKGwFrZXukufX
XPGfaxMlcqMbbM3YWvTLHyu5dUm71ToqysoPxUILjvJ1LfbpuJpjaskLqXz7j14rcGx/u8HWzIUL
gfJ9fCvF2l0DjfaCjqNd+0yOybjG+LGa4M3GKDP1hKI8aXNN2bTLm+XMVsZxjUpumagPLv3W0Si3
1tSUyCjlz8qK0VumSUuO0afI6YhEalKTLNfDJdgtG345ay+uiXaTPqeX95eiL6Jx7m+fxnRzDVnS
0mAouzGO2ij3ujibpETaHFWYlYudlJl6PHvi3v4JWg6HLsmcq9pjFeUHOMc14wgurVtfDCMp0kzs
BoAdWkGltualmXyxTJN2x1cZY/bgtBPhDNl7zKL2Lh6srwbKGXl260XRLvcl9Xj9pSj8Mca/75iL
FmbmAeYjjnkQ4IcoF9pG4XXe0IaoqK0k9GQpM/VBY2jfOVYOF4yxO/ibKYH1ONu6o5/r0Pr1PTjn
po4xXVzGePV1ZX0NWec2xpjNcxYuwTENLL5FtWr9copMYNW864v3l/d8ktOO8lNAnXyxxNi7ezC8
aueYLV1emSyXeq0QhfW5qmGO6+lCZf2VmgFXQ1YwZkcPLgqhWXPnh4/s87Rq/fJkmYhuVRqtUKPl
urmj7yhBan9YU8vC7xwbRqPdAE57vNmKRwSixOe4+jq0fn0z2EyltqyvIbuFm7y9QxaMtO1bvjXn
P4Hwy8tR2bc+10scmG7u9QuXosP4HKMdP0bSbkdlvNlyPVmuHQuMQatHyRg0Ckqfq0Mr6qfTJk2s
TjkgDfQeIo2dhcEwHcnXkLUHmJzuYmemk8fMkpQR60Q6B4Plp70w4Tq6lX1bgDfxrgnNXc0wJih7
F5edtF14/b4Qe4HyZkfK9WQNl0k7nRjJk6BS9sP5BVeHVtS/PMx0a6UYWLfPka0Ltyhl2rJWXBYa
slZRpXVP5BjzVf4MROc/IzIsqlXrlz/S74U+09E9X9G3jGaPs43ZbzD/52w5QapecxTjqD1yr7qy
s5bBfN2L12+8lTI1Wsy9ArlXi5/a1/HUYrF1vr4w99bjG2/lzc98OTgr41P7wFN7pNE2GLgYGmm0
rbi0CMAFOQgMLwSGFwKB4YVoJTC1xzvHJt7eYHi1y3xw9cwjSKNFYO6FwPBCIDC8EBheCAyvKwaz
BRYbs0O0c3g5MXl42WfGJssOb68sWgV31rB4MrYuu2T1fsXwW+xNEV7xzkvPJK6reXhljdhqKFS3
MO9NrctOoPyQlcfRbjOEV+mcYcyqlL8qxYJMWnBUxdWIVR0Y1QIatcmE4tZPGoo2GmC/HhJ02GRc
lbguboIPPLvl69dlR/oh1GjTEVlNANiSovWCJKEa7WYIL3mn0UdHjp4LjmDSdlrFY2Trq1qXqxEr
/xxult1yimezXv1SViVjX6dcPEq/i9j6dModaCYuc13cwyJKXl2fHXx14jj3evNPilRquTtWeH6O
9OkhjKNNEF7WSH5WPQVwR4+rEatKcIBsfcrXiH31WSj90C2neLPh1Z82xij5aAy6KZ/HZ8SeZ8Ta
wjnjWhFe/7M+O9hrDPF+2EOMias46T2kgZc/hXFUA222GNocsPMua7aqRqzZXxg5EtCoZSRXrz7V
b6zKtPWFcsEj1q7Zzmf4Cu6toxe2dE3xBr3PCH7n2A402ipQTDCspRBrljNpfQYiGFL8O0GGLYVb
3wRza1VmLv8geeWu5Oxa7Xw12gOceyvNvxqZBzA7cJjaBJ8ZZZdpJkj6o0yDIVizDrxItjoHsodc
jdgfXNvplbt2ov5OGJDJZKbBGTFxDgbjRdnt6uJS9ux67CAOZzmNdnmScW9V23j2boCzj2AcbYLw
Gv+rbducn5Fc6A3yAlegnU7Ih5lG7M5fA/w104jtPpXxygXc+luU4jgZmnvl28SSkG9vC7Q+7chH
+JZ0z/rs4GfqrZxXG33PNlrWpcvDdwHsx9R+k+ReG8HqBFyhi2u+Lsh7rd+uBpzui41Qo70qc6+r
KLyUwoqHY85y5xjn+RuF3LrsqmO5JziXYnihGm0zn67gJUAabQsuLQJwQQ4CwwuB4YVAYHghWglM
7fHOsYm3NxheLZgPXmNTBNJoEZh7ITC8EAgMLwSGFwLD67UB5JZheDUBaVXRqHpjLc5uDSotAsOr
Djg3xQrRm/pW1MClSOGlwvBaOxLRKZiK/APn0dojMtO1vZXq2iYTXL4qq0W4Im2vduuIDmAoMqU8
IjC8VkcpQ/77v09xzu41D88yXdvjTNe2Y4LVePRiZAfbmH/++N4cQC5S1N6PF64GcLVqOLVyiZCU
5/g9g76oeaD/6B6t8BNJcB1F9eh8T1DCtupi6Nfal0LtyXNsA/yC3jG6vEUeNfuSyeSitwcSwDJP
0xIxKs30SiTX34cXDifHesAokIMh3qKva8tzLzD5NetenvwjjTo7G3kfXjgMr3qg5XqhN3ctwCnv
d8Z8XVuGQTjLM/nFKZv+tMkh2+h4Ci8chlc9mOyaV3Jd+0n6td8teimuCF1bhoh2C1/SdbKr/wny
8qAh5aJ44TC1bw0wtcfUHtGqXBYvQYOxVFcRhhdiPcBcA1N7BIYXAsMLgcDwQmB4ITC8EAgMLwSG
FwLDC7EmWFfYvr0awPBC4OiFwPBCIMqA673aLPe6GoA/PN6Ca7vO8Nzox70NGsDJEYG5FwLDC4HA
1B5xJe5zMLVvxr2jzl70+tNkz4a9rsnUT6f19fn203G97h7wQ36vaznF8Gp4dPGLzP7WHV3uG6OL
vfpNQzes6/Htm1tQbw+ssjOt6RRzrzZ6mLH+RwKW3rDPRUO94ejV5IFsPfPqOkyt8gdua/et190D
ve4TxvBq1oBk0b9W3XdO7txIXtdqCp7lOn1XtLOuHlSzwfBq5oQnMpM1zpHrMNU37HujPahug7lX
e8yN1ganto3Py/rGs7lKGwyvNorE9X8d3qgv0hv9hTw+Vm18qASfEtR3eQNPndZqGna6gQb0tXS+
2nOvKjYWhheiiZ80nBwRTQSGFwLDC4HhhUBgeCEwvBBXBQJfCiHHBdEg6FXCC5+AIRoDCydHBOZe
CAwvBALDC4Hhhbi60Lly5r/57imx720fXuVj2tImPqPSZup7R3h3GSdHBALDC9Hm4WXVebSinmX5
pVfoiyerqnNrU5yP1/daXWrnS98oItpqP0ew2XLVNjwffRNe+rVPjpYlPkneJ8Nif8SR4CeO17TK
Pkmiml+7pcOY6zx4Nu6L1dbnw31BqP/tfunXPHpV+yUCSw8fCe67v2rhESzDP3zR8vjS/b+VnfH7
2p7nQ/2EnLf7pV/n5Khb4k/ZuKtXjMkVY7N+RcdrvapvPfzaXudjlV35yg6276Vv4I8A6IEfqVr9
culWW2RiK+S97XI+dTBs2/bSdzb2OtBPzyo/TWAFfqTsyseXHurTpj2fdu3qep976ex3VPT1PLkI
3BS07OpbFROHtcpTi3Y9H2sjD41afuk713hieu2R1T/C4y5cU7e8g/xISyfHMm/BztAt0ae2P5+q
/WznSx/4EQD/013O3V7aTF8Ll3/nuJn6Xv6do77aw6w2PQ+9xpuBaO/3DTbZKgoMr82ETbdAp3p4
LW3it6C0ifu+fLV9Hjqvig8J9r1NgQtyEBheCAwvBALDC4HhhcDwQiBWRvDBBP4CE6J54YW/v4TA
yRGB4YVAYHghMLwQGF4IBIYXAsMLgUAgVsf/A5unpGh8bHtRAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-01-17 11:22:24 +0000" MODIFIED_BY="Leanne V Jones" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWQAAAL5CAIAAAAIacl3AAAnM0lEQVR42u3dvY4dR3rG8QEWMBxM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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-10-31 11:35:51 +0000" MODIFIED_BY="[Empty name]"/>
<EXTENSIONS/>
</COCHRANE_REVIEW>